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xABSTRACT
Ion channels are a large class of integral membrane proteins that allow for the
diffusion of ions across a cellular membrane and are found in all forms of life.
Pentameric ligand-gated ion channels (pLGICs) comprise a large family of proteins
that include the nicotinic acetylcholine receptor (nAChR) and the γ-aminobutyric
acid (GABA) receptor. These ion channels are responsible for the fast synaptic
transmission that occurs in humans and as a result are of fundamental biological
importance. pLGICs bind ligands (neurotransmitters), and upon ligand-binding
undergo activation. The activation event causes an ion channel to enter a new
physical state that is able to conduct ions. Ion channels allow for the flux of ions
across the membrane through a pore that is formed upon ion channel activation.
For pLGICs to function properly both ligand-binding and ion channel activation
must occur. The ligand-binding event has been studied extensively over the past few
decades, and a detailed mechanism of binding has emerged. During activation the
ion channel must undergo structural rearrangements that allow the protein to enter
a conformation in which ions can flow through. Despite this great and ubiquitous
importance, a fundamental understanding of the ion channel activation mechanism
and kinetics, as well as concomitant structural arrangements, remains elusive.
This dissertation describes efforts that have been made to temporally control the
activation of ligand-gated ion channels. Temporal control of ion channel activation
provides a means by which to activate ion channels when desired. The majority of
this work examines the use of light to activate ion channels. Several photocages
were examined in this thesis; photocages are molecules that release a ligand under
irradiation, and, for the work described here, the released ligand then activates the
ion channel. First, a new water-soluble photoacid was developed for the activation
of proton-sensitive ion channels. Activation of acid-sensing ion channels, ASIC2a
and GLIC, was observed only upon irradiation. Next, a variety of Ru2+ photocages
were also developed for the release of amine ligands. The Ru2+ systems interacted
in a deleterious manner with a representative subset of biologically essential ion
channels. The rapid mixing of ion channels with agonist was also examined. A
detection system was built to monitor ion channels activation in the rapid mixing
experiments. I have shown that liposomes, and functionally-reconstituted ELIC,
are not destroyed during the mixing process. The work presented here provides the
means to deliver agonist to ligand-gated ion channels in a controlled fashion.
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PREFACE
Dear Reader,
The work I carried out in graduate school started with a very interesting idea: to
monitor how ion channels open. The goal is to observe the physical motion of
an ion channel under activation; more specifically, I wanted to monitor activation
of a pentameric ligand-gated ion channel (pLGICs). pLGICs are a large family
of receptors that include the biologically important nicotinic-acetylcholine receptor
(among others). Ligand binding results in the activation of the ion channel allowing
ions to diffuse across the cell membrane through the channel. The Dougherty group
has studied the binding event of pLGIC receptors for decades, but the gating event
was less well characterized. I wanted to look at the activation of pLGICs using
time-resolved fluorescence energy transfer (TR-FET), a technique that had been
developed in the Gray group to monitor conformational changes during protein
folding (Figure 0.1). Easy, right? All I had to do was express, label, reconstitute,
and trigger ion channel activation and then boom goes the dynamite!!!
Figure 0.1: A cartoon scheme outlining the motivation for this thesis. pLGICs (gray, bottom) are
labeled with a donor (blue star) and acceptor (red star). Without agonist bound, the ion channel is
closed. A photocage (orange semicircle) is bound to a protected agonist (green wedge) in solution,
and the ion channels are closed. Upon irradiation (lightning bolt) the photocage releases the agonist,
the agonist binds the ion channel (bottom middle), and the photoproduct (orange semicircle) remains
in solution. After some time, activation occurs (bottom right) resulting in a conformational change in
the ion channel. Ion flux can occur and the fluorescence energy transfer between donor and acceptor
changes. The conformational change is read out as a change in donor lifetime upon activation,
allowing for the distance change to be quantified.
At the start of my research, the project seemed attainable for several reasons. The
technology for expression and purification of pLGICs existed. Prokaryotic pLGICs
xii
had been recently discovered, which allowed for overexpression of protein in E.coli.
This resulted in the first high resolution crystal structures of pLGICs, and meant I
would be able to obtain enough protein with which to perform experiments. New
andmore efficient bioorthogonal labeling techniques were being developedmeaning
I could label the ion channel with the necessary two fluorophores that are needed
for TR-FET. I quickly realized that the main hurdle, assuming that I could adapt
the other protocols as needed, was the ability to control the activation of the ion
channels. TR-FET measurements are ensemble measurements; to get specifics of
ion channel gating, one has to know what stage of gating the ion channel is in. No
agonist results in a situation where all the channels are closed; if ligand is present in
excess, some channels would be open, some would be desensitized, and some might
be in any number of hypothesized states that ion channels can exist in. The goal
is to watch the movements from closed to open and observe any intermediates in
between, which is not possible without precise knowledge of the timepoint at which
activation occurs.
This need to control the activation of ion channels drove my research at Caltech and
gives the title to my thesis. I knew that none of the most important experiments
that were designed to monitor conformational changes could be done if I could not
activate ion channels with precise control. I brushed aside the other requirements of
the project with the hubris that only exists in a new graduate student. In hindsight,
this was a terrible idea, because if I had developed a method of activation, I would
still need to express, purify, and functionally reconstitute the ion channels. None
of those tasks are trivial, as I would learn later. Regardless, I would ignore those
requirements of the project in an attempt to develop methods to trigger activation of
ligand-gated ion channels.
In the brain, agonists are delivered into a bulk solution, diffuse to the ion channel,
bind, and then activate the channel. For monitoring the activation of ion channels I
need to control the delivery of ligand precisely; the delivery also needs to occur faster
than the activation process. Ideally delivery of ligand would occur on the single
millisecond timescale, ruling out simple addition of ligand to a solution. Mixing
of two solutions can take place faster than a millisecond, and will be discussed in
Chapter 4. The main focus of this thesis is use of light to trigger ligand delivery.
This is in part because both the Gray and Dougherty groups have expertise in
photochemistry. Also the color, intensity, length of exposure, and arrival time
of light can be precisely controlled. Photochemical cages have also been used
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previously in biology and chemistry; the idea was to adapt a previous cage for the
activation of pLGICs. What could go wrong?
Any photochemical trigger used for ion channel activation must be compatible with
the ion channel environment. Ion channels are integral membrane proteins. This
requires that any compound used must be water soluble; I am not able to work in
acetonitrile, or any other organic solvents. It would also be useful if the compound
is stable to dioxygen, but this is not a strict requirement. Working in an inert
environment is possible, but O2 sensitivity limits the generic applicability of any
photochemical trigger developed. It would be nice, after all, if any new photocage
that is developed can be used for other applications. Activation by visible light is also
preferred; UV irradiation can result in damage to proteins (sunburns come to mind)
and should be avoided if possible. There aremany established photolabile protecting
groups that fit these requirements, and adaptation of some will be discussed below.
The compatibility of the photocage with pLGICs must also be examined. For the
photocage to be useful it must not perturb the ion channel in any way. Most of my
research at Caltech dealt with examining the biocompatability of various photocages.
The photocage, in the dark, must not activate the ion channel. The phototriggered
release of the ligand must occur with high yield and faster than the timescale of
activation. Ion channel activation, monitored by single-channel electrophysiology,
appears as a step function with the time resolution of one millisecond. If the
yield of ligand release is poor, all the ion channels will not be activated, which
will complicate the TR-FET analysis. Likewise, if the ligands are released on the
timescale of activation, the ligand-binding event and the ion channel gating event
will be convoluted. After the ligand is released, the photocage minus the ligand (the
photoproduct), will still exist in solution. The photoproduct must not interact with
the ion channel. Perturbation of the ion channel will not provide measurements
representative of native ion channel activation. I found, throughout the course of
my work that the development of photochemical cages that do not, in any manner,
interact with ion channels is extremely difficult. I was able to use many different
systems to activate the ion channel, which in some manner also inhibited the ion
channel.
The aim of this thesis is to share with you, the reader, the successes and failures of
the work that I have done on this project. I will motivate the work in the introduction.
The hope is that I will be able to sell the project one tenth as well as Harry Gray
did in our first meeting together. I will then outline the status of methods used in
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my project. I will discuss the various successes I have had with the photoactivation
of acid-sensitive ion channels (Chapter 2). In Chapter 3, I follow this up with
the discussion of using ruthenium coordination complexes as photocages for the
activation of ion channels. I discuss the work that has been done to functionally
reconstitute ion channels in Chapter 4. Using the functionally reconstituted channels
I will discuss a brute force approach to ligand delivery, ultra-fast mixing, and the
prospects of that work (Chapter 5). I believe that I have been able to lay the
groundwork upon which this project could move forward, however I caution anyone
who is foolish enough to try. The ultimate goal of this project (and beer) is what has
driven me throughout my thesis, and I only regret taking on the challenge a little bit.
I will watch the field with much anticipation to see the advances made and hopefully
someday will be able to see someone succeed.
Sincerely,
Oliver Syed Shafaat
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1C h a p t e r 1
INTRODUCTION
1.1 Introduction
Ion channels are membrane proteins found in all forms of life that provide a path
for passive diffusion of ions from one side of a cell membrane to the other. Ion
channels can be voltage-sensitive, and open with changes in the potential that is
applied across the membrane. Ligand-gated ion channels bind a ligand, a naturally
occurring neurotransmitter or a recreational drug for example, and after binding of
the ligand open. Finally, mechanosensitive ion channels respond to the changes in
the mechanical forces of the membrane. After an ion channel is triggered, opening
occurs and ions (different ion channels are selective for different ions) flow through.
My primary interest is ligand-gated ion channels. This family of ion channels is
involved in fast synaptic transmission between cells, or in other words, intercellular
communication. As a result, it is of vital importance to understand how these ion
channels function. For a ligand-gated ion channel to function properly, a ligand
has to bind (e.g a neurotransmitter for native cellular signaling), and then the ion
channel has to open. The ligand-binding event is a a reversible process where the
ligand can bind, and dissociate. The ion channel gating event occurs only in a
ligand-bound state, and as monitored by electrophysiology, occurs in at least one
millisecond. Many groups, including the Dougherty group, have studied the ligand-
binding event. Through the use of structure-function studies, the Dougherty group
has been able to understand the binding mode of many different ligands to a variety
of receptors. The ion channel activation event remains more elusive. After ligand
binding, changes have to occur that create a state in which ions can flow through
the ion channel. These changes result from physical conformational changes in the
protein structure. The ion channel activation event is really an unanswered question.
How does the ion channel go from blocking ion flux to allowing ions to flow?
The goal of understanding this fundamental, and essential, process in ion channel
function is what has motivated this thesis.
1.2 Pentameric Ligand-Gated Ion Channels
The pentameric ligand-gated ion channels (pLGICs) are a large family of ligand-
gated ion channels [1, 2]. Members of the pLGIC family include the cation selective
2nicotinic acetylcholine (nAChR) and 5-hydroxytryptamine (5HT3, or serotonin) re-
ceptors, and anionic γ-aminobutyric acid (GABA) and glycine (GlyR) receptors.
pLGICs play a crucial role in fast synaptic transmission and proper function re-
quires at least two events to occur: ligand (also called an agonist) binding and
ion channel opening [3]. Synaptic signal propagation results from the release of
neurotransmitters at the axon of one nerve cell, the neurotransmitters then diffuse
across the space between two cells to the dendrite of the next cell. The ion channel
then binds a specific neurotransmitter and after binding the ion channel will open
and ions will flow through. This event allows for further propagation of the signal.
Both ligand binding and ion channel gating must occur for the protein to function
properly.
Since pLGICs were first identified, work by many labs on the biochemistry and
physiology of these receptors has been carried out. The most studied receptor is
the nAChR; a good source of these channels is the electric plaques of Torpedo
californica. This abundant natural source of nAChRs allowed for the study of these
proteins before many of the molecular biology techniques we now take for granted
even existed.
A pLGIC is made up of five segments (subunits) that self-assemble into a pentamer.
pLGICs can either be homopentameric (five identical subunits) or heteropentameric
(two or more different subunits) depending on the specific subtype. Each monomer
consists of a large extracellular domain, a transmembrane region, and a cytoplasmic
domain (Figure 1.1a). The extracellular domain contains the ligand binding site.
The transmembrane domain consists of four helicies, with helix 2 (M2) of each
monomer forming the pore. The cytoplasmic domain is highly variable between
receptors and is known to effect downstream signaling (Figure 1.1b). pLGICs allow
ion flow through the pore only in a ligand-bound state; upon ligand binding, the
ion channel opens. The ligand binding event somehow signals the opening of the
pore, located tens of angstroms away from the ligand-binding domain and in the
transmembrane region.
pLGICs can exist in many different states, three states will be discussed below. The
ion channel also can be in a closed state without a bound ligand (also referred to as
a resting state); ion flux does not occur in the resting state. Ligand can bind, open
the ion channel, and allow ion flow, known as the open state. I use the terms open,
activate, and gate interchangeably in this thesis. The ion channel can also be in a
ligand-bound non-conducting state, the so-called the desensitized state [1–4]. There
3are many other states of the ion channel that have been suggested in complicated
analyses, but for the sake of this thesis, only the three states above will be considered.
(a)
(b)
Figure 1.1: (a) The general architecture of pLGICs, with only two subunits shown for clarity. The
extracellular domain (blue) contains the agonist binding pocket, and is connected to transmembrane
domain. The transmembrane domain (red) has four helices, with the second helix (magenta line)
lining the pore. The ligand-binding site is tens of angstroms away from the gate (horizontal black
lines). Upon ligand binding, the gate has to open to allow ions to flow through. (b) The crystal
structures of ELIC (left, PDB code 3RQW) and the mouse 5HT3A receptor (right, PDB code 4PIR)
shown. Each monomer is a shown as a different color. From the crystal structures, the large
extracellular domain (above the black box) is seen. The transmembrane region (black box indicating
where the membrane would be) consists of four helices per monomer. The serotonin receptor has a
cytoplasmic domain (below the box), while ELIC does not.
4The ligand binding event has been extensively probed by the Dougherty group and
many others over the past 20 years. The Dougherty group has used unnatural amino
acid mutagenesis to probe ligand binding (see [5] for a good review on the method).
Amino acids are chemically synthesized, allowing for subtle changes in amino acid
structure and enabling detailed structure-function studies. The unnatural amino acid
is incorporated at the residue of interest using nonsense suppression methodology.
In a variety of examples, the group provided detailed binding mechanisms for many
drugs and channels. One example provided insight into the differences in binding of
nicotine and the native agonist acetylcholine to nAChRs [6, 7]. Structure-function
studies showed that a cation-pi interaction drives the binding of acetylcholine to the
nAChRs [4, 8]. nAChRs are found at the neuromuscular junction and involved
in every muscle movement that we (humans) make. nAChRs are also located in
the brain, and responsible for the reward properties that accompany smoking a
cigarette. The Dougherty group showed that the affinity for nicotine of the muscle-
type receptor is different from that of the neuronal subtype [6, 7, 9]. Nicotine
does not make a cation-pi interaction with the muscle-type receptor, whereas in the
primary neuronal nAChR subtype, a strong cation-pi interaction between nicotine
and nAChRs exists. The muscle-type nAChRs are not activated by nicotine ingested
by smoking [9], explaining why paralysis, among other effects, is not observed
every time someone smokes tobacco. This is just one example of the extensive work
that has been done to examine the properties that drive ligand binding to pLGICs.
Investigation into the gating event of pLGICs has proven more difficult. Using
similar methodology as above, cis-trans isomerization of a proline located at the
interface of the extracellular domain and the transmembrane domain was shown to
be crucial for the gating of the 5HT3A receptor [10]. Unfortunately, direct struc-
tural information is difficult to obtain because ion channels are membrane proteins
and isolation and in vitro structural analysis methods (such as crystallography) are
very difficult. Very recently high-resolution structural information of pLGICs has
emerged [11–16]. Prior to the X-ray structures, Unwin was able to resolve a 4 Å
structure of the electric ray nAChR using electron microscopy (EM) [17, 18]. The
EM structures initially provided the general topology, and information about the
side chains at higher resolution. The EM structures were solved in the absence of
ligand; a picture of a single state provides minimal insight into the transition be-
tween states. An acetylcholine binding protein (AChBP) had also been isolated and
structurally characterized [19, 20]. This protein shares some sequence homology
to the extracellular domain of the nAChRs, and importantly binds acetylcholine.
5Crystal structures of AChBP confirmed many of the ligand-binding results previ-
ously obtained with structure-function studies. Prokaryotic homologs were the first
members of the pLGIC family that were crystallized [11–13, 21]. Structures of two
different homologs were solved in different proposed states and comparison of these
two structures provided the first direct evidence for the conformational changes that
occurred during the gating process.
The pLGICs that are the focus of this thesis are the two prokaryotic proteins, Erwinia
ligand-gated ion channel (ELIC) and Gleobacter ligand-gated ion channel (GLIC).
ELIC and GLIC were predicted to be prokaryotic homologs of pLGICs through a
large bioinformatics screen [22], and have about 20% sequence homology with the
nAChRs. ELIC and GLIC were both structurally and functionally characterized.
The crystal structures of ELIC and GLIC were the first high resolution structures of
pLGICs and showed close structural similarities toUnwin’s EM structures of nAChR
[11–13, 17, 18]. ELIC andGLIC are pentameric, with a large extraceullular domain,
and four transmembrane helicies with the M2 helix of each subunit lining the pore.
While structural homology is important, functional homology is also needed to
be a good model system. Both GLIC and ELIC are monovalent cation selective
channels and are blocked in a similar fashion as the eukaryotic homologs (divalent
cations and NR4+ ions for example) [21, 23]. GLIC is activated by an increase
in extracellular proton concentration, making GLIC a proton-gated ion channel.
ELIC is activated by small molecule amines, such as cysteamine, propylamine,
and GABA. The functional and structural similarities of ELIC and GLIC with the
cation-selective members of the pLGICs family, make these ion channels a good
model system to study activation of pLGICs.
1.3 Investigation into Ion Channel Gating
The difficulty in elucidating the mechanism of gating of ion channels lies largely
in the nature of the proteins themselves; ion channels are membrane proteins. At
the onset of my research, the only information about the conformational changes
associated with pLGIC gating was a result of the crystal structures of ELIC [11],
in the presumed closed state, and GLIC in the presumed open state [12, 13].
Ion channel activation is a dynamic process, and the crystal structures provided
snapshots of the potential end points of that process. We want to monitor channels
during the gating event using dynamic methods.
Many more high resolution X-ray structures have been solved for members of the
6pLGIC family since I started this work. Structures of GLIC and ELIC have now
been solved under many different conditions: agonist present, antagonist present,
potentiators, inhibitors, etc. [23–25]. More recently mammalian serotonin and
glycine receptors, as well as nematode GluCl, were crystallized [14–16]. With the
surge of structures solved by single-particle cryo-EM, it will not be long until many
more members of the pLGIC family are solved. With a relatively large number of
pLGIC structures available (recall no structure existed until 2008), comparison of
structures provides some of the first insight into the gating mechanism of pLGICs.
Each structure is of the channel in a presumed state given the crystallographic
conditions. GLIC is a pLGIC that has X-ray structures in many different proposed
conformations. Comparison of the same protein provides the safest analysis of ion
channel movements between states; the crystal structure of the same ion channel
affords direct comparison of the structural changes. Delarue and coworkers were
able to solve GLIC at pH 7 [24]. GLIC is a pH-sensitive ion channel that is not
activated at pH 7, and the structure is assigned to the closed form. The structure
of GLIC in the presumed closed state exhibited some disorder, suggesting that the
closed state is dynamic. The closed structure of GLIC is compared with the low
pH, open, structure and provides a model for gating in Figure 1.2. The extracellular
domain becomes more rigid in the open structure, a twisting and a blooming motion
of the extracellular domain occurs during the transition from closed to open. The
extracellular domain is coupled to the transmembrane domain through motions in
the transmembrane helices. The M2 helix bends away from the pore, causing a
widening of the upper region of the pore in the open structure. The functional
state of GLIC is not known, but presumed. This is an issue in applying differences
observed in X-ray structures to the gating problem. Enzymatic reactions of proteins
in crystals have been used to show the functional nature of the protein structure [26].
The mointoring of ion flux through the ion channel would need to occur to examine
the functional state of ion channels in a crystal. Regardless, the crystal structures
that have been solved provide some of the best experimental insight into a potential
gating mechanism.
7Figure 1.2: The overlaid structures of GLIC in the closed state (red, PDB code 4NPQ) and the
desensitized state (green, PDB code 4NPP). Overlaying the closed and open structures of GLIC
provides insight into the gating mechanism. The transmembrane helices (top right) show a large
motion of the M2 helix that lines the pore. A rotation and slight outward bend of the top of the M2
helix occurs from the closed to desensitized state. The extracellular domain undergoes a rotation,
as well as a inward motion. The space-filling models (bottom) highlight the compact extracellular
domain in the desensitized state (green) as well as the slight opening of the top of the pore.
Long timescale molecular dynamics (MD) simulations can monitor large-scale con-
formational changes of ion channels. MD simulations are being used for large scale
protein simulations with X-ray structures of ion channels providing the starting point
for the simulations. The channels are perturbed in silico, and resulting structural
changes are monitored. Since ion channels are membrane proteins, simulations
require not only the whole 300 kDa protein structure, but the addition of a simulated
membrane environment. As a result of the size, MD simulations of ion channels
8are very computationally expensive. Recently, specialized computers designed for
MD simulations have become available enabling long timescale simulations, on
the order of 100s of µs to ms to be performed [27]. These computers have been
used for the study of large membrane proteins such as ion channels which require
long simulation times. Recall that activation of ion channels does not occur on
the ns timescale. Work done at the D.E. Shaw Institute used MD simulations to
monitor the activation of voltage-sensitive ion channels [28]. In silico membrane
potential reversal, an event used to open voltage-sensitive ion channels, reveals
large movements of the voltage-sensing domain. These MD motions are consistent
with the results obtained from experimentally monitoring the voltage-sensing do-
main under activation. These movements were only observed under conditions of
a hyperpolarized membrane environment, an environment where the ion channel is
experimentally shown to be open. Little large-scale structural motion is observed on
the nanosecond timescale, highlighting the importance of the long MD simulations.
Conformational changes associated with ion channel activation were observed. This
work was not performed on pLGICs and measurements of pLGICs in the presence
of an agonist might provide insight into the movements of the ion channel during
activation. Like crystal structures, the MD simulations provide valuable guidance
for experiments. In our experiments, we want to observe ion channel activation in
a functional, physiologically relevant environment.
Another technique used to investigate ion channel activation is electron paramagnetic
resonance (EPR) spectroscopy. Spin-labeling of GLIC M2 pore residues allowed
for the comparison of the continuous wave EPR signal in the closed or desensitized
state. The EPR line shapes were monitored under a resting and desensitized state
of GLIC. Changes in the EPR signal result from different coupling to the different
spin-labels in the system. Broadening of the lineshape is assigned to the decrease
in distance between spin-labels, and conversely narrowing indicated that the spin-
labels move apart. Chakrapani and coworkers showed that in transition from the
closed to desensitized state, the top of the pore moves outward, while the bottom
of the pore clamps in [29, 30]. In the desensitized state GLIC is non-conducting;
closure of the bottom of the pore would prevent ion flux through the channel.
PELDOR (pulsed electron-electron double resonance), or DEER (double electron-
electron resonance) are pulsed EPR techniques that also have been used to monitor
ion channel activation. Proteins are spin-labeled through site directed mutagenesis,
and the dipolar coupling between the two unpaired spin labels is measured. The
9dipolar coupling between spin-labels enables PELDOR to be used to evaluate of
distances between the spin labels from 1 nm to 10 nm [31]. The gating of GLIC
has been investigated using PELDOR. Czajkowski and coworkers labeled GLIC at
several different positions on the protein and examined the conformational changes
that occurred during the transition from closed to desensitized state [32]. Large mo-
tions were found at the interface of the extracellular domain and the transmembrane
domain, showing that the closed and desensitized state are structurally distinct. The
PELDOR measurements provided direct physical measurements of GLIC in the
closed and desensitized state. The closed state structure obtained from PELDOR
also suggest that ELIC is not a good structural model for the closed state of GLIC.
PELDOR measurements were performed on purified, reconstituted GLIC shown
to be functionally similar to in vivo GLIC. However, PELDOR measurements are
performed at 80K, a temperature where the ion channels are not functionally active.
This allows PELDOR to provide snap-shots of the gating events of functional ion
channels.
Single-molecule FRET (SM-FRET) measurements have been used to monitor ion
channel activation. SM-FRET measurements have been made simultaneously with
electrophysiology measurements, allowing the SM-FRET signals to be assigned to a
known state of the ion channel as reported by electrophysiology. Lu and coworkers
applied SM-FRET and electrophysiology to the NMDA receptor, a member of
the ionotropic glutamate receotors [33]. The NMDA receptor is a ligand gated
ion channel that belongs to a different family than the pLGICs described above.
NMDA receptors were expressed in cells, and labeled with donor and acceptor
fluorophores. The activation of the receptor was then monitored by both single-
molecule electrophysiology and SM-FRET. Measurements showed a single FRET
efficiency associated with the conducting state of the NMDA receptor. However,
unique insight into the non-conducting state was also elucidated. Electrically silent
states of the NMDA receptor showed at least two distinct SM-FRET conformations.
This highlights the ability of FRET to provide information on distinct states that are
indistinguishable by electrophysiology. These measurements were used to correlate
the electrical and optical signals, and provide information about the conformational
organization of the ion channel. The time resolution of SM-FRET is the same as that
of the single-channel electrophysiology, on the order of one millisecond. While end
states can be observed, information about the transition between the states remains
elusive.
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Time-resolved energy transfer techniques have been used to monitor the conforma-
tional changes associated with ion channel gating. Selvin and coworkers employed
luminescence resonance energy transfer (LRET) to study voltage-sensitive ion chan-
nels during activation [34–36]. Voltage-sensitive ion channels open under change
in the polarization of the membrane, accomplished routinely in electrophysiology.
LRET uses a lanthanide donor with a millisecond lifetime, to sensitize the emission
of a fluorescent dye acceptor. The LRET donor and acceptor are attached, through
site specific labeling to the ion channel. Relative changes in the distance between
donor and acceptor are extracted from lifetime measurements of the sensitized emis-
sion. Using LRET to monitor the relative change in the distance of various parts
of the voltage-sensing domain, Selvin and coworkers observed slight movement in
the voltage-sensing domain of 3.2 Å between the closed and activated state. Using
a basic geometric analysis, this movement was assigned to a rotation of a helix and
a slight vertical (perpendicular to the membrane) displacement. Follow-up work
used LRET to test the gating hypothesis of another voltage sensitive ion channel.
Selvin and coworkers were able to show that, contrary to the hypothesis, only small
movements of the ion channel occurred during activation. Conducting the LRET
measurements on ion channels in an in vivo environment allows for the ion channel
to be in a native environment; a strength of this system is using an environment
where the physiology of the ion channel is well characterized. LRET provided in-
formation about the conformation of voltage-sensitive ion channels under activation,
and I hope to use a similar technique to monitor pLGIC activation.
The method that we want to use is time-resolved fluorescence energy transfer (TR-
FET), a method similar to LRET. TR-FET was used previously to monitor large
conformational changes that occurred during protein folding. Winkler and cowork-
ers were able to show that during the folding of a small, soluble protein, some
regions folded in a two-state fashion, while some regions folded with an additional
intermediate state [37–40]. This study monitored the transition from the fully un-
folded state to the native state of the protein, where the LRET measurements above
examined only either the open or closed conformation. TR-FET measurements will
allow monitoring ion channels during the transition process between closed and
open states. Because we will study ligand-gated ion channels, this requires precise
delivery of the ligand at a known time. Methods to accomplish this will be discussed
later and are the focus of this thesis. The TR-FET measurements will be performed
on ion channels that are functionally reconstituted in order to probe activation in
a near-native system, much like the LRET oocyte measurements. The TR-FET
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measurements enable us to monitor the ion channel activation of a functional ion
channel during the transition from closed to open.
1.4 Photocages: A Method To Deliver Ligands
I want to use TR-FET, an ensemble measurement, to monitor the conformational
changes associated with ion channel activation. Measurements in the absence of
agonist will provide pictures of the closed state; likewise, measurements made in
the presence of agonist will provide a picture of either the open or desensitized
state. This work aims to provided insight into the transition from closed to open.
To accomplish this, we need to precisely control delivery of agonist in order to
control the activation. Photocages are used in this study to deliver ligands upon
irradiation of a compound. I want to release small-molecule amines or protons
for the activation of ELIC or GLIC, respectively. Many native neurotransmitters
(GABA, serotonin, glutamate, etc.) are small molecule primary amines. In addition,
compounds that release propylamine for the activation of ELIC have potential to
be generically applied for release of other neurotransmitters. To activate GLIC,
we release H+ using a type of photocage commonly referred to as a "photoacid."
Photocages are used to activate pLGICs in an effort to control the precise timing of
agonist delivery.
To monitor the ability of photocages to activate ion channels whole-cell voltage-
clamp electrophysiology will be used. ELIC or GLIC (or any other ion channel of
interest) will be expressed in X. laevis oocytes. Two electrodes are then injected into
the oocyte, and a potential is set (-60 mV vs. ground in my experiments) across the
membrane. Changes in the membrane potential are measured and a feedback loop
adjusts the current needed to keep the potential at the set value. No perturbation
to the system results in a constant current reading seen in Figure 1.3 (black line)
under the left magenta buffer box. Application of agonist (Figure 1.3, black box)
activates the ion channels, resulting in ion flow into the cell. A current change is
needed to keep the potential at the set value and reflected as the downward reflection
of the black line in Figure 1.3. This current change indicates that ion channels are
activated. Removal of the agonist (Figure 1.3, right magenta box) results in closing
of the ion channels, and a return to the baseline current required to hold the potential
constant. If the ion channel studied enters the desensitized state, ions no longer
flow through the channel when agonist is present. This results in a decrease in the
current observed to hold the potential at the set point (Figure 1.3, red line). Any
photocage in the dark should not activate the channel (i.e. the photocage should
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not be an agonist), and application of a photocage will not result in an observed
current change (Figure 1.3, orange line). In other words, activation of the ion
channels should occur only under irradiation of the photocage. If the photocage is
irreversible, each irradiation (Figure 1.3, blue line) should result in release of agonist,
and activate some ion channels. The activation is reflected in the change in current
seen at the point of each irradiation (lightning bolt). Further irradiation results in
release of more agonist, and thus more activation of ion channels. A reversible
photocage will activate the ion channel under irradiation (Figure 1.3, green line),
but after irradiation stops, the ion channels will close as the photocage undergoes
the re-binding of the agonist. In all cases the current required to hold the membrane
potential at the set value should be the same before and after manipulation (Figure
1.3, magenta bars). The above mentioned examples are the most straightforward
cases of ion channel activation.
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Figure 1.3: The ideal electrophysiology response to ion channel activation under a variety of
conditions. Each trace is vertically offset for clarity. Application of agonist alone will result in
a large increase (negative in the experimental setup) in current (black line) that remains until the
agonist is removed when the buffer is exchanged (denoted by a return to baseline). Ion channels can
undergo desensitization (red line). Full activation is observed, however under prolonged exposure to
agonist the signal decreases before the buffer is exchanged. Application of the photocage will result
in activation of the ion channel under irradiation only (blue line). An irreversible photocage will
result in activation at each irradiation event (yellow lightning bolt). More activation will be observed
until all the ion channels have been activated. After, the buffer is exchanged and the signal returns
to baseline. Photocage applied without irradiation (orange line) will not result in any activation. A
reversible photocage will activate ion channels under irradiation only (green line). After irradiation
stops, the released agonist will rebind the photoproduct, and result in a decrease in signal observed.
In all examples the signal before and after manipulation should be the same, indicating that there is
no prolonged effect of the ion channel.
A few general considerations must be applied to any potential photocage (Figure
1.4). To study the activation of ion channels requires that the photocage be soluble
in water and stable to air. The photocages must also be triggered by visible light.
Irradiation by UV light can cause oxidation of proteins, which could alter the ion
channel properties. The light-triggered release of agonist must be faster than ion
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channel activation. Ligand release and ion channel activation become convoluted if
the rate of release is slow. The quantum yield for release of agonist under irradiation
must be high; low quantum yields diminish potential for signal to be observed over
background. Finally, and in my opinion, the most important requirement for any
photocage (or its product) is the absence of any interaction between the photocage
and the protein.
Irradiation of the photocage, should release the caged molecule, which will activate
the ion channel (Figure 1.3, blue and green line). Any interaction of the photocage,
or the molecule that remains after release (photoproduct), with the ion channel
results in perturbation of the ion channel out of the native form. To probe for
potential interactions, the photocage (or photoproduct) is applied to ion channels
in the presence of additional free agonist. Application of photocage with agonist
(Figure 1.4, black outlined boxes) should activate the ion channel as just agonist
alone (1.4, black line). No interactions between the photocage (or photoproduct) and
the ion channel are outlined with the blue and purple lines in Figure 1.4. The current
with any agonist present is the same as just the agonist current alone. Perturbation
to the ion channel will result in a decrease in the observed current (Figure 1.4,
green and orange lines). Any perturbation renders the photocage useless in the
study of ion channel activation. In the following section, I discuss the use of two
different photocages that are relevant towards the research in this thesis: ruthenium-
polypyridyl photocages and photoacids.
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Figure 1.4: The ion channel electrophysiology response to agonist along (black line). Activation is
only observed in the presence of agonist, and when the buffer is exchanged (magenta bar), the signal
returns to baseline. The photocage, or photoproduct, in solution (blue and orange lines) with the ion
channel in the absence of agonist does not result in any signal observed, indicating that the photocage,
or photoproduct, does not activate the ion channel alone. Following pre-incubation, application of
the photocage, or photoproduct, with agonist will result in a current change (blue line, blue bar
with Black outline), to the level of activation without photocage (black line). If any deleterions
interaction exists between the photocage and the ion channel, a different signal will be observed upon
co-application of agonist and photocage (orange line). To monitor for interactions with open ion
channels, the ion channel is activated prior to photcage exposure (purple and green lines) and displays
similar currents to the agonist alone application. Application of photocage with agonist following
ion channel activation results in the same signal observed (purple line) if no interaction is observed.
If the photocage (or photoproduct) somehow interacts with the ion channel a change in current will
be observed (green line), shown as inhibition in this example. After the buffer is exchanged, the
signal should return to baseline indicating no persistent interactions between the molecules and the
ion channel. The photocage, or photoproduct, is not useful if any inhibition of the ion channel occurs
(signal less than the agonist alone, black line) in the presence both photocage and agonist (orange
and green lines). Each trace is vertically offset for clarity.
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1.4.1 Use of Ruthenium Complexes for Photocaging Amines
Ru2+-polypyridyl complexes are known to undergo efficient visible-light photodis-
sociation of amine ligand, and motivated my use of Ru2+ as a photocage for the
temporal control of ion channel gating [41]. Ru(bpy)2(L)2n+ complexes have been
used previously for release of biologically active molecules. Here, I will highlight
the work of Etchenique and coworkers who developed systems for the release of
neurotransmitters. These compounds are now available commercially, though I
recommend preparing them, as the syntheses are straightforward. Etchenique ini-
tially released 4-aminopyridine, which was used to block potassium channels [42].
Follow-up work examined the in vitro release of a variety of neuroactive molecules
such as nicotine, serotonin, and GABA [43–48]. The Ru(bpy)2(L)2n+ systems have
small quantums yield for photochemical release, consistent with the workmentioned
below. Addition of a PPh3 ligand, to afford the generic Ru(bpy)2(PPh3)(L)n+, re-
sulted in a large increase in the photosubstitution quantum yield (0.3 from 0.01).
Etchenique and coworkers then demonstrated GABA receptor activation upon ir-
radiation of Ru(bpy)2(PPh3)(GABA)+. Use with a variety of cells and channels
demonstrated the Ru(bpy)2(PPh3)(L)n+ platform as a generic photocage of amines,
with quantum yields around 0.3. Knowledge of the mechanism of photodissociation
from Ru(II)-polypyridyl complexes allows for the development of new systems with
specific tailored properties such as the efficiency of release or wavelength of light
used for photodissociation.
Ru2+-polypyridyl photochemistry is a well studied field [49]; I will only briefly
outline some key characteristics that are required to understand the use of Ru2+
complexes as photocages. Extensive studies of the photochemical and photophysical
properties of Ru2+ complexes have been carried out in a variety of solvents [50, 51].
For the purposes of this discussion, the values that are given will be the values that
have been collected in water due to their relevance to this study. The prototypical
polypyridyl-Ru(II) complex is Ru(bpy)32+. Ru(bpy)32+ is a very stable complex in
the resting state, is water soluble, and has strong visible light transitions, which are
all requirements for use as a photocage. Ru(bpy)32+ is a low-spin d6 complexwithD3
symmetry, often thought of as octahedral symmetry for simplicity. The complex has
intense absorption features in the UV corresponding to the ligand-centered pi→pi∗
transitions [52]. A broad feature at 453 nm is observed in the visible region of the
spectrum [50–52]. This transition is assigned with a metal-to-ligand charge transfer
(MLCT). The MLCT transition has a large molar absorptivity of 104 M−1cm−1 [52,
53]. Excitation of Ru(bpy)32+ results in population of a 3MLCT state that radiatively
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relaxes to the ground state with a luminescence peak at 600 nm, and a quantum yield
of ca. 0.3 [52, 54, 55].
The dissociation of a ligand must occur upon irradiation for these complexes to be
photocages. Irradiation of the Ru2+ complex results in population of the 3MLCT
state. The decay from the excited 3MLCT, can occur via a radiative pathway
where luminescence is observed (Figure 1.5, dotted arrow). However, for the
efficient ligand dissociation to occur, the decay pathway must proceed through
a non-radiative mechanism. Thermal population of the ligand-field (LF) excited
states is the non-radiative decay mechanism that leads to photodissociation (Figure
1.5, solid arrow), and population of the LF states is known to result in efficient
dissociation [51]. Population of the LF states generates antibonding character in
the d orbitals. The antibonding character along the dz2 axis results in release of a
ligand [56]. The relative energy difference between the MLCT states and the LF
states affects the thermal population of the LF states (Figure 1.5, ∆E). The smaller
the energy difference, the larger the photodissociation quantum yield (Figure 1.5,
left side). If a large energy difference between the MLCT and LF states exists, the
complexes are photostable (Figure 1.5, right side). For use as a photocage, a small
energy difference between the MLCT and LF states must exist.
Since population of the dissosiative LF states is a non-radiative decay mechanism,
thermal population must occur faster than the radiative decay lifetime for Ru2+ com-
plexes. In the example of Ru(bpy)32+, radiative decay lifetime is 600 ns, suggesting
dissociation must occur faster than 600 ns. All of the above-mentioned ruthenium
complexes with efficient photosubstitution yields have low quantum yields of room
temperature luminescence. This is evidence that increased photodissociation re-
sults in a concurrent diminishing of the radiative relaxation pathway. Dissociation
is known to be very efficient after population of the LF states occurs, which allows
for the rapid release of ligands [51].
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Figure 1.5: A general outline of potential energies of the states involved with ruthenium photodis-
sociation. Low energy differences between the MLCT state and the ligand field states (left) result in
effective thermal population of the LF state and high photosubstitution. A large energy difference
between the MLCT state and the LF state (right) does not allow for thermal population of the LF
state and results in substitutionally inert molecules.
Amechanistic understanding of photosubstitution allows for the synthetic modifica-
tions to the system that result in other related compounds to be made. Recent work
has shown that Ru2+ complexes containing bulky bipyridine ligands can efficiently
release amines. Turro and coworkers examined a series of Ru(tpy)(6,6’-X-bpy)(L)n+
complexes and observed an increase in photosubstitution occurs when the 6 and 6’
position of the bipyridine ligand is stericly bulky [57]. The steric bulk around
the metal center distorts the geometry out of pseudo-octahedral symmetry. The
distorted geometry lowers the energies of the LF states and enables more efficient
thermal population from the MLCT states [58, 59]. Turro and coworkers have
shown that the quantum yield for distorted Ru2+ cages is increased by 1000 fold.
Ultra-fast transient spectroscopy has been used to directly visualize the population of
the LF states from the MLCT state. Population of the LF states of the Ru(tpy)(6,6’-
X-bpy)(L)n+ complexes occurred in 7 ps [60]. The population of the LF states of
the distorted Ru2+ complexes occurs about 50 times faster than the Ru(bpy)2(L)2n+
system. The Ru(tpy)(6,6’-X-bpy)(L)n+ complexes also undergo photodissociation
under red-shifted irradiation, compared with the Ru(bpy)2(L)2n+ complexes. Re-
lease of a molecule with red light is useful for application in photodynamic therapy.
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Above I outlined the photochemistry and photophysics of Ru2+-polypyrdial com-
plexes. These complexes are water soluble, highly stable complexes that are known
to undergo photodissociation upon irradiation into the visibleMLCT transition. The
efficiency of release is strongly dependent on the monodentate ligand properties,
with photodissociation quantum yields of 0.3 possible in some systems. Photodis-
sociation occurs as a result of thermal population of the LF states, a non-radiative
decay pathway of the excited state. This mode of release results in rapid photodis-
sociation of the ligand. Most importantly, these systems have been used previously
in the photoactivation of pLGICs. I seek to use these systems for temporal control
ELIC activation. The highly efficient, and rapid release of propylamine will allow
for the study of conformational changes associated with ELIC activation.
1.4.2 Photoacids
Photoacids are molecules that release a proton upon irradiation, inducing a local
pH change. This requires that the molecule’s excited-state pKa is lower than the
ground-state pKa. To activate acid-sensitive ion channels, irradiation must release
protons that are available to bind and activate the ion channel. Protons must be
released in sufficient quantity and remain free in solution for a period that allows
binding to, and activation of, the ion channel. I will use naphthol and merocyanine
photoacids in an effort to activate acid-sensitive ion channels.
Some of the most well studied photoacids are naphthols. Naphtols, upon UV
irradiation undergo a S0 → S1 transition, and the excited-state pKa is substantially
lowered, releasing a proton and forming the naphtholate [61]. Water-soluble
naphthols are able to induce bulk pH changes in aqueous environments within
nanoseconds of irradiation [62]. Naphthols are reversable photoacids and the
reprotonation of the naphtholate occurs in ca. 1 ms. UV irradiation and the short-
lived proton lifetime, however, prevent use of naphthols for photoactivation of ion
channels.
Recently, the merocyanine-spiropyran photochromatic reaction (Figure 2.1c) has
been used to induce large pH changes upon irradiation. The merocyanine-to-
spiropyran reaction results in a large rearrangement; under irradiation, cis-trans
isomerization occurs, followed by ring closure [63]. Mechanistic investigations of
the merocyanine-spiropyran reaction are mostly done with the deprotonated form,
so it is unclear at which step the proton is lost. It is known that upon formation
of the ring-closed spiropyran the pH is altered, suggesting that the latest point the
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proton could be lost is ring closure. These large rearrangements have the potential
to result in the slow release of a proton. The proton-release kinetics will be ex-
plored in Chapter 2. Liao and coworkers developed a water-soluble merocyanine
photoacid that was shown to induce pH changes of 2 units upon visible-light irradi-
ation [64–66]. The lifetime of the pH change was on the order of seconds, about 9
orders of magnitude longer than the naphthol lifetime. The bulk pH of solution was
able to be cycled multiple times, highlighting the robust nature of this molecule.
The authors were able to induce hydrogel crosslinking and perform esterification
reactions under irradiation of the merocyanine photoacid [64]. The merocyanine
photoacid meets the in vitro requirements for a phototrigger for GLIC, and will be
used to photoactivate acid sensitive ion channels.
1.5 Reconstitution
This work aims to study the ion channel opening, and the experimental techniques
requires study in an in vitro environment. In vitro study of ligand-gated ion channels
requires that the ion channels be reconstituted, or placed in, an artificial membrane
environment. Here, the reconstituted channel must also be amenable to study
by pulsed laser methods. Ion channels must function in vitro the same way as
observed in vivo for a relevant mechanistic study. The physiological properties
observed in oocytes will serve as the baseline. A variety of ion channels have been
reconstituted into many different artificial membrane environments [67]. Prior
work on reconstitution has used planar lipid bilayers, vesicles of varying sizes, and
detergent as the artificial membrane environment. The membrane environment used
for reconstitution dictates the assay(s) that can be used to test for ion channel function.
Electrophysiology can be used on planar lipid bilayers and large vesicles. Smaller
vesicles and detergent environments are not amenable to electrophysiology; function
of ion channels in these environment have been measured through radioactive ion
flux, fluorescence quenching (or turn-on) assays, and if the ion channel is ligand-
gated through ligand affinity. The above reconstitution environments and assays are
described in more detail below. Functional reconstitution of pLGICs requires the
binding of an agonist, and ion flux through the pore; any assay that is used must be
able to report on both ligand-binding and ion flux.
Reconstitution of ion channels into planer lipid bilayers is common for in vitro
ion channel studies [32, 68, 69]. Planer lipid bilayers are formed across teflon
holes, allowing for lipid composition to be controlled. The ion channels are then
added to the bilayers, and assayed using single-channel electrophysiology. GLIC
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and nAChRs (among others) have been reconstituted and studied in vitro using
planer lipid bilayers [32, 68]. The single-channel in vitro properties are compared
to the single-channel recordings of in vivo systems, providing a direct measure of
perturbation of the reconstituted ion channels. While this is a common and robust
method for reconstitution, unfortunately the experimental setup is not amenable to
TR-FET measurements.
Ligand-gated ion channels must bind a ligand and then open to allow ions through.
To monitor the ligand-binding event, radiolabeled affinity binding studies have been
employed. This assay introduces a radiolabeled agonist, or antagonist, and monitors
the ligand-binding affinity of the reconstituted ion channel. The reconstituted affinity
is then compared to the binding affinity in an in vivomembrane environment. Large
changes of the reconstituted ion channel binding affinity indicates perturbation of the
reconstituted system. The radiolabeled assay highlights discrepancies in the ligand
affinity of the reconstituted ion channel; purified GABA receptors were shown
to have similar binding affinity of muscimol (an agonist) as observed in in vivo
systems [70]. However, these assays do not report on the ion channel activation,
and subsequent accompanying ion flux. Assaying both the ligand-binding and ion
channel gating is crucial. Neither ligand binding or activation can be altered in the
reconstituted system if information about the native system is to be gained.
Lipid vesicles are a common membrane environment used for the reconstitution of
ion channels. Vesicles of defined composition and size can be formed using robust
assays. The vesicles can range from 10s of nm to microns in diameter; molecules
such as cholesterol or fluorescently-labeled lipids can be easily added into the lipid
membrane composition. The vesicles are then mixed with purified protein to form
vesicles with embedded proteins (proteoliposomes). Many methods have been used
to verify the function of reconstituted ion channels in vesicles.
If giant unilamellar vesicles (GUVs) are used as the membrane environment, single-
channel electrophysiology can be used to monitor the binding and gating of reconsti-
tuted ion channels. GUVs are amenable to electrophysiology due to the micrometer
dimensions of the vesicles, and purified 5HT3A receptors have been reconstituted
using this method [14]. The size of the GUVs might result in a large amount of
scattered light that is required for future measurements. Little precedent for the
reconstitution of ion channels into GUVs led to this membrane environment not
being explored.
Smaller vesicles, such as large unilamellar vesicles (LUVs, 100 nm in diameter),
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require different assays; the small size prohibits the use of electrophysiology. LUV
proteoliposomes have been injected into oocytes and the function of the ion channels
was examined using electrophysiology (vida supra), and has been used to examine
reconstituted GLIC function [32]. Injection of oocytes with proteoliposomes does
not assay the function of the ion channel LUV environment, but in the oocyte. To
measure function of an ion channel in a LUV, the ion channel function must be
assayed in the LUV.
Functional reconstitution into lipid vesicles provides a defined "inside" and "out-
side", in analogy to a cell. The defined spatial separation allows ion flux to be
monitored as change in selective ion concentration of the inside of the vesicles (lu-
men) or the bulk. To monitor the flux of ions into, or out of, a vesicle two different
methods are commonly used: radioisotope ion flux or thallium flux. Radioisotope
flux has been used to monitor the ion flux into a variety of reconstituted ion channels
such as: K+ channels, nAChRs, 5HT3A, and Na+ channels [71–73]. To monitor
the ion flux using radioactive ions 86Rb+, or 22Na+ (for example), are added to a
solution of proteolipsomes. The ion channel is then activated by addition of an
agonist. The proteoliposomes are then isolated from any excess radioactive ions,
and analyzed for radioactivity. In the example of 5HT3A, the agonist mCPBG was
added, and after an incubation period, the vesicles were separated from the excess
radioactive isotope, and the radioactivity assayed using scintillation counting [71].
Experiments with radioactivity can measure ion flux over time, and the modulation
of the ion flux as a result of known agonists or blockers. An increased flux of 22Na+
into the proteoliposomes was observed in the presence of mCPBG with the ion flux
blocked by a known antagonist in the serotonin example above [71]. Measurements
of ion flux under conditions can be compared to the current response recorded under
similar conditions in electrophysiology of the in vivo system. These measurements
allow for analysis of the ligand-binding event as well as the ion channel activation
event.
Thallium (Tl+) flux through cation selective ion channels is another common assay
used to monitor the reconstituted ion channel function. Tl+ has a similar ionic
radius as potassium, allowing flux through cation-selective potassium channel. In
this assay, a fluorescent dye is encapsulated inside the proteoliposomes. Under
activating conditions, the ion channel will open, and thallium will diffuse through
the ion channel (Figure 1.6). Thallium inside the vesicle quenches the fluorescence
of the dye; monitoring the fluorescence over time provides a readout of ion flux
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through the ion channel. Thallium flux has been used to monitor the activation of
reconstituted nAChRs and other ligand-gated ion channels [74, 75]. Addition of
thallium in the presence of agonist, choline in the case of nAChRs, resulted in rapid
quenching of the fluorescence. A choline concentration dependence of quenching
was observed and analyzed in a similar fashion to the concentration-dependent
current of electrophysiology. The Tl+ flux measurements also provide information
about the ligand-binding events and ion channel activation events.
Figure 1.6: Ion channels are reconstituted into proteoliposomes with fluorescent dye (green) enca-
puslated inside the vesicles. Application of agonist will activate the ion channels, and allow for
ions to flow through the pore. If thallium is present, thallium will enter the vesicle and quench the
fluorescence of the dye. Non-functional channels will not result in quenching of fluorescent dye,
allowing for fluorescence as a readout of the functional state of reconstituted ion channels.
The two different ion-flux assays mentioned (radioisotope flux and thallium flux)
above are able to report on both the ligand-binding and ion channel gating properties
of the reconstituted ion channels, while being compatible with the constraints of the
future experiments. These assays are not ideal, as handling radioactive isotopes, or
thallium, can be dangerous. However, monitoring reconstituted ion channel activity
by ion flux will be the assay used in this thesis because of the ability to report on
both ligand binding and ion channel activation.
1.6 Concluding Remarks
The aim of this chapter is to provide the motivation behind the research conducted
in this thesis and a background to previous work done in this field. The ultimate goal
of my thesis is to monitor the conformational changes, the physical motions, that
ligand-gated ion channels undergo during the activation process. I aim to monitor
the activation of pentameric ligand-gated ion channels, which are responsible for
fast synaptic transmission in the nervous system. For pLGICs to function properly,
at a minimum, the ligand must bind, and the ion channel must open to allow ion
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flux through the pore. The ligand-binding event has been studied in the Dougherty
group for the past 20 years, but information about activation remains elusive. How
ion channel activation occurs is largely an unanswered question. To monitor the
activation, I want to use time-resolved fluorescence energy transfer, an ensemble
measurement that allows for precise distance changes to be measured. To measure
the conformational changes associated with ion channel activation, I need to develop
methods for temporal control of the activation. I will discuss in detail my efforts
toward this end in the remainder of the thesis. Enjoy!
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C h a p t e r 2
ACTIVATION OF ACID-SENSITIVE ION CHANNELS USING
PHOTOACIDS
2.1 Introduction
The use of photoacids provides a promising experimental tool for the temporal
control of acid-sensitive ion channels, because when and where light is delivered is
easily controlled. Given the nature of the system being studied, any photoacid that
is employed must be compatible with biological systems. The requirements are as
follows: 1 - water soluble, 2 - air stable, 3 - visible-light triggered, 4 - long-lived
proton release, and 5 - no perturbation of the system studied beyond proton delivery.
Photoacid use in the induction of pH change for the investigation of biological and
chemical systems is not a new idea. Traditional photoacids, such as 2-naphthol,
suffer from limitations in water solubility, H+ release lifetime and generally require
UV light to trigger the proton release [1, 2]. Use of a nitrobenzyl-protected sulfate
group allows for the rapid release of protons in water under near-blue irradiation
[3]. Nitrobenzyl protecting groups are common photocages, and the photochemical
reaction affords permanent displacement of the cargo, a proton in this case. Recently
a new photoacid was synthesized using a merocyanine scaffold [4, 5]. This system
is triggered by visible light, unlike the aforementioned systems, and causes a long-
lived (seconds) and reversible pH change in water. To the best of my knowledge,
photoactivation of acid-sensitive ion channels has not been reported. In this chapter,
I will describe the synthesis, characterization, and ability to activate acid-sensitive
ion channels using the above systems.
2.2 Methods and Materials
2.2.1 General Procedures
Samples of the photoacids for study were all prepared using the following methods.
A stock solution was prepared by dissolving a known amount of photoacid (variable
amounts given nature of experiment) in minimal 18 MΩ purified water (Barnsted
E-Pure). The stock solution was then diluted to the desired concentrations for further
experiments. For experiments where a pH change was required, the photoacid was
diluted (ca. 100 to 1000 times) into ND96 salts (96 mM NaCl, 2 mM KCl, 1
mM MgCl2) and the pH was adjusted to the desired pH using a pH meter (VWR
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sympHony, SB70P). pH switching studieswere performedwith photoacids dissolved
in ND96 salts using the pH meter to measure the pH before and after irradiation
by a 455 nm LED (Thor Labs, M455L1). UV-visible studies were carried out
using a HP 8453 spectrometer, using 1 cm path-length quartz cuvettes. Extinction
coefficients were calculated by dissolution of a known amount of photoacid into pure
water, followed by dilution at various concentrations into the mixed buffer system at
both pH 4.0 and pH 8.0. Electrophysiology experiments were carried out with the
OpusXpress (Molecular Devices) using established methods for ASIC2a or GLIC
expression and whole-cell voltage clamp protocols [6, 7]. Organic chemicals were
obtained as indicated in each section below, and used without further purification.
3, 4, 3-formyl-4-hydroxybenzenesulfonate and 3-(2,3,3-trimethyl-3H-indol-1-ium-
1-yl)propane-1-sulfonate were synthesized according to literature methods [4, 5,
8]. All data processing was performed using MATLAB R2013b (Mathworks, Inc.).
2.2.2 Synthesis of 3H-Indolium, 2-[(1)-2-(2-hydroxyphenyl)ethenyl]-3,3-dimethyl-
1-(3-sulfopropyl) (Merocyanine Photoacid, MEH)
MEH was synthesized as previously described [4]. Briefly, 1,3-propane sultone
(Aldrich) was added to 2,3,3-trimethylindolenine and stirred at 90°C for 4 hours
under argon. The purple solid was collected by filtration and washed with ether and
dried under vacuum. This product was then added to 2-hydrozybenzaldehyde in
ethanol. The mixture was refluxed overnight, and the orange product was collected
by filtration and washed with ether and finally ethanol. Characterization by 1H
NMR, mass spectrometry, and UV/Vis spectroscopy agree with published data [4].
2.2.3 (E)-3-(2-(2-(1H-indazol-7-yl)vinyl)benzo[d]thiazol-3-ium-3-yl)propane-1-
sulfonate (Indazol-MEH)
Indazol-MEH was synthesized as previously described [5]. Briefly, 1,3-propane
sultone (Aldrich) was added to 2-methyl-1-(3-sulfonatepropyl)-benzothiazoium and
stirred at 90 degrees C for 5 hours under argon. The yellow solid was collected
by filtration and washed with ether and dried under vacuum. This product was
then added to 1-H-indazole-7-carbaldehyde in ethanol, with 5 mg NH4OAc and was
refluxed for 2 hours. An orange product was collected by filtration and washed with
ether and finally ethanol. Characterization by 1H NMR, mass spectrometry, and
UV/Vis spectroscopy agree with published data [5].
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2.2.4 Synthesis of (E)-3-(2-(3,3-dimethyl-1-(3-sulfonatopropyl)-3H-indol-1-ium-
2-yl)vinyl)-4-hydroxybenzenesulfonate (Sulfonated-Merocyanine,MEHSO3)
MEHSO3 was prepared by a modification of literature procedures [4]. Briefly,
3-formyl-4-hydroxybenzenesulfonate (419 mg, 2.02 mmol) and 3-(2,3,3-trimethyl-
3H-indol-1-ium-1-yl)propane-1-sulfonate (501 mg, 1.84 mmol) were combined in
dry ethanol (5 mL). The resulting dark purple solution was stirred vigorously and
refluxed overnight under argon. The reaction was then filtered to yield an orange
solid, which was then washed with excess cold ethanol, and dried overnight, to give
MEHSO3. 1H NMR (300 MHz,(CD3)2SO) 11.45 (s, 1H), 8.53 (d, J = 16.3 Hz,
1H), 8.28 (d, J = 2.1 Hz, 1H), 8.12-8.02 (m, 1H), 7.98-7.81 (m, 2H), 7.75-7.54 (m,
3H), 6.98 (d, J = 8.6 Hz, 1H), 4.76 (t, J = 7.8 Hz, 2H), 2.63 (t, J = 6.8 Hz, 2H),
2.17 (m, J = 7.6 Hz, 2H), 1.79 (s, 6H). ESI-MS (Negative Mode) Calculated for
C21H22NO7S2− 464.1, found 464.2.
2.2.5 Synthesis of 1-(2-Nitrophenyl)Ethyl Sulfate (Caged Sulfate)
The caged sulfatewas synthesized as previously described [3]. Briefly, sodiumboro-
hydride was added to 2-nitroacetophenone (Matrix Scientific) in methanol:dioxane
(3:2 by volume). The reaction was stirred for 3 hours, then quenched with water.
1-(2-nitrophenyl)ethanol was extracted into chloroform, and dried under vacuum
to yield a yellow oil. Sulfur trioxide-triethylamine was added to the isolated 1-(2-
nitrophenyl)ethanol in DMF and stirred for 1 hour. Water was added to quench the
reaction and the solvent removed under vacuum yielding a yellow oil. Ion exchange
chromatography was performed using a DEAE cellulose column (GE Healthcare).
The oil was dissolved into pH 7 water and loaded onto the column, and rinsed with
5 column volumes of water. Pure compound was eluted with 0.1 M NaOH, and
dried under vacuum to yield a yellow oil. The 1H NMR and mass spectrometry of
the eluted product agrees with published data [3].
2.2.6 Synthesis of 5-sulfonic-6-bromo-2-naphthol
Sulfonation of 6-bromo-2-naphthol was carried out using a literature preparation
modified from that for 2-naphthol [9]. 6-bromo-2-naphthol (Sigma-Aldrich) was
dissolved in concentrated sulfuric acid to yield a viscous dark brown solution.
The solution was stirred for 45 minutes, followed by quenching with a saturated
aqueous NaCl solution. This solution was filtered to give a clear filtrate and a
fine pink powder. This powder was then washed with DCM to remove unreacted
6-bromo-2-naphthol and dried under vacuum. Further purification was achieved
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by slow evaporation of diethyl ether into an acetone/benzene solution containing
the naphthol, yielding white crystals, which were characterized using 1H NMR and
mass spectrometry. 1H NMR (300 MHz, (CD3)2SO)) 12.03 (s, 1H), 8.55(d, 1H, J
= 9.30), 8.03 (d, 1H, J = 2.23), 7.78 (d, 1H, J = 8.95), 7.57 (dd, 1H, J = 2.22, 9.27),
7.07 (d, 1H, J = 8.94). LC-MS (ESI) Calculated for C10H6BrO4S− 302.1, found
302.9.
2.2.7 UV-Visible Kinetics Studies
MEHSO3 and MEH was dissolved as described above, and diluted such that A455
<0.4. The kinetics were followed for two hours, collecting a spectrum every 30
seconds using the kinetics software package for the spectrometer. The first two
points were baseline of MEHSO3, followed by 30 seconds of irradiation with a 455
nm LED, and the remaining time in the dark. It is important to note that complete
conversion of MEHSO3 to Spiropyran-SO3 occurs in a few seconds; however, for
the kinetics traces irradiation for the entire dead-time between spectrum collection
was needed for a valid baseline.
2.2.8 Transient Absorption Spectroscopy
Samples of MEHSO3, MEH, or Indazole-MEH were prepared as above, and
bromocresol green (BCG) was prepared by dissolution of BCG into ethanol, fol-
lowed by 1:1000 dilution intoND96 salts at pH6.0. The concentrations ofMEHSO3,
MEH, or Indazole-MEH were 10 µM, and the concentration of BCG was 20 µM.
These solutions were then placed in a quartz cuvette open to air, and the laser
experiments conducted. Excitation using the third harmonic from a Q-switched
Nd:YAG laser (Spectra-Physics, Quanta-Ray PRO Series) provided 355 nm pulses,
8 ns FWHM, at 10 Hz. This pulse was then used to pump an optical paramet-
ric oscillator (Spectra-Physics Quanta-Ray MOPO-700) to provide 455 nm laser
pulses. Single-wavelength transient absorption experiments were conducted with
a 10 mW He-Ne Laser passed through the sample colinearly with the excitation
pulse. The probe wavelength of 632 nm was selected using a double monochro-
mator with appropriate short-pass and long-pass filters to remove stray light, as
well as a neutral density filter to regulate intensity. Light was detected by a pho-
tomultiplier tube (Hamamatsu R928), and amplified using a custom built voltage
amplifier. Around 15 shots were collected for each wavelength, and the data were
logarithmically-compressed, then fit, in MATLAB using custom scripts.
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2.2.9 Electrophysiology
In general, electrophysiology experiments were conducted as previously published
[6, 7]. Briefly, Xenopus laevis oocytes were injected with 5 ng of wt-rASIC2a
or 50 ng of wt-GLIC in vitro transcribed mRNA. Cells were whole-cell voltage-
clamped at -60mV, and experiments were performed following a 24 hour incubation.
Expression was tested using low-pH buffers 96 mM aqueous NaCl, 2 mM KCl, 1
mM MgCl2 + buffer (ND96 salts + MES buffer). To test the ability of MEHSO3
to open ASIC2a or GLIC, 3 rounds of pH 5.5 or 5.0 buffer (ASIC2a or GLIC,
respectively) was applied to oocytes. Following the third round, MEHSO3 (ca. 500
µM), in ND96 salts, was applied. Solution transfer paused for 180 seconds, during
which after a short incubation period (ca. 25 seconds) each oocyte was individually
irradiated by a 455 nm LED for ten seconds. Following the irradiation, the solution
was exchanged and two more pH 5.5 or 5.0 buffer (ASIC2a or GLIC respectively)
doses were applied to monitor ASIC2a and GLIC expression. Experiments with 1
dissolved in buffer were performed in a similar manner, with 10 mM or 5 mMMES
buffer (ASIC2a or GLIC respectively) present in the salts solution. All data were
then processed using MATLAB with custom scripts.
2.2.10 UV-Visible pH Titrations
Assignment of the visible optical bandswas determined by pH titration ofMEHSO3,
andmonitoring of the change in the optical spectrum using UV-visible spectroscopy.
A stock solution of MEHSO3 was prepared as described above. A mixed buffer
solution was then prepared with ND96 salts supplemented with a buffer mixture
(2.5 mM MES, 2.5 mM NaOAc, and 5 mM Tris) known to support a pH range of
4.0 - 9.0 [10]. Solutions were prepared from pH 4.0 to 8.9 by 0.1 steps in pH, using
HCl or NaOH to adjust the pH. Then MEHSO3 stock was diluted 1:1000 in each of
the above pH buffer solutions occurred and the optical spectrum recorded. The data
were then processed using MATLAB with custom scripts.
2.3 Results and Discussion
2.3.1 Synthesis and Characterization of Merocyanine Photoacids
The structures, general syntheses, and photoreactivity of merocyanine-derived pho-
toacids are shown in Figure 2.1. MEH and indazole-MEH were previously char-
acterized [4, 5]. The 1H NMR spectra of MESO3 and spiropyran-SO3 are shown
in Figure 2.2a. The spectra are in good agreement with published NMR of related
compounds [11, 12]. Under irradiation the phenolic proton (11.5 ppm) is no longer
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present, and the di-methyl resonance splits and moves up field. Interestingly, a shift
in the water residual peak (in (CD3)2SO ) is observed. This shift might be indicative
of a change in the protonation state of OH2.
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Figure 2.1: (a) Structures of the merocyanine derived photoacids. (b) Three step synthesis of
MEHSO3, adaptable for the synthesis of the other two photoacids shown in (a). (c) The photoreaction
of merocyanine photoacids
After 1H NMR characterization of the newly synthesized MEHSO3, I examined
the solubility of all the merocyanine photoacids. The indazole-MEH compound
was soluble in DMSO to ca. 10−4 M; indazole-MEH is insoluble in water at this
concentration. Both MEH and MEHSO3 display vastly different solubility pro-
files. Compounds MEH and MEHSO3 have minimal solubility in common organic
solvents (chloroform, acetone, dichloromethane, benzene, toluene, ethyl acetate,
hexanes, diethyl ether, THF, isopropyl alcohol, and acetonitrile). However, MEH
and MEHSO3 are soluble in methanol, ethanol, DMSO, DMF and water. These
compounds precipitate out of ethanol during synthesis, indicating limited solubility
in ethanol. The purification of MEHSO3 from the starting materials proved diffi-
cult; the reactants and the product display similar solubility properties. The product
mixture was washed with cold ethanol to remove excess starting materials. This
removed both the starting materials and the MEHSO3 product, lowering the yield of
the reaction. Use of anion exchange chromatography might provide an alternative
purification method.
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(a) (b)
(c)
Figure 2.2: The 1H NMR of MEHSO3 (a), and spiropyran-SO3 (b), stacked (c) in (CD3)2SO.
Biological control over local and global proton concentration (pH) is critical to
cellular viability. Enzymatic function [10, 13], protein structure [14], and lysosomal
function [15, 16] are a few examples highlighting the importance of pH for proper
cellular function. To this end, it is of value to develop photochemical proton control
systems for use in kinetic investigations of these systems. A common method to
increase the water solubility of organic compounds is to add ionizable groups, such
as sulfonate, to the compound. Given the limited solubility of MEH (600 µM ),
it was anticipated that sulfonation would increase the solubility of this compound.
In fact, sulfonation increased the solubility about 140 fold to at least 85 mM in
water. The solubility of MEHSO3 relates to the hydrophillic properties of this
compound. Often in biology hydrophobic regions of proteins are found. The
solubility of MEHSO3 should help limit the interactions with any hydrophobic area,
not perturbing the system beyond the release of a proton.
The merocyanine photoacids are yellow solids; in solution the absorbance profiles
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of the merocyanine photoacids are pH dependent. MEHSO3 has a peak in the
visible region of the spectrum at 416 nm, with a shoulder centered around 519 nm
consistent with the published values of MEH and indazole-MEH [4, 5]. Previous
work assigned the 416 nm band is to the protonated-phenolic moiety of the open
merocyanine compound [4]. The 519 nm band is assigned to the deprotonated form.
In order to confirm this assignment, stock solutions of MEHSO3 were prepared in
water and diluted into a buffered solution (pH 4.0 to pH 8.9 by 0.1 pH increments
[10]) and the optical spectrum recorded.
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Figure 2.3: (a) Raw UV-visible optical spectrum of pH titration of MEHSO3 from pH 4.0 (red) to
pH 8.8 (yellow) by 0.2 pH units. Clean isosbestic behaviour is observed, with an isosbestic point at
458 nm in the visible region. (b) Plotted normalized absorption at 416 nm (blue) and 519 nm (red)
of MEHSO3 at indicated pH. When the protonated (416 nm) peak and deprotonated (519 nm) peak
are normalized and plotted, the intersection pH indicated the ground-state pKa of the compound, ca.
6.2
The pH titration yields clean conversion between two species (Figure 2.3). From
the titrations, the 416 nm band is assigned to the protonated merocyanine, and the
519 nm band to the deprotonated merocyanine, consistent with literature. The pKa
for MEHSO3 is estimated to be 6.2 (Figure 2.3b, crossing point). This is lower than
the published pKa of MEH (7.8) and much lower than the pKa of indazole-MEH
(13.0) [4, 5]. Unfortunately the pKa ofMEHSO3 is slightly lower than is desired for
work at physiological pHs; most ofMEHSO3 present at pH 7.4 will be deprotonated.
Photochemistry can still occur butwith no net pH change induced because no protons
are released. The ion channels of interest are activated in bulk by solutions with a
pH around 5.0, allowing MEHSO3 to be suitable for the photoactivation purposes.
The extinction coefficients of MEHSO3 were determined (Figure 2.4). MEHSO3
is well behaved at pH 4.0 and pH 8.0, allowing for the extinction coefficient of
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the completely protonated (pH 4.0, 416 nm band), completely deprotonated (pH
8.0, 519 nm band), and an isosbestic point (458 nm) (Figure 2.4). MEHSO3 has
a large extinction coefficient at visible wavelengths, consistent with the published
values for MEH and indazole-MEH [4, 5]. The pH 4.0 and pH 8.0 extinction
coefficients at 458 nm are in good agreement with each other, which is an important
self consistency check. The extinction coefficient at the isosbestic point (458) can
be used to calculate the total concentration of MEHSO3 in solution. The high
extinction coefficient at 416 nm dominates the spectrum and results in the bright
yellow colour in acidic solutions. Deprotonated MEHSO3 has an intense band at
519 nm, and a weaker band at 416 nm, resulting in the observed purple color. The
pH of the solution, using the pKa and the extinction coefficients, can be calculated.
(a) (b)
Figure 2.4: (a) UV-visible optical spectrum of the extinction coefficients of MEHSO3 at pH 4.0.
416 = 20500 M−1cm−1, 458 = 8800 M−1cm−1, and 519 < 100 M−1cm−1. (b) UV-visible optical
spectrum of the extinction coefficients of MEHSO3 at pH 8.0. 416 = 2400 M−1cm−1, 458 = 8500
M−1cm−1, and 519 = 20500 M−1cm−1.
This compound must undergo a photochemical reaction (Figure 2.1c) to release a
proton and serve as a photoacid. This photochemical conversion from MEHSO3 to
spiropyran-SO3 and back was examined using UV-visible spectroscopy. MEHSO3
was dissolved in (ND96 salts) to a final concentration of 20 µM; the pHwas adjusted
to ca.6.0 using NaOH. The resulting orange solution exhibits absorption maxima at
416 and 519 nm (Figure 2.5, black trace). Upon irradiation with a 455 nm LED,
these visible bands are lost and new bands at 204, 226, and 276 nm developed
over the course of seconds (Figure 2.5, red trace). These bands are assigned to the
ring-closed, deprotonated spiropyran-SO3. The room temperature thermal opening
of spiropyran-SO3 to MEHSO3 was monitored by UV-visible spectroscopy (Figure
2.5). Clean isosbestic points are present at 197, 260, and 301 nm, and complete
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Figure 2.5: Electronic absorption spectra of MEHSO3 (black trace) in the dark, and Spiropyran-SO3
(red trace) after irradiation. Arrows indicate changes observed proceeding from Spiropyran-SO3 to
MEHSO3 (in the dark) over the course of 75 min.
conversion back to MEHSO3 occurs over one hour. Shown in Figure 2.6 are
absorbance traces at 416 nm and 519 nm during the thermal conversion of the
spiropyran-SO3 to MEHSO3 at pH 6.0 and pH 8.0. The lifetime of MEHSO3 is
on the order of minutes (Figure 2.6), a period that will allow for the study of ion
channel activation.
Irradiation outside of the major absorption bands of MEHSO3 (e.g 632.8 nm, HeNe
laser) produced only minimal conversion at pH 6.0 after 140 min, and no conversion
after 60 min at pH 8.0 (Figure 2.7). The initial conversion under HeNe irradiation
at pH 6.0 is perplexing, as MEHSO3 has no absorbance at 632.8 nm. It could be
possible that upon dissolution of MEHSO3 there is some induction period in which
the compound might be equilibrating, and that the initial UV-visible spectrum is not
representative of the final equilibrium state of the solution. I find this explanation
unsatisfying, and cannot reconcile why pH 6.0 would behave differently than pH
8.0; the involvement of a proton is the only likely explanation. Regardless, complete
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(a) (b)
(c) (d)
Figure 2.6: The conversion of Spiropyran-SO3 toMEHSO3 observed at 416 nm (a, c) and 519 nm (b,
d) at pH 6.0 (a, b) and pH 8.0 (c, d). Each value is plotted versus time and fit to a single exponential
equation ( f (t) = A ∗ exp−t/τ + c). The lifetime (τ, in seconds) are: (a) 726, (b) 1361, (c) 623, (d)
556.
conversion of MEHSO3 to spiropyran-SO3 under 455 nm irradiation is observed
in a few seconds. Irradiation with a HeNe for an hour or more does not result in
substantial conversion. This shows irradiation into the optical bands is required for
the photochemical proton release to occur.
To examine the ability of MEHSO3, MEH, and indazole-MEH to induce long-lived
bulk pH changes in water the compounds were dissolved and the pH monitored
under 455 nm irradiation. I will briefly mention the behaviour MEH and indazole-
MEH as those two compounds are reported elsewhere [4, 5]. MEH is able to
induce bulk pH change of 1.5 units (initial pH ca. 6.0), persisting for minutes at
saturating concentrations. I was unable to obtain a bulk pH change upon irradiation
of saturated indazole-MEH solutions (initial pH ca. 6.0) due to the insolubility
in water. The pH of solutions of MEHSO3 (ca. 1 mM) in ND96 salts was also
monitored. The starting pH was 6.0, and upon irradiation the pH of the solution
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(a) (b)
Figure 2.7: UV-Visible spectrum of MEHSO3 upon irradiation using a HeNe laser at pH 6.0 (a) and
pH 8.0 (b). The spectra are normalized to the initial starting absorbance at 416 nm (a) or 519 nm
(b). Minimal conversion upon irradiation is observed in (a); complete conversion of the spectrum
occurs within a few seconds upon 455 nm irradiation. No conversion is observed for (b), again noting
complete conversion is observed under 455 nm irradiation conditions in a matter of seconds.
dropped and stabilized at ca. 3.6 over the course of 2 min, at which time the solution
had become colorless. Irradiation into the electronic absorption bands was required
for the photochemical process to occur; no pH change was observed after 2 h of
632.8 nm irradiation. When 455 nm irradiation was stopped, the solution slowly (60
min) returned to the initial pH and colour. The solution was cycled further resulting
in the same net pH changes during and after irradiation. At an initial pH of 6.0,
a little over half of the MEHSO3 molecules in solution are protonated. Irradiation
would release around 500 µM protons into solution, resulting in a pH of 3.3. A
pH of 3.6 achieved under the pH cycling conditions demonstrates that nearly all of
the protons available from MEHSO3 are released under irradiation and result in the
decreased pH. The bulk pH change can be modulated by the starting pH, as well
as the concentration of photoacid in solution; MEHSO3 is soluble to at least 85
mM in water. Notably, at high concentrations of MEHSO3, the rate of formation of
spiropyran-SO3 is limited by the irradiation intensity.
I sought to investigate the rate of proton delivery by the photoacids. Proton release
must occur much faster than the process being studied (ca. one millisecond for ion
channels). To monitor the proton release kinetics protonation of a pH sensitive dye,
bromocresol green (BCG, pKa 4.9), was monitored using time-resolved nanosecond
transient absorption spectroscopy (Figure 2.8) [2, 17]. MEHSO3 was dissolved
in ND96 salts (pH ca. 6.0) and BCG was added. The UV-visible spectrum of the
two component system (Figure 2.8a, red line) appears as the sum of the individual
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spectra. This indicates no ground-state interactions exist between MEHSO3 and
BCG.
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Figure 2.8: (a) UV-visible spectra of MEHSO3, Bromocresol Green (BCG), and MEHSO3 +
BCG before nanosecond transient absorption experiments. This is a representative sample, as the
other photoacid samples appeared similar. (b) The transient absorption signal at 632.8 nm of all
the individual components of the reaction, upon excitation with 455 nm light. (c) The transient
absorption signal at 632.8 nm of the merocyanine photoacids combine with BCG, upon excitation
with 455 nm light.
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Deprotonated BCG has an intense absorbance peak centered at 616 nm, which
decreases upon protonation [18]. To observe the rate of proton release, MEHSO3
was photoactivated with 455 nm laser light. Protonation of BCG was observed at
632.8 nm, where there is no interference of any merocyanine photoacid band. Upon
excitation of any of the merocyanine photoacids, or BCG alone, no transient signal
at 632.8 nm was observed (Figure 2.8b).
A solution ofMEHSO3with BCGwas excitedwith a 455 nmpulse. Rapid bleaching
at 632.8 nm was observed. The decrease at 632.8 nm (Figure 2.8c, black line) is
consistent with protonation of BCG. The protonation of BCG by MEHSO3 was
complete in 1 ms. The transient bleach fit well to a single exponential and results
in a time constant of ca. 100 microseconds. The protonation kinetics of BCG were
examined using two other previously established merocyanine photoacids (MEH
and indazole-MEH) [4, 5]. The concentrations of all the merocyanine photoacids
and BCG were the same, allowing for the observed protonation rates to reflect
the intrinsic reactivity differences of each photoacid. Replacing the sulfonate with
a proton (MEH), and the phenol with an indazole (indazole-SO3) resulted in a
markedly slower protonation of BCG (Figure 2.8c, blue and red lines, respectively)
when compared to MEHSO3.
The protonation of BCG serves as a good model for the ion channel binding studies.
The pH50 values for the ion channels of interest are 5.5 and 3.9. These values are
proportional to the equilibrium constant for binding to a proton, and are similar
to the pKa of BCG. Ion channel activation measurements have time resolutions
approaching one millisecond suggesting that delivery of the activating ligand needs
to occur on shorter timescales. The indazole-MEH photoacid requires more than
500 ms for complete BCG proton delivery and is not a viable candidate ion channel
activation. The MEHSO3 and MEH photo-protonation of BCG are complete by 1
ms and 10 ms respectively. This suggests that of the three merocyanine photoacids,
MEHSO3 is the most likely to be viable (in terms of proton delivery kinetics) for
use in photoactivation of acid-sensitive ion channels. The rate of proton delivery is
not the only concern, the yield of proton production is also crucial for any potential
photoacid. Qualitative calculations for both MEHSO3 and MEH, using the raw
∆OD measurements and the BCG extinction coefficient obtained from the transient
absorption experiments, result in about 100 nM of protonated-BCG formed, which
translates to 1 percent generation of protons. The low quantum yield of proton
production is an issue if the functional readout is not robust, as it might be in the
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case of some measurements.
Complete characterization of three differentmerocyanine photoacids, two previously
published (MEH and indazole-MEH) and the newly synthesized MEHSO3 provides
insight into the properties of these photoacids. Comparison of the determined prop-
erties, with the requirements for photoacids mentioned in the introduction to this
chapter, allows for the determination of the photoacid applicability for photoactiva-
tion of ion channels. All of the merocyanine photoacids are air stable, and undergo
a photochemical reaction with visible light (455 nm LED used in these studies).
The indazole-MEH compound lacks solubility in water, does not induce a bulk pH
change, and has slow release of a proton. This compound will not be used in the
photoactivtion of ion channels. MEH, in contrast, is fairly soluble in water, can
induce a bulk pH change that lasts for minutes, and delivers protons on the order
of 10 ms. MEHSO3 is very soluble, induces a bulk pH change, and has rapid (1
ms) delivery of protons to an external base. I will address the issue of biological
compatibility in the next section. MEH and MEHSO3 will be used to investigate
the ability of these compounds to photoactivate acid-sensitive ion channels.
2.3.2 Activation of ASIC2a and GLIC by the Sulfonated-Merocyanine Pho-
toacid
In this section I discuss the use of MEHSO3 in the photoactivation of acid-sensing
ion channel isoform 2a (ASIC2a) and Gloeobacter ligand-gated ion channel (GLIC).
ASIC2a and GLIC respond to bulk pH changes, and the (pH50) values for each are
3.9 and 5.5 respectively [6, 7]. The low sensitivity ion channels will allow for
MEHSO3 solutions to be prepared at a starting pH where MEHSO3 is protonated,
and the ion channels are not activated. I express ASIC2a and GLIC in X. laevis
oocytes by injection of in vitro transcribed mRNA. I will examine the ability of the
photoacid to activate the ion channels, as well as potential undesired interactions of
MEHSO3 with the channels.
ASIC2a (Rattus norvegicus) DNA was a gift of Professor Stefan Gründer. ASIC2a
mRNA was injected into oocytes with the expression levels and functional charac-
terization tested by exposure to low pH buffers. As seen in Figure 2.9, ASIC2a
expression was observed after 24 hours of incubation; the observed dose-response
to proton concentration agrees well with published data [6]. Desensitization at low
pH values is observed and consistent with published results [6, 19]. Desensitiza-
tion occurs at pH values where all the channels are open (the lowest pH); for the
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Figure 2.9: Activation of ASIC2a by application of low pH buffers
photoactivation and biocompatibility studies discussed here, pH 5.5 will serve as a
reference response. This pH value allows for the monitoring of the ASIC2a channel
response, without the added complication of desensitization.
First, the dark response of ASIC2a to MEHSO3 was examined. A photocaged
compound must not be active until irradiated. MEHSO3 was applied to ASIC2a
expressing oocytes and the current monitored in the dark. No current response
was observed in the absence irradiation (Figure 2.10a). The irradiation require-
ment demonstrates the ability of temporal and spatial activation of ASIC2a with
MEHSO3. Oocytes not expressing ASIC2a did not show response upon appli-
cation, or irradiation, of MEHSO3 (Figure 2.10b) showing that native oocyte ion
channels are not activated.
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Figure 2.10: (a) Exposure to MEHSO3 (480 µM) without irradiation (cyan trace) does not show
activation of GLIC-expressing oocytes. A minimal current change is observed upon application (ca.
50 seconds), seen across all samples. (b) Naive oocytes exposed to MEHSO3, and irradiated. Upon
irradiation no current change is observed, indicative that native oocyte channels are not activated by
500 µM of MEHSO3.
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To demonstrate photoactivation (Figure 2.11a), MEHSO3, dissolved in the ND96
salts, was pH adjusted to ca. 5.8, and applied to oocytes expressing ASIC2a.
Application of MEHSO3 in the dark resulted in a small current change due to the
small basal response of ASIC2a to pH 5.8 solutions. After an incubation time of ca.
25 s, a 455 nm LED was then used to irradiate a single oocyte. Irradiation occurred
for 10 s, which resulted in rapid current response (Figure 2.11a, black line). This
current change is consistent with the activation of ASIC2a resulting from the binding
of protons released by irradiated MEHSO3 (Figure 2.1c). After the LED was turned
off, current from ASIC2a returned to near-baseline. The oocyte solution was then
exchanged and further electrophysiological manipulation occurred. Before and after
exposure to MEHSO3, pH 5.5 current response of ASIC2a-expressing oocytes was
measured (Figure 2.11a, red and blue lines, respectively). The pH 5.5 current did
not change after exposure to MEHSO3 showing that the photoacid does not have
any prolonged effect on the channel.
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Figure 2.11: (a) Activation of ASIC2a upon irradiation (black line, irradiation occurring at position
indicated by arrow) for 10 s of MEHSO3 (480 µM) with a 455 nm LED (700 mW peak power)
compared to a 30 sec application of a pH 5.5 buffered solution before and after (red and blue lines
respectively) application of MEHSO3.(b) ASIC2a activation in the presence of MEHSO3 (280 µM)
dissolved in pH 5.5 buffer and irradiated (black line), compared with ASIC2a activation to pH 5.5
buffered solution alone (red and blue lines). The pH 5.5 solutions were exchanged for pH 7.0 buffers
after 30 sec, while the sample containing MEHSO3 was exchanged after 200 sec, with a 10 sec
photolysis occurring after 25 sec, as indicated by the arrow.
When considering the use of photoactive molecules in a biological context, it is
crucial to evaluate the effect of both the “pro-drug” (pre-photolysis) and the “post-
drug” (post-photolysis products) on the system of interest. In the present system,
that means that both MEHSO3 and spiropyran-SO3 cannot interact with the ion
channel. To address this concern, MEHSO3 was dissolved in pH 5.5 MES buffer
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and applied to ASIC2a-expressing oocytes (Figure 2.11b). The currents observed
with MEHSO3 in buffer (Figure 2.11b, black line) are consistent with the pH 5.5
response of ASIC2a before application of MEHSO3 (Figure 2.11b, red line). This
result indicates that MEHSO3 (pro-drug) does not affect ASIC2a channels. Upon
irradiation of this oocyte, no change in current was observed (Figure 2.11b, black
line). Irradiation under these conditions will form spiropyran-SO3 (post-drug)
however, a bulk pH change is not induced due to the presence of buffer. Formation
of the spiropyran-SO3, without a pH change, allows the interaction between ASIC2a
and spiropyran-SO3 to be observed directly. No change in current was observed
upon irradiation in buffered solution. NeitherMEHSO3 nor spiropyran-SO3 interact
with ASIC2a beyond H+ delivery.
I also demonstrated the photoactivation of GLIC, an acid-sensitive member of the
pentameric ligand-gated ion channel family. The specific function of GLIC in the
native ogranism Gloeobacter violaceus is not known. However, GLIC was one of
the first pentameric ligand-gated ion channels crystallized, exhibits typical ion flux
characteristics of the cation-selective members of this family, and as a result has
served as a goodmodel system for the study of pentameric ligand-gated ion channels.
MEHSO3 activates GLIC only upon irradiation (Figure 2.12a) and no deleterious
interactions were observed between GLIC and either MEHSO3 or spiropyran-SO3
(Figure 2.12b).
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Figure 2.12: As observed with ASIC2a (Figure 2.11), photoactivation of GLIC is also observed,
and no inhibition by spiropyran-SO3 is observed. (A) Activation of GLIC is triggered by the
release of protons by MEHSO3 under irradiation using a 455 nm LED. (B) No inhibition of acid-
induced activation of GLIC by MEHSO3 (before irradiation, black trace) or spiropyran-SO3 (under
irradiation).
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I have demonstrated the use of MEHSO3 as a photoactivation method of ASIC2a
and GLIC. In vitro characterization of MEHSO3 showed a rapid, bulk pH change
occurs under irradiation; the biocompatibility of MEHSO3 was addressed in this
section. Application ofMEHSO3 in unbuffered solution results in activation of acid-
sensitive ion channels only upon irradiation. Further biocompatibility experiments
with MEHSO3 addressed the interactions of MEHSO3 or spiropyran-SO3 with the
activated or closed channel. Interaction of MEHSO3 with the open channel will
alter the observed pH signal, while interaction of MEHSO3 with the closed channel
can alter the channel activation properties after exposure to MEHSO3. With both
ASIC2a and GLIC, minimal change in signal is observed when activated channels
are exposed toMEHSO3 or spiropyran-SO3. Any perturbation to the system beyond
activation is undesirable and would render MEHSO3 useless for the photoactivation
of the ion channels. The irradiation of MEHSO3 in buffered solutions results in
a small change in both ASIC2a and GLIC signals; these changes are proportional
to [MEHSO3]. MES (pKa = 6.1) is the buffer used in these experiments, and
pH 5.0 is approaching the edge of the effective buffering range. As a result this
buffer is less effective when large amounts of protons are introduced into the system.
Irradiation of 500 µM MEHSO3 in the buffered solutions (in vitro) does cause a
moderate decrease in the pH of the solution. The decrease in pH could cause the
modest current change observed in the buffered experiments. One potential method
to address this is to go to higher ionic strength buffers, or switch buffers that have
a pKa closer to the operating pH. Regardless, it is clear that MEHSO3 can be used
to photoactivate ASIC2a and GLIC ion channels. This establishes that MEHSO3
is a generic photoacid, capable of activating a range of channels and, by extension,
other acid-sensitive proteins.
2.3.3 Activation of GLIC and ASIC2a by MEH
MEH was also found to have in vitro properties that could be translated to the
activation of GLIC and ASIC2a. The MEH biocompatibility was tested using
methods similar to those used in the MEHSO3 evaluation. Oocytes were exposed to
saturated MEH solution (adjusted to pH 5.8). After application, a small response to
the MEH solution was observed, consistent with GLIC and ASIC2a response to the
slightly acidic pH 5.8 solution. Following an equilibration period inwhich no further
change in current was observed, an individual oocyte was irradiated using a 455 nm
LED for ten seconds (Figure 2.13a). Upon irradiation, immediate current response
is observed. After irradiation ceases, the current slowly returns to pre-irradiation
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levels. No response is observed under dark conditions, and uninjected oocytes do
not exhibit a response to MEH in the dark or under irradiation. This experiment
demonstrates that the bulk pH change under irradiation can trigger GLIC activation.
The response of GLIC to irradiated MEH solutions is much less than the response to
pH 5.0 buffer. This suggests the final pH of the irradiated sample is higher than 5.0,
or that MEH is interacting with the channels. At similar concentrations irradiation
of MEHSO3 is able to activate GLIC to a comparable level as the low pH buffers
(Figure 2.12a). This suggests that MEH is inhibiting the GLIC signal. The blocking
appears to be reversible, as GLIC ion channels before and after exposure to MEH
(Figure 2.13a, red and blue traces respectively) respond similarly to the low pH
buffers, indicating no prolonged interactions with MEH.
(a)
0 100 200 300 400 500 600 700 800 900
−8
−7
−6
−5
−4
−3
−2
−1
0
Time (seconds)
Cu
rr
en
t (µ
A
)
pH 6.0
pH 5.5
Saturated
MEH + hν
(b)
0 50 100 150 200 250 300 350 400−18
−16
−14
−12
−10
−8
−6
−4
−2
0
Time (seconds)
Cu
rr
en
t (µ
A
)
 
 
pH 5.0 Buffer Before
Saturating MEH
pH 5.0 Buffer Afterhν
(c)
Figure 2.13: (a) The activation of GLIC-expressing oocyted upon irradiation of a saturated solution
of MEH. (b) Current response of GLIC in the presence of low pH buffers, and under irradiation in a
solution of MEH. (c) GLIC response to pH 5.0 buffer (red and blue lines), followed by exposure to
low pH buffer with saturated MEH with irradiation occuring as indicated by the arrow (black line).
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In the above experiments, a saturating concentration of MEH was used. The solu-
bility of the photoacid has been published [4], but it is unclear the proton concentra-
tion produced under irradiation. To examine the final pH of the irradiated solution,
oocytes were first exposed to a known pH, and response measured (Figure 2.13b).
The buffer was then exchanged for a saturated solution of MEH, and the oocytes
irradiated as above. This was repeated for pH 6.0 and pH 5.5 buffers. The current
response of the oocyte under irradiation was then compared to the response of the
same oocyte to a given pH. The observed signal upon irradiation of the saturated
MEH solution is much larger when compared to the pH 6.0 response. The response
to pH 5.5 buffer, and the irradiatedMEH solution, are similar in magnitude. Current
is proportional to the number of GLIC channels activated; these experiments use
GLIC response as a biological pH meter. Testing the same oocyte results in little
variation of the current response across multiple applications of the same proton
concentration. Correspondingly, testing the GLIC response to a known pH, then
to irradiated MEH samples allows for the approximation of the pH that the MEH
solution reaches under irradiation. To obtain the pH under irradiation using GLIC,
the dose-response of GLIC towards protons, and the maximum current for each
oocyte is needed. Though useful, this only qualitatively allows for pH achieved
under irradiation of saturated MEH to be bracketed between 6.0 and 5.5.
Above, MEH was shown to photoactivate GLIC, investigations into the biocompati-
bility ofMEH and spiropyran-Hwere needed. Similar to theMEHSO3 experiments,
MEH was dissolved in pH 5.0 buffer to saturating concentrations. Irradiation of
saturated MEH in buffer does not result in a pH decrease. However, irradiation does
result is the photochemical conversion of MEH to spiropyran-H (structure shown in
Figure 2.1c). GLIC pH 5.0 activation was examined by exposure to buffer (Figure
2.13c, red and blue lines), before and after exposure to MEH in buffer. Application
of saturatedMEH in pH 5.0 buffer results in a substantial decrease in GLIC response
(Figure 2.13c, black line) compared to the pH 5.0 response in the absence of MEH.
This suggests that the merocyanine form of MEH interacts with activated GLIC
in a deleterious fashion. Irradiation of MEH in buffer causes further decrease in
signal. The decrease in GLIC signal under irradiation shows that spiropyran-H also
inhibits GLIC. The mechanism of inactivation caused by MEH is not known. This
deleterious interaction is not permanent; after buffer exchange response to pH 5.0
buffer is slightly attenuated when compared to pre-MEH pH 5.0 response (Figure
2.13c, blue and red lines respectively).
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The ability for MEH to photoactivate ASIC2a was also investigated. ASIC2a
expressing oocytes were exposed to pH 5.5 buffers before and after application of
saturated MEH solutions, either buffer free or in a pH 5.5 buffer (Figure 2.14, (a)
and (b) respectively). Activation of ASIC2a occurs only under irradiation of the
saturated MEH solution (Figure 2.14a, black line), consistent with the above studies
with MEH and MEHSO3 on ASIC2a and GLIC. Application of MEH in a pH 5.5
buffer results in a moderate attenuation of the AISC2a response to pH 5.5 buffer.
This attenuation suggests MEH interacts with the ASIC2a channel in a manner that
inhibits signal. Minimal change in the ASIC2a signal is observed under irradiation
of MEH in buffer (Figure 2.14b). Following buffer exchange, application of pH 5.5
buffer results in a smaller response when compared with pre-MEH pH 5.5 signal
(Figure 2.14b, blue line). The response of ASIC2a channels to MEH is much
different than GLIC. GLIC exhibited substantial inhibition by both the merocyanine
and spiropyran form of MEH. Only minimal inhibition of AISC2a is observed. One
complication with ASIC2a is the formation of a desensitized state, even at pH 5.5.
Competition between entering the desensitized state, and MEH interactions with
ASIC2a could explain the different interaction of ASIC2a with MEH. Incomplete
recovery of pH 5.5 response after exposure to MEH suggests moderate perturbation
of the ASIC2a ion channels exist. In general, less perturbation of the ASIC2a
by MEH is observed when compared to the GLIC/MEH interactions; however, a
deleterious interaction still exists.
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Figure 2.14: (a) The activation of ASIC-expressing oocyted upon irradiation of a saturated solution
of MEH. (b) ASIC response to pH 5.5 buffer (red and blue lines), followed by exposure to low pH
buffer with saturated MEH with irradiation occurring as indicated by the arrow (black line).
It is not unusual for small molecules with significant hydrophobicity and a cationic
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center, like MEH, to block ion channels. With GLIC, and to a lesser extent ASIC2a,
perturbation of ion channel activity is observed when exposed to MEH. This inter-
action persists even when the molecules have been thoroughly washed away. The
addition of a sulfonate, as in MEHSO3, was designed to increase the hydrophilicity
of the photoacid. The addition of an extra sulfonate creates a photoacid that is
compatible with GLIC and ASIC2a ion channels.
2.3.4 Caged Sulfate Photoacid Characterization and GLIC Activation
The synthesis of a nitrobenzyl-protected sulfate was previously reported [3]. Ab-
bruzzetti et al. show rapid release (107 s−1) of protons occurs; this compound is
extremely water soluble due to the sulfate group. UV irradiation is needed to trigger
the nitrobenzyl photochemistry that results in the release of a proton (Figure 2.15a).
While UV irradiation is not desirable for biological systems, 355 nm irradiation
does not excite the protein backbone (220 nm) or aromatic amino acids (280 nm).
This compound was synthesized, characterized (Figure 2.15b), and irradiated with
a 365 nm LED to produced a decrease in pH. With the caged-sulfate in hand, I
examined the ability to photoactivate GLIC, as well as the biocompatibility.
(a)
(b)
Figure 2.15: (a) The photoreaction that occurs upon irradiation of the caged sulfate molecule (left).
(b) 1H NMR spectrum of the purified caged sulfate molecule. Caged sulfate was purified from the
starting materials using a DAEA cellulose anion exchange column.
A 1 mM solution of caged sulfate was prepared in ND96 salts and the initial pH
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was adjusted to ca. 7.0. Application of the caged sulfate results in minimal GLIC
response, consistent with no GLIC response to pH 7.0 solutions. Irradiation of the
GLIC-expressing oocyte exposed to caged sulfate results in a rapid change in signal
(Figure 2.16a, black trace). A sharp return to baseline currents was observed after
irradiation was stopped. The solution was exchanged and the oocytes exposed to the
low pH buffers. GLIC response to low pH buffer before and after exposure to the
caged sulfate photoacid were similar (Figure 2.16, red and blue traces respectively),
suggesting prolonged interactions do not exist between the caged sulfate or the
photoproduct and GLIC. The sharp decrease in signal after irradiation is perplexing.
GLIC ion channels do not desensitize until extremely low pH exposures [20].
One cause of the decrease in signal could be desensitization resulting from low
pH. The sharp decrease could also result from interaction between GLIC and the
caged sulfate photoacid. The caged sulfate in these experiments (1 mM) allows for
a theoretical maximum release of 1 mM protons, assuming complete conversion
under the 5 seconds of irradiation. The result of releasing 1 mM protons is a pH
= 3.0. Experience with oocyte electrophysiology suggests that, in general, oocytes
do not survive pH 3.0 solutions well. The response to pH 5.0 buffer after caged
sulfate irradiation is unaltered compared to the pre-exposure response (Figure 2.16,
red and blue lines). Combined with the survival of the oocytes, this would suggest
that pH 3.0 is not reached. Complete conversion is unlikely to occur in 5 seconds of
irradiation; the quantum yield for the nitrobenzyl photochemistry is not unity [3].
To examine the effect of the pH on GLIC activation/inactivation, the concentration
of caged sulfate was decreased. Caged sulfate dissolved at 100 µM was exposed to
GLIC. Irradiation for five seconds afforded a rapid increase in current (Figure 2.16c,
black trace). Following an equilibration period, irradiation of the same oocyte
saw further increase current. This process was repeated multiple times with the
same phenomenon being observed. The caged sulfate is an irreversible photoacid
resulting in the observed step-function responses to irradiation. The presence of
multiple activation steps demonstrates that complete conversion does not occur
during 5 seconds of irradiation. At the lower concentrations of caged sulfate, the
rapid decrease in signal after irradiation stops is not observed. After multiple
irradiation events of a single oocyte, the desensitization-like events start to occur.
This could suggest that the pH has reached a level whereGLIC desensitizes (pH< 4.0
and 100% conversion). Another consequence of themultiple irradiation events is the
formation of more activated GLIC channels, and more photoproduct. To examine
the observed decrease upon prolonged irradiation, a 200 µM solution of caged
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Figure 2.16: (a) The activation of GLIC-expressing oocytes upon irradiation of a 1 mM solution of
caged sulfate. (b) Exposure of GLIC to low pH buffers with (62 µM Caged sulfate) in the dark and
under irradiation. (c) GLIC activation under irradiation in the presence of 100 µM caged sulfate and
(d) 200 µM caged sulfate.
sulfate was tested. The step function response is also present upon irradiation of the
200 µM sample (Figure 2.16d, black trace). However, after the first irradiation the
desensitization-like behaviour is present. A higher proton concentration is achieved
under prolonged irradiation of the 100 µM sample, as well as a higher photoproduct
concentration. Similar proton concentrations are achieved under shorter irradiation
periods with 200 µM caged sulfate. These experiments are only able to determine
that higher concentrations of protons and/or photoproduct result in the decrease in
GLIC signal observed.
To determine interactions between GLIC and the caged sulfate or photoproduct a
similar set of experiments were performed as for the merocyanine photoacids. In
these experiments GLIC expressing oocytes were exposed to pH 5.0 in the presence
and absence of caged sulfate. Exposure to 65 µM caged sulfate dissolved in pH
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5.0 buffer results in attenuation of observed current response (Figure 2.16b, black
trace) indicating that the caged sulfate interacts with GLIC in a deleterious manner.
Upon irradiation of that sample, a further decrease is observed in GLIC current
response, suggesting that the photoproduct also interacts with the channel. Buffer
exchange returns the pH 5.0 current response to the pre-caged sulfate level, showing
the interactions between GLIC and the caged sulfate are reversible.
While the caged sulfate photoacid displays the necessary in vitro properties for
use in the photoactivation of ion channels, the biological characterization argues
otherwise. Upon irradiation the caged sulfate does activate GLIC; however, further
investigation revealed that both the pre-irradiation molecule (caged sulfate) and
the proton released form (photoproduct) significantly attenuate of the pH-induced
current response of GLIC. This attenuation eliminates the use of the caged sulfate
photoacid as a viable compound for the photoactivation of GLIC.
2.3.5 Sulfonated Naphthol Synthesis, Characterization, and GLICActivation
Use of naphthols as photoacids are well studied and derivatized easily to afford water
solubility [2, 9]. Naphthols are known to release protons on the order of nanoseconds
[21] under UV irradiation. The lifetime of the deprotonated naphtholate is very
short (ns), as opposed to minutes or infinite for the other photoacids examined in
this chapter. Despite these potential complications, naphthols were investigated as
photoacids to trigger the activation of GLIC.
The synthesis of the sulfonated naphthol was achieved readily though the use of
concentrated sulfuric acid following a published procedure [9]. From the analysis
of the 1-D, and 2D-COSY 1H NMR (Figure 2.17) a single sulfonate group was
added at the one position of the ring. Both substitution at the one and the five
position results in the coupling observed; however, the 1-position is more activated.
To confirm the precise substitution position a crystal structure or more advanced
2-D NMR is needed. This sulfonate group affords solubility in water, crucial for the
use in biological studies. Irradiation of a sulfonated naphthol sample dissolved in
water did not result in a decrease of the bulk pH.
Despite the lack of measurable bulk pH change, GLIC was expressed in oocytes as
above, and activation in the presence of sulfonated naphthol was examined. For the
irradiation of the sulfonated naphthol, both a 254 nm Hg-lamp and a 365 nm LED
were used. GLIC-expressing oocytes under irradiation using either light source
showed no activation (Figure 2.18, black and green lines). Current response to
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(a)
(b)
Figure 2.17: The 1-D 1H (a) and 2-D 1H (b) NMR of the sulfonated Naphthol.
pH 5.0 buffer was attenuated after exposure and irradiation of naphthol. Because
254 nm is not desirable for biological applications more effort was placed into the
irradiation with 365 nm LED. No current change was observed under 5 minutes
irradiation with the LED. This demonstrates that the sulfonated naphthol is not
viable as a photoacid trigger of GLIC. While the lifetime of naphthols are short,
constant irradiation could provide a labile pool of protons. If GLIC was able to bind
one of these free protons, and activate, the hopewas that the protonwould stay bound
to GLIC, and extend the naphtholate lifetime. It is not clear whether this assumption
was wrong, or the irradiation does not result in the desired photochemistry, but no
activation of GLIC is observed. The sulfonated naphthol was not pursued further as
a result of the requirement of UV irradiation, and no observed activation of GLIC.
56
0 50 100 150 200 250 300 350 400
−40
−35
−30
−25
−20
−15
−10
−5
0
Time (Seconds)
Cu
rr
en
t µ
A
 
 
pH 5.0 before
Sulfonated Naphthol (254 nm)
Sulfonated Naphthol (365 nm)
pH 5.0 after
Figure 2.18: Activation of GLIC by application of low pH buffers, and exposure to sulfonated
naphthol under irradiation
2.4 Conclusions and Future Outlooks
In this chapter a variety of photoacids was examined for the potential use in the
activation of ASIC2a and GLIC acid-sensitive ion channels. The study of biological
systems requires any photoacid to be water soluble, air stable, visible light activated,
and biocompatable. Each of these properties were examined with merocyanine
photoacid derivatives, a nitrobenzyl-protected sulfate, and a naphthol photoacid.
The naphthol photoacid was solublized by addition of a sulfonate group through
synthetic modification. Unfortunately under UV irradiation, GLIC activation was
not observed, eliminating the use of sulfonated naphthol as a potential photoacid
trigger for ion channel activation.
The caged sulfate molecule was well characterized in the literature [3], and was
easily synthesized. This compound displays rapid, irreversible proton release, and
the necessary solubility and stability properties. While UV irradiation is required,
365 nm irradiation is amenable to biological systems. Photoactivation of GLIC
was observed under irradiation of the caged sulfate. Unfortunately the caged sulfate
molecule did not have the desired biocompatible properties. Both the caged sulfate,
and its photoproduct, interact with GLIC in a deleterious manner.
The last class of photoacids investigated were merocyanine-derived photoacids. In
vitro characterization of the proton release rate of all of the merocyanine photoacids,
and full characterization of the newly synthesized MEHSO3 occurred. All the
merocyanine photoacids are visible-light triggered unlike the previously mentioned
photoacids. Unfortunately, the indazole-MEH is not soluble at concentrations that
will elicit a bulk pH change. The very slow release of a proton (> 500 ms),
combined with the solubility issues resulted in the indazole-MEH compound not
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being subjected to biological testing. The remaining merocyanine photoacids differ
by a single substitution. The protonation of a pH sensitive dye occurred on the
order of 1 ms for MEH and 100 µs for MEHSO3. The difference of a single
sulfonate group results in an increase in protonation by an order of magnitude. No
dark activation of ion channels was observed for MEH or MEHSO3 and no native
oocyte ion channels were activated in the presence or absence of light for both
MEH and MEHSO3. The application, and subsequent irradiation, of MEH in the
presence of an acid-sensitive ion channel results in activation only upon irradiation, a
requirement for the compound to be a phototrigger. However, further studies showed
that the MEH, and the photoproduct (spiropyran-H), inhibited the ion channel. This
eliminates the possibility of MEH as a viable photoactivation method. Application
and irradiation of MEHSO3 also activated acid-sensitive ion channels. In contrast
to all the other compounds discussed in this chapter (spoiler alert...the whole thesis),
MEHSO3 and the photoproduct (spiropyran-SO3) did not interact with the channel
in any detectable manner. The addition of the sulfonate group enhances the water
solubility of the molecule, presumably eliminating any potential interaction with
the hydrophobic membrane of the oocyte or ion channel. MEHSO3 is the only
photoacid examined in this chapter that meets all of the requirements for use in the
photoactivation of acid-sensitive ion channels.
MEHSO3 has potential use in other pH sensitive systems, not just the activation of
acid-sensitive ion channels. The low pKa (6.2) of MEHSO3 will hamper the use
under physiological conditions. The substitution of phenols is well studied, and I
think that with some modest synthetic modifications to the MEHSO3 phenolic ring,
the pKa could approach 7. A pKa of around 8.5 would result in almost all of the
molecule being protonated at physiological pH, and would be ideal. It would be
important to examine the new molecule’s properties, as any synthetic modification
that eliminates the biological compatibility, or solubility is undesired. I also think
further analysis of the MEHSO3 protonation of BCG is of interest. Examining the
rate of protonation would allow for the determination of the order of this reaction.
These exercises are left to a future graduate student. What is attractive about this
molecule is the relative inertness to biological conditions, suggesting that MEHSO3
can act as a generic photoacid with potential use in the study of other pH sensitive
chemical and biological systems.
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C h a p t e r 3
CHARACTERIZATION AND USE OF RUTHENIUM
COMPLEXES AS PHOTOLABILE PROTECTING GROUPS FOR
THE ACTIVATION OF LIGAND-GATED ION CHANNELS
3.1 Introduction
This chapter focuses on the photoactivation of ligand-gated ion channels using ruthe-
nium complexes as cages. The basis for the caged compounds is a polypyridyl-Ru(II)
center. Polypyridyl-Ru(II) photochemistry and photophysics have been extensively
studied [1–4]. TheRu(II) chromophore has strong absorption bands in the visible re-
gion of the spectrum; a visible peak at 453 nm in tris-(bipyridyl)-Ru(II) (Ru(bpy)32+)
has an extinction coefficient on the order of 104 M−1cm−1 [1]. This electronic band
is assigned to the metal-to-ligand charge transfer transition (MLCT), where an elec-
tron is excited from the ruthenium center onto a primarily ligand-centered orbital
[5, 6]. Inter-system crossing, followed by relaxation back to the ground state results
in luminescence at 600 nm. The Ru(bpy)32+ excited state is long-lived; the excited
state of Ru(bpy)32+ can be quenched by both electron donors and acceptors afford-
ing the (formally) Ru(I) or Ru(III) species, respectively [2]. The excited state of
Ru(II) is a good (0.8 V) oxidant and reductant, while Ru(I) and Ru(III) are powerful
(ca. 1.24 V) oxidants and reductants [7]. The favourable photochemical and pho-
tophysical properties have seen Ru(bpy)32+ used in a wide variety of applications
including: solar energy conversion [8], chemical catalysis [9], biological electron
transfer [10], and cellular toxicity [11, 12].
Ru(II) complexes have also been used for photochemical caging studies. The Ru(II)
photocage utilizes the transition from the populated MLCT orbitals into ligand-field
(LF) centered orbitals (Figure 1.5). Population of the LF orbital results in distortion
of octahedral geometry and release of a ligand [3, 13]. Population of the LF states
is a competing decay pathway of the excited Ru(bpy)32+. For photodissociation
to occur, LF states must be populated before the radiative decay of the excited
state. This competition results in rapid photodissociation of the ligand. Substitution
of a pyridine ligand of Ru(bpy)2(py)22+ was shown to have efficiencies of 0.3 in
dichloromethane with excess halide present [3]. Interestingly the substitution of
Ru(II) complexes in neutral water is significantly attenuated. This highlights the
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importance of the relative energies of the MLCT and LF states, and the sensitivity
to solvents and ligands [14]. Photodissociation of nitriles from Ru(bpy)2(L)2n+, is
readily achieved, and has been implemented in a photodynamic therapy application
[15, 16]. The photosubstution of amines using the Ru(bpy)2-platform is not as
efficient.
Many native neurotransmitters (serotonin, GABA, glutamate, etc.) and common
drugs (nicotine, DMT) contain amine functional groups. Etchenique and cowork-
ers recently developed Ru(bpy)2-based photocages for amine ligands [17–22].
Importantly, they demonstrated the release of nicotine, GABA, and glutamate
using the photochemical platform of Ru(bpy)2(PPh3)(L)n+. I sought to use the
Ru(bpy)2(L)(L’)n+ systems as photochemical triggers of ion channel activation. The
Ru(II) systems display visible-light activation, high quantum yield of substitution,
rapid release of ligand, and stability in water and air. I focus mostly on the release
of propylamine (PrNH2) for the activation of ELIC. I will discuss the use of the
Etcheniuqe system, as well as other derivatives of Ru(II)-polypyridyl. I will outline
the benefits and shortcomings of these systems for use in ion channel activation.
3.2 Methods and Materials
3.2.1 General Procedures
Chemicals, Ru(bpy)2(Cl)2, RuCl3, 2,2’-bipyridine (bpy), (4,4’-dicarboxy)-bpy, (6,6’-
dimethyl)-bpy, NH2-PEG1K,PPh3, 2,2’:6’2”-terpyridine (tpy), propylamine, GABA,
5-hydroxytryptamine, were purchasedSigma-Aldrich. Ru(bpy)2(PPh3)(L), Ru(bpy)2(L)2,
Ru(tpy)(L)3, Ru(dmb)2(L)2, and Ru(tpy)(dmb)(L) were synthesized as previously
described [14, 15, 18, 21, 23–26]. Synthesis of the bpy-PEG ligand occured through
standardHATUcouplings outlined in Figure 3.11. UV-Visible spectrawere obtained
using a 1 cm quartz cuvette and a HP-8453 spectrometer. Steady-state luminescence
experiments were conducted using a Jobin Yvon Spex Fluorolog-3-11 spectrometer.
Samples were excited by a 450 W xenon arc lamp through a monochromator for ex-
citation at 455 nm. Emission was collected using a scanning monochromator, with
detection achieved by a Hamamatsu R928P photomultiplier tube in photon counting
mode. For 77K measurements, complexes were dissolved in a 1:1 methanol:ethanol
solution and flash frozen in liquid nitrogen in a standard NMR tube. The measure-
ments were made with the tube submerged in liquid nitrogen contained in a glass
dewar. NMR solvents were purchased fromCambridge Isotope. All 1H spectra were
reported in reference to the solvent peak. Spectra were collected using a VarianMer-
cury 300 MHz spectrometer. Steady-state irradiation occurred using a Thorlabs 455
62
nmLED (M455L1) unless otherwise noted. All electrophysiology experiments were
carried out as mentioned elsewhere [27–29]. Briefly, oocytes were injected with
mRNA coding for the ion channel of interest, incubated for 24 hours, then subjected
to whole-cell voltage-clamp electrophysiology using the OpusXpress (Molecular
Devices) with a holding voltage of -60 mV, and a sampling rate of 125 Hz. HEK
cell studies and FlexStation measurements were made as previously described [30].
All data work up was done in MATLAB R2013b (Mathworks, Inc.).
3.3 Results and Discussion
3.3.1 Use of Ru(bpy)2(PPh3)(Agonist)n+ in the Photochemical Activation of
Ion Channels
In this section I discuss the use of Ru(bpy)2(PPh3)(Agonist)n+ in the photochemical
activation of ELIC and GABAA receptors. Synthetic modification of the bipyridine
and phosphine ligands afforded new derivatives that were used in activation studies.
I will examine the biocompatibility of the Ru(II) photocages with a series of repre-
sentative of ligand-gated ion channels. The section will conclude with the prospects
of these systems for use in the photoactivation of ion channels.
The photoactivation of GABA receptors using Ru(bpy)2(PPh3)(GABA)+ was ex-
plored previously [18]. The photochemical modulation of pH by release of buty-
lamine has also been studied [21]. The Ru(bpy)2(PPh3)(PrNH2)2+ ion was synthe-
sized as described above (Figure 3.1a) for use in the photoactivation of ELIC by
release of propylamine. Synthesis in the absence of light is crucial; the yield for
photodissociation of propylamine is very high and occurs under room light irradi-
ation. A red-shift in the absorbance spectrum (Figure 3.2c), and pH increase, was
observed upon irradiation of an aqueous solution of Ru(bpy)2(PPh3)(PrNH2)2+. The
photodissociation was monitored by NMR and the release of free propylamine upon
irradiation was observed (Figure 3.2a and b). The in vitro release of propylamine is
consistent with published results of related compounds [21].
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Figure 3.1: A general scheme outlining the synthetic pathways taken for the various ruthenium
photocages synthesized in this chapter. The derivatives with a PPh3 ligand were synthesized as in
(a). The Ru(dmb)2 complexes were synthesized as in (b). Ru(tpy) protecting groups were synthesized
as in (c) and (d) depending on the remaining ligands. The charge on the ruthenium complex is dictated
by the charges on the agonist. The oxidation state of ruthenium is 2+ for all photocages. (e) Structures
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acetylcholine is just shown for the sake of posterity.
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Figure 3.2: (a) The 1H and (b) 31P NMR spectra of the irradiation of Ru(bpy)2(PPh3)(PrNH2)2+ in
D2O. Free propylamine is observed in the 1H NMR, while there is no shift in the 31P peak. (c)
The UV-visible spectra of Ru(bpy)2(PPh3)(PrNH2)2+ under 10 minutes of irradiation. A red-shift is
observed consistent with release of propylamine.
Wild-type ELIC ion channels were expressed in oocytes and the dose-response of
ELIC to propylamine confirmed functional expression [28]. Ru(bpy)2(PPh3)(PrNH2)2+
was then used in for the photoactivation of ELIC. Propylamine response of ELIC
was measured prior to exposure to ruthenium (Figure 3.3a, red line). Propylamine
response before Ru provides a reference for ELIC sensitivity that will be used to
monitor any functional changes as a result of ruthenium exposure. Application of
Ru(bpy)2(PPh3)(PrNH2)2+ then occurred; in the dark no current change is observed
in response to the ruthenium compound. Any current change observed in the dark
might result from minor photolysis of the solution due to adventitious light. Irradi-
ation of the Ru(II)-caged propylamine for five seconds did not result in activation
of ELIC (Figure 3.3a, black line). Activation of ELIC upon irradiation would result
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in more current response, and the black line in Figure 3.3a would read a different
value than zero. Ru(bpy)2(PPh3)(PrNH2)2+ was added at a concentration of ca.
100 µM; under complete conversion the propylamine concentration would be much
lower than required for ELIC activation (EC50 = 500 µM ). This low concentration
used would result in a very small signal observed under complete conversion.
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Figure 3.3: (a) ELIC-expressing oocytes response to propylamine before Ru(bpy)2(PPh3)(PrNH2)2+
exposure, red line. Application of Ru(bpy)2(PPh3)(PrNH2)2+, black line, does not result in activation
of ELIC in the dark or under irradiation. (b) Application of 1 mM Ru(bpy)2(PPh3)(PrNH2)2+, black
line, results in cell death as evident by the loss of the washout current. After complete removal of
Ru(bpy)2(PPh3)(PrNH2)2+ the propylamine response was diminished, and the holding current was
significantly off 0 (blue line), a sign of very unhealthy cells.
Addition of a 1 mM solution of Ru(bpy)2(PPh3)(PrNH2)2+, a concentration that
would release ample propylamine for ELIC activation, resulted in cell death (Figure
3.3b). Cell death is evident by a change in the current observed after 350 seconds in
Figure 3.3b. Before exposure to Ru (Figure 3.3b, red line), when the propylamine
is removed from solution at 350 seconds, the current returns to zero. Addition
of Ru(bpy)2(PPh3)(PrNH2)2+ (Figure 3.3b, black line), followed by removal of the
ruthenium (350 seconds) results in a current response well below zero. The change
in current after removal of the applied buffer is indicative of cell death. Buffer ex-
change of the low concentration samples, and subsequent propylamine applications,
resulted in similar propylamine response of ELIC before exposure to the Ru pho-
tocage. The robust propylamine response after exposure to ruthenium suggests that
there is little prolonged interaction between the channel and the complex. Photodis-
sociation of propylamine results in the formation of Ru(bpy)2(PPh3)(H2O)2+ as the
photoproduct. Propylamine will activate ELIC, but it is unclear what interaction(s)
Ru(bpy)2(PPh3)(H2O)2+ has with the system. For an effective photocage, all the
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photoproducts must be inert (see Chapter 2).
To examine potential interactions of Ru(bpy)2(PPh3)(H2O)2+ (the photoproduct)
with ELIC, ELIC-expressing oocytes were incubated for 30 seconds with 50 µM
Ru(bpy)2(PPh3)(H2O)2+ followedby co-application of 50 µMRu(bpy)2(PPh3)(H2O)2+
in propylamine (Figure 3.4, black line). The application of Ru(bpy)2(PPh3)(H2O)2+
in propylamine resulted in complete attenuation of the ELIC response to propy-
lamine. An extended wash occurred to remove Ru(bpy)2(PPh3)(H2O)2+ from so-
lution. Application of propylamine following exposure to ruthenium resulted in
almost complete attenuation of ELIC response to propylamine (Figure 3.4, blue
line). The complete inhibition of ELIC response to propylamine by application
of Ru(bpy)2(PPh3)(H2O)2+ shows that a significant irreversible interaction exists
between ELIC and the Ru complex. The deleterious interaction between ELIC and
the Ru(bpy)2(PPh3)(PrNH2)2+ eliminates its use as a photolabile protecting group
for the activation of ELIC ion channels.
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Figure 3.4: Robust propylamine response was observed from ELIC before application of the ruthe-
nium photoproduct, Ru(bpy)2(PPh3)(H2O)2+, red line. Upon application of Ru(bpy)2(PPh3)(H2O)2+
with propylamine, the ELIC response to propylamine is completely inhibited, black line. After wash
out of Ru(bpy)2(PPh3)(PrNH2)2+, blue line, ELIC response to propylamine is not recovered.
The Ru(bpy)2(PPh3)(Agonist)n+ scaffold is incredibly modular and affords the re-
lease of many neurotransmitters and biologically active drugs. To examine if the
inhibition observed is a result of the need for high concentrations other, more
sensitive, ion channels were investigated. The GABA-protected compound was
synthesized (Ru(bpy)2(PPh3)(GABA)+), and photochemical activation of GABA
was examined. GABAA receptors were expressed in oocytes and photoactivation
studied. Irradiation of ca. 30 µM Ru(bpy)2(PPh3)(GABA)+ resulted in immediate
response, in a step-function shape (Figure 3.5a, black line). After irradiation the
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current reached a new steady-state. Additional irradiation events resulted in a sim-
ilar responses. The release of GABA from the ruthenium complex is irreversible;
each additional irradiation released more GABA that can activate the channels.
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Figure 3.5: (a) GABAA receptors, upon application of GABA, respond with a robust current change
(red line). Application of Ru(bpy)2(PPh3)(GABA)+ results in activation of the GABAA receptors
only upon irradiation, black line. After washout of the ruthenium, the GABAA response is similar to
the pre-ruthenium levels, blue line. (b) The ex vivo irradiation of Ru(bpy)2(PPh3)(GABA)+, black
line, results in a response of GABAA receptors that is similar to the in vivo irradiation, gray line.
Either irradiation method does not elicit current response on the level of just application of GABA
alone, red and blue lines.
GABAA receptor response was larger to 30 µM GABA than the response under
irradiation of 30 µM Ru(bpy)2(PPh3)(GABA)+ (Figure 3.5a, red and blue lines).
The difference could be due to incomplete photolysis of theRu photocage. Prolonged
irradiation resulted in a steady-state GABA response, where more irradiation did
not result in an increase in current, suggesting that a maximum current is reached.
Samples of the Ru(bpy)2(PPh3)(GABA)+ complex were irradiated ex vivo for 30
minutes, and applied to GABAA receptors. The GABAA response to the ex vivo
application was similar to what is observed under in vivo irradiation experiments
(Figure 3.5b, black and gray lines). This similar response suggests that in vivo
irradiation proceeds to completion. GABAA receptors also undergo desensitization
(the decrease in signal observed from 30 to 60 seconds in Figure 3.5 red and blue
lines), complicating comparison of the absolute current values. Application of
GABA results in desensitization observed within 30 seconds. The Ru photolysis
experiments occur over a five minute period. Desensitization under photolysis could
cause the observed current discrepancies. A simple explanation is the concentration
of Ru(bpy)2(PPh3)(GABA)+ in solution is lower than free GABA. In either case,
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activation ofGABAA receptors is observed under irradiation, suggesting that the lack
of activation of ELIC is likely due to the low affinity of ELIC towards propylamine.
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Figure 3.6: GABAA receptorswere exposed to saturatingGABAconcentrations (red line) followed by
application of Ru(bpy)2(PPh3)(H2O)2+ with saturating GABA (black line). A complete attenuation
of the GABAA receptor response was observed. After removal of ruthenium, the response towards
GABA did not return to pre-ruthenium levels (blue line).
GABAA receptor activation was then tested with Ru(bpy)2(PPh3)(H2O)2+, as with
ELIC, to test for possible interactions between the ion channel and the photoprod-
uct. Application of 11 µM GABA to provide a baseline GABAA response (Figure
3.6, red line). Receptors were then incubated with Ru(bpy)2(PPh3)(H2O)2+ for 30
seconds. Co-application of Ru(bpy)2(PPh3)(H2O)2+ + 11 µMGABA then occurred
and significant attenuation of the GABAA response was observed (Figure 3.6, black
line). This attenuation suggests interactions between GABAA receptors and the Ru
that results in inhibition. Removal of the Ru(bpy)2(PPh3)(H2O)2+ and application
of 11 µM GABA resulted in a diminished GABA response when compared with
the pre-ruthenium currents (Figure 3.6, blue line). The diminished GABA response
shows theGABAA-Ru interaction is prolonged, and not reversed by extended periods
of wash. The evidence for interaction between the Ru photoproduct and GABAA
receptors cautions against the use of the Ru(bpy)2(PPh3)(GABA)+ compound for
photoactivation. GABA is released upon irradiation and able to activate channels,
but the photoproduct also exists and inhibits the channels as well.
Perturbation by Ru(bpy)2(PPh3)(H2O)2+ of ELIC and GABAA receptors suggest
that the effect observed with ELIC is not unique. ELIC is a cation selective chan-
nel. One mode of interaction could be the blocking of ELIC by the divalent Ru(II)
complexes. Blocking of cation channels by divalent cations is a well known phe-
nomenon; Zn2+ and Ca2+ are known blockers of ELIC [31]. Blocking exclusively
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Figure 3.7: Unusually, no inhibition of the agonist response is observed in the presence of
Ru(bpy)2(PPh3)(H2O)2+, black line, for the AMPA receptor (a) and the Glycine receptor (b). The
current response of the AMPA receptor (a) and Glycine receptor (b) to agonist are not altered after
exposure to Ru(bpy)2(PPh3)(H2O)2+, blue lines.
by electrostatic interactions is unlikely as GABAA is an anion selective channel.
To examine if the Ru(bpy)2(PPh3)(H2O)2+ inhibition is general a variety of ligand-
gated ion channels were screened in the same manner. The glycine receptor and
the AMPA receptor did not display any attenuation of agonist response in the pres-
ence of Ru(bpy)2(PPh3)(H2O)2+ (Figure 3.7). The glycine receptor is, like GABAA,
an anionic selective pentameric-ligand gated ion channel. The different inhibition
properties suggests that inhibition is not just due to the ion selectivity. The AMPA
receptor is a member of the ionotropic glutamate receptor family, not the petameric
ligand-gated ion channel family. This family has vastly different molecular ar-
chitecture that might be the origin of the difference in response that is observed.
Significant inhibition was observed for ELIC, GLIC, GABAA, 5HT3A, α4β2, α4β4
α7 and mouse muscle nAChR receptors by Ru(bpy)2(PPh3)(H2O)2+ (Figure 3.8).
Regardless, significant and persistent perturbation is observed between the photo-
product and many ion channels. This perturbation limits the Ru(bpy)2(PPh3)(L)n+
platform for use in photoactivation of ligand-gated ion channels.
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Figure 3.8: Whole-cell voltage-clamp electrophysiology traces of ligand-gated ion channels exposed
to Ru complexes. The inhibition of GLIC (a), 5HT3A (b), A4B2 nAChR (c), A4B4 nAChR (d),
Mouse Muscle nAChR (e), and A7 nAChR by co-application of saturating agoinst in the presence of
Ru(bpy)2(PPh3)(H2O)2+ (black line). All of the ion channels show altered response to agonist after
exposure to ruthenium, blue line.
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A dose-response relation between Ru(bpy)2(PPh3)(H2O)2+ and the serotonin recep-
tor (5HT3A)was then examined. The serotonin receptor has anEC50 value of 1.6 µM;
the lowEC50 value suggests that the serotonin receptor does not need high ruthenium
concentrations for potential activation. Incubation with Ru(bpy)2(PPh3)(H2O)2+ for
30 seconds, followed by co-application with 4 µM serotonin resulted in an inhibi-
tion dose-response relationship for the serotonin receptor (Figure 3.9). The IC50
value for Ru(bpy)2(PPh3)(H2O)2+ is 2.5 µM (Figure 3.9b). This value is high in
comparison to known inhibitors of the serotonin receptor that have low nanomo-
lar inhibition [29]. Regardless, Ru(bpy)2(PPh3)(H2O)2+ displays clear inhibition
properties in a concentration regime that competes with agonist binding. The in-
hibition at these concentrations limits the use of Ru(bpy)2(PPh3)(serotonin)2+ for
photoactivation of serotonin receptors. The serotonin receptor dose-response does
not provide insight into the inhibition relationships with the remaining ligand-gated
ion channels, but clearly demonstrates dose-dependent inhibition of an ion channel
by Ru(bpy)2(PPh3)(H2O)2+.
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Figure 3.9: A dose-dependent inhibition is observed for 5HT3A receptors upon co-application of
Ru(bpy)2(PPh3)(H2O)2+ with serotonin. The complete inhibition of serotonin response is observed
by 10 µM serotonin, (a). (b) The concentration where 50% of the 5HT3A receptors are inhibited is
2.6 µM , with a hill coefficient of 3.
3.3.2 Synthetic Modification to the Bipyridine and Phosphine Ligands
One potential workaround to the inhibition would be to attach an agonist that acti-
vates the receptor at much lower concentrations than the inhibition concentration.
However, this is not possible for ELIC since propylamine is one of the most potent
agonists, highlighting the insensitivity of ELIC in general. In an effort to remove
deleterious interactions, synthetic modifications to the Ru(bpy)2(PPh3)(Agonist)n+
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scaffold were carried out (Figure (3.1a). The bipyridine ligands were substituted
with carboxylic acid groups at the 4 and 4’ positions. Also, each phenyl group of
the phosphine ligand was substituted with sulfonate groups at the 3 position. The
two modified ligands were used to synthesize a the series of Ru(II)-propylamine
complexes. At physiological pH both the carboxylic acid and the sulfonate will
be deprotonated, resulting in an overall charge of the Ru(II) species of +2, -1, -2,
and -5 for Ru(bpy)2(PPh3)(PrNH2)2+, Ru(bpy)2(PPh3-(SO3−)3)(PrNH2), Ru(bpy-
(COO−)2)2(PPh3)(PrNH2), andRu(bpy-(COO−)2)2(PPh3-(SO3−)3)(PrNH2), respec-
tively. Salt metathesis, used in the purification of Ru(bpy)2(PPh3)(PrNH2)2+, did
not result in the successful isolation of any of the modified complexes. To purify
these complexes, anion-exchange chromatography on a Q-column with an FPLC
was used. The modified ruthenium complexes stacked at the top of the column upon
loading. Reaction byproducts eluted in the void volume of the column, and the
column was washed with excess pH 7.0 water. Either acidic water, or excess NaCl
was used to elute of the modified Ru complexes. Each complex was then isolated by
evaporation of the water in vacuo. Characterization of the photochemistry by NMR
and UV-visible spectroscopy showed rapid release of propylamine in all cases
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Figure 3.10: (a) The photoactivation of ELIC is observed (black line, inset) by irradiation of the
modified ruthenium protecting group, Ru(4,4’-dicarboxy-bpy)2(PPh3-SO3−)(PrNH2)5−. The activa-
tion upon irradiation is very small compared with the response of ELIC to just propylamine, red and
blue lines. No inhibition of ELIC is observed after ruthenium exposure (blue line), when compared
to before ruthenium (red line). (b) The addition of Ru(4,4’-dicarboxy-bpy)2(PPh3-SO3−)(PrNH2)5−
to activated ELIC results in attenuation of the propylamine response (black line). After removal of
the ruthenium complex, the ELIC response to propylamine alone was significantly inhibited (blue
line).
The modified Ru complex (ca. 50 µM) was then applied to ELIC-expressing
oocytes and activation of ELIC was observed only under irradiation (Figure 3.10a,
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black line). Only a very small amount of activation was observed under irradiation
due to the low concentrations of ruthenium photocage used. The ELIC response
to propylamine is similar before and after exposure to the ruthenium complexes.
However, upon application of propylamine, and exposure to the modified photocage,
attenuation of the propylamine signal is observed (Figure 3.10b, black line). This
signal attenuation remained after extended wash periods suggesting perturbation
by either the ruthenium photocage, or the photoproduct. It is likely the inhibition
also attenuates the observed photoactivation signal. ELIC would be activated by the
released propylamine, and simultaneously inhibited by the presence of the ruthenium
complex. The synthetic modifications made did not allay the inhibition observed
between the ruthenium complexes and ELIC. These complexes were not tested with
other channels because of the difficulty in purification.
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Figure 3.11: The synthesis of the PEGylated ruthenium photocages occurred by two different
synthetic routes. Synthesis of the bpy-PEG ligand first (bottom), followed by metalation with
ruthenium to afford Ru(bpy-PEG)2Cl2. Alternatively, amide coupling of the Ru(4,4’-dicarboxy-
bpy)2Cl2 complex, with PEG afforded the same Ru(bpy-PEG)2Cl2 molecule. The PPh3 lignad was
then added to the complex, and the resulting Ru(bpy-PEG)2(PPh3)(H2O) was used.
In a effort to remove the deleterious interactions between the ruthenium complex
and the ion channels other synthetic modifications were used. PEGylation of the di-
carboxy-bipyridine, through amide bond formation chemistry, afforded a bipyridine
ligand with two PEG-1Kmoieties. The complex was either synthesized by synthesis
of the bpy-PEG ligand, then metalation, or by taking the Ru(4,4’(COO−)-bpy)2Cl2
and performing the amide-coupling reaction with PEG (Figure 3.11). Purifica-
tion by PD-10 size-exclusion chromatography separated the large Ru(bpy-PEG)2Cl2
product, from any byproducts. Any compounds smaller than 3000 Da are separated
from the heavier Ru(bpy-PEG)2(Cl)2, providing clean isolation from the bpy-PEG
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ligand, and other side products. Ru(bpy-PEG)2(PPh3)(H2O) was then synthesized
and the Ru-PEG interactions with ELIC and 5HT3A examined.
ELIC receptors were exposed to 200 µM Ru-PEG complex and the response was
examined in the presence of propylamine. Preincubation of ELIC with Ru-PEG,
followed by application of Ru-PEGwith propylamine resulted in an attenuated ELIC
response (Figure 3.12a). To examine if the effect was due to the pre-incubation,
ELIC was first exposed to propylamine, followed by co-application of propylamine
with Ru-PEG. Upon co-application, the ELIC response is lost (Figure 3.12b). After
exposure to Ru-PEG attenuation in ELIC response to propylamine was observed.
The attenuation in the presence of Ru-PEG is similar to the interaction observed for
the parent Ru(bpy)2(PPh3)(H2O)2+ complex. Less attenuation of ELIC by Ru-PEG
is observed, but the existence of any attenuation suggests that Ru-PEG is not suitable
to for the use in the photoactivation of ELIC.
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Figure 3.12: (a) The preincubation of ELIC with Ru(bpy-PEG)2(PPh3)(H2O), followed by activation
with propylamine in the presence of Ru-PEG results in attenuation of the ELIC signal (black line).
Removal of the Ru-PEG, followed by application of propylamine resulted in a diminished ELIC
response in the absence of ruthenium (blue line). (b) Exposure of activated ELIC to Ru(bpy-
PEG)2(PPh3)(H2O) results in a decrease in the signal (black line). The inhibition of ELIC response
to propylamine remains after removal of ruthenium (blue line). Pre-incubation (a), and co-application
(b), ofRu(bpy-PEG)2(PPh3)(H2O) suggests the order of application is not responsible for the observed
effects.
The serotonin receptor response to Ru-PEG was much different than to the parent
Ru(bpy)2(PPh3)(H2O)2+ complex. Exposure of 5HT3A receptors to Ru-PEG, in ei-
ther addition order, results in positive modulation of the serotonin receptor response
to agonist (Figure 3.13). The response of 5HT3A receptors to serotonin after Ru-
PEG exposure is robust. The concentration of Ru-PEG used in these experiments
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was 200 µM , a value 100 times the IC50 of the parent complex (Figure 3.9b). This
dramatic increase in tolerance of the Ru-PEG complex appears to suggest that PE-
Gylation of the molecule does remove the inhibition interactions. However, positive
modulations of the channel are now observed. Any interaction with the channel is
undesired, thus also ruling out this complex in the activation of serotonin receptors.
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Figure 3.13: The preincubation (a), or co-application (b), of Ru(bpy-PEG)2Cl2 with serotonin
results in a large positive modulation of the serotonin receptors response to application of saturating
serotonin concentrations (black line) when compared to serotonin alone (red line). After removal
of the Ru-PEG complex from solution the 5HT3A receptor response to serotonin alone (blue line) is
similar to the response observed before ruthenium exposure (red line).
The non-selective inhibition that was observed between Ru(bpy)2(PPh3)(H2O)2+
complexes, and ion channels, motivated some investigation into the mode of in-
hibition. To determine the origins of the interactions of the ruthenium photocage
with the ion channels studied Ru(bpy)2(PPh3)(H2O)2+ was dissected. ELIC ex-
posed to bpy-PEG with propylamine after preincubation displayed inhibition of the
propylamine response, that persisted after the removal of the bpy-PEG compound
(Figure 3.14a). Exposure of activated ELIC to bpy-PEG resulted in slight posi-
tive modulation of the signal (Figure 3.14b), with no inhibition of the propylamine
signal observed after removal of bpy-PEG. Application of just the bpy-PEG ligand
to serotonin receptors does not result in substantial change of response to agonist
(Figure 3.14c and d). This suggests that the interaction is not exclusively due to the
bpy-PEG ligand.
ELIC and serotonin receptors were then exposed to Ru(bpy)2(H2O)22+. The Ru(II)-
polypyridyl system allows for efficient photosubstitution; removal of the phosphine
ligand will determine if the base Ru(bpy)2 complex can be used for the photoacti-
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Figure 3.14: The preincubation (a) of bpy-PEGwith propylamine results in inhibition of the response
to propylamine by ELIC (black line). This inhibition lasted after removal of the bpy-PEG compound
(blue line). (b) Co-application of the bpy-PEG with propylamine to activated ELIC ion channels
results in a slight positive modulation of the signal (black line). In the co-application example, the
propylamine response of ELIC after removal of bpy-PEG (blue line) is similar as before exposure
to bpy-PEG (red line). The 5HT3A receptor response to serotonin are not affected by addition of
bpy-PEG in either order of addition (c) and (d). The concentrations of bpy-PEG in these experiments
is 150 µM .
vation of ion channels. Removal of the phosphine ligand resulted in the elimination
of the inhibition properties observed for both ELIC and serotonin receptors (Figure
3.15). This result suggests that the inhibition is likely due to the phosphine ligand
on the ruthenium photocage. The effect of the phosphine moiety was mentioned
briefly previously [32]. However, only effects of millimolar phosphine concentra-
tions were discussed. The high-concentration requirement previously observed is
not in agreement with my observations. Preparation of phosphine-free ruthenium
photocages with similar electronic structures was then examined.
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Figure 3.15: (a) The inhibition of propylamine signal observed upon co-application of
Ru(bpy)2(H2O)2 and propylamine to ELIC receptors. Little inhibition is observed across the 10
µM range, however these concentrations are much lower than needed to ELIC activation. (b) 5HT3A
receptor response to co-application of Ru(bpy)2(H2O)2 and serotonin. There is little inhibition ob-
served at any of the concentrations tested. This is in contrast to the inhibition interactions observed
between 5HT3A and Ru(bpy)2(PPh3)(H2O)2+ (Figure 3.9).
3.3.3 Synthesis and Characterization of Phosphine-Free Ruthenium Pho-
tocages
The addition of a phosphine ligand to Ru complexes lowers the energy difference
between the MLCT and LF states, allowing for more thermal population of the dis-
sosiative LF state at room temperature (Figure 1.5). Removal of the PPh3 ligand from
the Ru photocage results in a significant decrease in quantum yield for ligand release
[18]. Ru(bpy)2(PrNH2)2 was synthesized (Figure 3.1b) and irradiated to examine
the photochemistry. Free propylamine appears in the NMR over five hours, and the
expected red-shift in the UV-visible spectrum also occurs (Figure 3.16a and b). In
comparison, the release of agonist from Ru(bpy)2(PPh3)(Agonist)n+ was complete
in minutes (Figure 3.2). The prolonged irradiation time of Ru(bpy)2(PrNH2)22+
required for propylamine release renders this complex useless for photoactivation
studies.
Ru(tpy)(PrNH2)32+ was also synthesized (Figure 3.1c) as a phosphine-free deriva-
tive. The known photophysical properties of Ru(tpy)22+ motivated the synthesis of
Ru(tpy)(PrNH2)32+. Ru(tpy)22+ has a short excited-state lifetime, suggesting effi-
cient non-radiative decay. Population of the LF states, and subsequent dissociation
of a ligand, is amechanism of non-radiative decay that could lead to a shorter excited-
state lifetime. No release of propylamine was observed from the Ru(tpy)(PrNH2)32+
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complex following 5 hours of irradiation. The NMR and the UV-visible spectrum
are almost identical before and after irradiation (Figure 3.16c and d). However,
given the photostability, it does not appear that the Ru(tpy)(PrNH2)32+ complex
decays via the LF states.
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Figure 3.16: The irradiation of Ru(bpy)2(PrNH2)22+ followed by UV-visible (a) and NMR spec-
troscopy (b). There is little change in the UV-visible spectra over the course of an hour irradiation.
Release of propylamine is observed in the NMR after 5 hours of irradiation. The methyl peaks
of propylamine are highlighted in the blue triangles for clarity. Caged propylamine resonance is
present at ca. 0.5 ppm, and the free propylamine resonance is at ca. 1.0 ppm. Irradiation of
Ru(tpy)(PrNH2)32+ does not result in a change in the UV-visible spectrum (c) after an hour of irra-
diation. There is no free propylamine observed in the NMR (d) after 5 hours of irradiation. In the
case of Ru(tpy)(PrNH2)32+, there is no change observed in the NMR.
The photostability of Ru(bpy)2(PrNH2)22+ and Ru(tpy)(PrNH2)32+ led to further
modifications of the Ru(II) platform. I was able to synthesize Ru(dmb)2(PrNH2)22+
and Ru(tpy)(dmb)(PrNH2)2+; these derivatives used 6,6’-dimethyl-bipyridine (dmb)
in place of the unsubstituted bipyridine ligand. The methyl groups on the bpy ligand
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point toward the metal center of the complex. The resulting steric crowding creates
distortion of the symmetry. It was recently shown that the distorted octahedral results
in a large increase in photodissociation of amine ligands in aqueous environments
[15, 26, 33].
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Figure 3.17: Monitoring the phosphine-free Ru complexes by UV-visible (a and c) and 1H NMR
spectroscopy (b and d). In the NMR spectra the propylamine methyl peaks are highlighted in the
blue triangles; the methyl peaks are the easiest to track. The caged propylamine is observed at ca.
0.5 ppm, and free propylamine is observed at ca. 1.0 ppm. The irradiation of Ru(dmb)2(PrNH2)22+
by 455 nm light, monitored by UV-visible (a) and NMR spectroscopy (b). Rapid change in the
UV-visible spectrum is observed even after 1 minute, and appears to be complete after 10 minutes of
irradiation. After 30 minutes of 455 nm irradiation, release of propylamine is observed in the NMR
as well. The release of propylamine occurs much faster than the analogous Ru(bpy)2(PrNH2)22+
complex. Irradiation of Ru(tpy)(dmb)(PrNH2)2+ results in complete conversion in 60 seconds as
monitored by UV-visible spectroscopy (c). Free propylamine is observed in the NMR after five
minutes of irradiation, and complete conversion is observed by 15 minutes of irradiation (d).
The Ru(dmb)2(PrNH2)22+, and Ru(tpy)(dmb)(PrNH2)2+ complexes were examined
for use as a photocaged for propylamine. Irradiation of Ru(dmb)2(PrNH2)22+ re-
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sulted in the rapid release of propylamine. Complete conversion of the UV-visible
spectrum is observed after 10 minutes of 455 nm irradiation (Figure 3.17a). Mon-
itoring the photoreaction by NMR shows the rapid appearance of free propylamine
(Figure 3.17b). Ru(dmb)2(PrNH2)22+ can release two equivalents of propylamine.
Quantification of the release could be achieved using a NMR standard. Also, under
irradiation the NMR peaks corresponding to the dimethyl groups disappear. No
free dmb is present in the NMR, and it is unclear what is occurring and further
investigation is needed.
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Figure 3.18: Irradiation of Ru(dmb)2(PrNH2)22+ (a), and Ru(tpy)(dmb)(PrNH2)2+ by a 10 mW
HeNe laser resulted in release of propylamine after 60 minutes. This timescale for release is
longer than with 455 nm irradiation; however, this demonstrates that Ru(dmb)2(PrNH2)22+ and
Ru(tpy)(dmb)(PrNH2)2+ can release ligands under red light irradiation.
Ru(tpy)(dmb)(PrNH2)2+ also displayed favourable release kinetics. Irradiation with
a 455 nm light resulted in complete conversion of the UV-visible spectrum in
60 seconds (Figure 3.17c), with propylamine release complete in 15 minutes as
observed by NMR (Figure 3.17d). The difference in irradiation time required
is due to differences in experimental setup. UV-visible experiments were done
on an optically dilute sample, while the NMR experiments require much higher
concentrations; the light source is the same, and the intensity of the irradiation
limits the conversion rate in the NMR experiments. The release of propylamine
from the 6,6’-dimethyl-bpy derivatives is much more rapid than the bpy complexes,
highlighting the importance of the geometric distortion. Another exciting feature
of these complexes is the red-shifted MLCT transition in the absorption spectrum.
Irradiation using a HeNe laser (632.8) resulted in release of propylamine from both
complexes (Figure 3.18). Decaging of molecules using red-light is of interest for
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use in a photodynamic therapies. The release of propylamine using 632.8 nm light
showcases the potential application of Ru(dmb)2(L)22+ and Ru(tpy)(dmb)(L)2+ as a
generic photocage for biological applications.
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Figure 3.19: (a) Application of Ru(dmb)2(PrNH2)22+ to ELIC in the presence of propylamine results
in an attenuated response to propylamine (black line). After removal of Ru(dmb)2(PrNH2)22+, the
ELIC response to propylamine is not the same as the propylamine response before ruthenium exposure
(blue line). (b) The ELIC response to propylamine with Ru(tpy)(dmb)(PrNH2)2+ is attenuated (black
line) comparedwith the propylamine response before ruthenium exposure (red line). After removal of
Ru(tpy)(dmb)(PrNH2)2+ the ELIC response to propylamine is diminished (blue line). This suggests
that phosphine-free ruthenium complexes also interact in a deleterious manner.
Ru(dmb)2(PrNH2)22+ and Ru(tpy)(dmb)(PrNH2)2+ were then tested for interac-
tions with ELIC. Application of 100 µM Ru(tpy)(dmb)(PrNH2)2+ did not re-
sult in any ELIC activation upon application in the dark. Co-application of
Ru(tpy)(dmb)(PrNH2)2+ with propylamine resulted in significantly attenuated ELIC
response to propylamine (Figure 3.19b, black line). The buffer was exchanged, and
ELIC response to propylamine after exposure to Ru(tpy)(dmb)(PrNH2) was signifi-
cantly attenuated compared to before rutheniumapplication (Figure 3.19b, blue line).
This suggests that some deleterious interactions still exists even with the removal of
the phosphine ligand. Ru(dmb)2(PrNH2)22+ was also tested, and similar attenuation
of ELIC activation was observed (Figure 3.19a). The phosphine-free ruthenium
complexes display favourable photosubstitution properties in vitro, though interac-
tions between the complexes and ELIC still exist. ELIC is significantly perturbed,
which prohibits the use of these complexes as molecules for use in the photoacti-
vation of ELIC. ELIC is a very agonist-insensitive ion channel and requires high
concentration of propylamine. As a result, 100 µM ruthenium was used, at a con-
centration much higher than was used in the Ru(bpy)2(H2O)22+ response curves
83
previously. This inhibition suggests at high concentrations, even the phosphine-free
ruthenium complexes complex still inhibit ion channels.
3.3.4 Inhibitions by Ruthenium Complexes in Mammalian Cells
Inhibition has been observed with a variety of Ru(II) photocages and ion channels.
All of these studies used Xenopus laeviss oocyte cells to express the ion channel
under study. To examine if the effect observed is an oocyte phenomenon inhibition
studies with mammalian cells were conducted. Serotonin receptors were expressed
in HEK293T cells, and activation assayed by monitoring the fluorescence of a
membrane-potential sensitive fluorescent dye. The membrane-potential sensing dye
incorporates into the membrane bilayer, and the resting potential of the membrane
results in dye localizing on the extracellular side of the membrane. An external
quencher is applied resulting in fluorescence quenching of the dye. Upon activation
of receptors, the dye moves across the membrane toward the cytoplasm, and away
from the quencher, resulting in an increase in fluorescence observed.
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Figure 3.20: The application of varying concentrations of serotonin to HEK293T cells expressing
the 5HT3A receptor. A fluorescence increase is observed for all concentrations of serotonin added.
This fluorescence increase is indicative of receptor activation.
To test for 5HT3A expression in HEK293T cells, serotonin was applied and an
increase in fluorescence of the dye was observed (Figure 3.20). The increase in
fluorescence indicates activation of ion channels. Following verification of expres-
sion, the cells were exposed to either 10 µM or 100 µM Ru(dmb)2(PrNH2)22+,
with or without 5 µM serotonin present. No activation of serotonin receptors was
observed upon application of Ru(dmb)2(PrNH2)22+ alone (Figure 3.21a and b, red
lines). Co-application of serotonin with Ru(dmb)2(PrNH2)22+ does not result an
increase in fluorescence as observed with just 5 µM serotonin alone (Figure 3.21a
and b, blue lines). Ru(tpy)(dmb)(PrNH2)2+ was tested in the same way, to simi-
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lar ends (Figure 3.21c and d). No activation of serotonin receptors was observed
with just Ru(tpy)(dmb)(PrNH2)2+ alone. No activation of the serotonin receptor
upon co-application of Ru(tpy)(dmb)(PrNH2)2+ and serotonin at either concentra-
tion used was observed. The inhibition of 5HT3A receptors in mammalian cells with
Ru(tpy)(dmb)(PrNH2)2+ and Ru(dmb)2(PrNH2)22+ suggests that these compounds
are not a viable for use in the photoactivation of ion channels. The activation as-
say method does not provide information to distinguish between inhibition or cell
death. Both cell death, or inhibition, are undesired perturbations of the system. The
HEK293T experiments indicate that the inhibition that was observed for a variety of
ruthenium photocage complexes is most likely not an oocyte-specific phenomenon.
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Figure 3.21: Application of 10 µM (a) and 100 µM (b) Ru(dmb)2(PrNH2)22+ without serotonin
(red lines) does not activate 5HT3A receptors. Co-application of Ru(dmb)2(PrNH2)22+ with sero-
tonin (blue lines) does not result in activation of the 5HT3A receptors. (c) and (d) Application
of Ru(tpy)(dmb)(PrNH2)2+ alone (red line), and with serotonin (blue lines) does not result in the
activation of the serotonin receptors expressed in HEK cells. Inhibition of the serotonin receptor is
observed by both Ru(dmb)2(PrNH2)22+ and Ru(tpy)(dmb)(PrNH2)2+ in HEK293T cells.
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3.3.5 Potential Applications for Ruthenium Photocages
In an effort to find a use for Ru(dmb)2(L)2n+ and Ru(tpy)(dmb)(L)n+ photocages the
AMPA receptors were investigated. Previous studies with Ru(bpy)2(PPh3)(H2O)2+
showed no interaction between the AMPA receptors and the Ru photoproduct (Fig-
ure 3.7a). This assay was then repeated with Ru(tpy)(dmb)(H2O)2+ to see if the
previous result holds for the phosphine-free derivatives. Application of 50 µM
Ru(tpy)(dmb)(H2O)2+ with glutamate present did not result in the significant in-
hibition of the AMPA receptors (Figure 3.22). There is about 20 % decrease in
signal observed upon co-application, however it is unclear if this decrease is due
to the presence of Ru. Rundown behaviour like this has been observed before with
repeated Imax doses of agonist. Multiple application of Imax doses of just gluta-
mate will determine if the behaviour observed is just rundown. The use of 50 µM
ruthenium is still higher than would be needed with the AMPA receptor. The po-
tentially low ruthenium concentration requirement, and the very mild inhibition of
the APMA receptor, suggest that the Ru(tpy)(dmb)(Glutamate) complex might be
viable for photoactivation.
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Figure 3.22: (a) An electrophysiology trace of the average response ofAMPA receptors to the applica-
tion of 14 µM glutamic acid (Glu). The currents are normalized to the Glu response before exposure
to ruthenium (red line). Application of Ru(tpy)(dmb)(H2O)2+ with Glu (black line) results in very
modest inhibition of the AMPA receptors. Exposure of the AMPA receptors to Glu after ruthenium
(blue line) results in the same response as observed in the presence of Ru(tpy)(dmb)(H2O)2+. (b) A
bar-graph representation of the same experiment as in (a).
3.3.6 Luminescence Properties of Ruthenium Photocages
The effective photodissociation of a ligand from the ruthenium complexes results
from efficient crossing to the LF states, from the excited MLCT state. Effi-
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cient radiative decay indicates relaxation of the excited state in a non-productive
manner for photodissociation. Thermal population of the LF states results in
an increase in non-radiative decay pathways, a decrease in room-temperature lu-
minescence, and an increase in photodissociation. The room-temperature and
77K luminescence spectra were examined for a series of ruthenium photocage
complexes: Ru(bpy)2(PPh3)(PrNH2)2+, Ru(bpy)2(PrNH2)22+, Ru(tpy)(PrNH2)32+,
Ru(dmb)2(PrNH2)22+, andRu(tpy)(dmb)(PrNH2)2+. These complexes display vary-
ing levels of photodissociation. Luminescence of all the complexes is only present
at 77K in a MeOH:EtOH glass (Figure 3.23, solid lines). No room temper-
ature luminescence is visible (Figure 3.23, dashed lines). The luminescence
spectra of all the complexes are similar to Ru(bpy)32+ emission. This obser-
vation is consistent with the thermal enhancement of non-radiative decay path-
ways. Thermal activation of the LF states is likely a dominant decay pathway
for the complexes with efficient photosubstitution: (Ru(bpy)2(PPh3)(PrNH2)2+,
Ru(dmb)2(PrNH2)22+, and Ru(tpy)(dmb)(PrNH2)2+). However, it is interesting in
the case of the Ru(tpy)(PrNH2)32+ complex, where photostability is the greatest, that
no room temperature luminescence is observed. The lack of luminescence suggests
non-radiative decay from the excited state is the predominant form of relaxation,
but not through the population of a dissociative LF state. Further investigation
into the photophysics of these compounds might yield insight into the excited state
energy surfaces. This could help in the further design of highly efficient ruthenium
photocages.
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Figure 3.23: The steady-state luminescence measurements of Ru(bpy)2(PPh3)(PrNH2)2+
(a), Ru(bpy)2(PrNH2)22+ (b), Ru(tpy)(PrNH2)32+ (c), Ru(dmb)2(PrNH2)22+ (d), and
Ru(tpy)(dmb)(PrNH2)2+ (e), in a 1:1 methanol:ethanol solvent mixture at 77K (solid lines), com-
pared with the room temperature spectrum (dashed lines). All figures contain the same Ru(bpy)32+
luminescence spectrum (black line) obtained at 77K. No room temperature luminescence is observed
for any of the ruthenium complexes.
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3.4 Conclusions and Future Outlooks
I investigated Ru(II) complexes for use in the photoactivation of ion channels.
Ru(bpy)2(PPh3)(L)n+ had previously been used for the photoactivation of ion chan-
nels, and I sought to use established systems for activation of ELIC. The propy-
lamine derivative was synthesized, and displayed the reported in vitro proper-
ties. Unfortunately ELIC is a very insensitive channel, and oocytes did not sur-
vive the high concentrations (1 mM) of ruthenium required. Lower concen-
trations of ruthenium were able to photoactivate ELIC. However it was shown
that photoproduct (Ru(bpy)2(PPh3)(H2O)2+) significantly inhibits activated ELIC.
This inhibition was present even after extensive washing to remove the ruthenium.
Ru(bpy)2(PPh3)(H2O)2+ was then tested across a panel of ligand-gated ion channels.
Inhibition of all ion channels tested, except for two, occurred. A dose-dependent
inhibition was observed for the serotonin receptor, with an IC50 value of 2.6 µM.
This inhibition affinity is weak, but in a concentration range that competes with
the activation of the receptors. Competitive inhibition and activation limits the
functionality of these complexes as phototriggers.
Synthetic modifications such as PEGylation of the complexes did not eliminate the
deleterious interactions observed between the ion channels and the ruthenium pho-
toproduct. Little inhibition was observed with Ru(bpy)2(H2O)22+, a difference of
just a single phosphine ligand. The addition of the phosphine ligand to the Ru(bpy)2-
platform substantially enhances the efficiency of photodissocation. Derivatives of
phosphine-free ruthenium photocages were then synthesized; complexes with a
bulky 6,6’-dimethyl-bipyridine were able to efficiently release amine ligands under
red light irradiation, which is a notable result. Inhibition was still observed between
the phosphine-free ruthenium photocages, and ELIC. This is likely due to the high
concentrations needed for ELIC activation. Inhibition was also observed between
serotonin receptors expressed in mammalian cells, demonstrating that the inhibi-
tion is not oocyte cell specific. The conclusions from this work show that these
compounds are useful for the photodeprotection of amine-based ligands. However,
significant perturbation is observed across a large variety of channels. This limits
the use of these compounds when studying ion channels.
The use of Ru(II) as photolabile protecting group is an attractive platform for the
delivery of biologically active molecules. The ruthenium complexes are strongly
absorbing in the visible region of the spectrum, and can display very efficient
photodissociation. This system is also modular, and one can envision many different
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amines being protected using this method. However, I have shown in this chapter
that significant interactions exist between the Ru(II) class of photocages and many
different ion channels. I think examination of the specific interactions that exist
between the ion channels and the Ru(bpy)2(PPh3)(H2O)2+ is warranted. If an
interaction is identified, new Ru(II) complexes could be synthesized that would
eliminate this interaction. I would also be interested in obtaining the dose-dependent
inhibition for all the channels tested. The dose-dependent behaviour might provide
insight as to the specificity of ion channel inhibition. One of the few remaining
experiments that I think are worth trying is to examine the photoactivation of the
AMPA receptor and the glycine receptor. These are the only two receptors that were
not inhibited by the Ru(bpy)2(PPh3)(H2O)2+ photoproduct. I think that making the
analogous glycine and glutamate protected Ru(tpy)(dmb)(L) is worth pursuit. These
complexes are triggered by red light irradiation, providing potentially interesting
biological photoactivation. I would recommend focusing on the glutamate receptor,
as it is a common receptor found in the brain, and responsible for the excitatory
signals.
From the work above I conclude that these Ru(II) protecting groups are not generally
applicable for use in the study of ion channels. I would also caution the use of these
complexes in systems that also have ion channels present. Side interactions are likely
to occur. These complexes are an interesting platform for the generic photoprotection
of amine ligands, and a good study of inorganic photochemistry.
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C h a p t e r 4
THE IN VITRO ACTIVATION OF FUNCTIONALLY
RECONSTITUTED ELIC
4.1 Introduction
The ultimate goal of this project is to monitor the conformational changes associated
with ion channel activation. The technique that was ultimately to achieve this is time-
resolved fluorescence energy transfer (TR-FET). The use of the TR-FET technique
requires the study be conducted in an in vitro setting. Any in vitro study must
retain the in vivo function of the system being studied. The in vitro study of
ion channels requires functional reconstitution of the desired ion channel into a
membrane environment.
Functional reconstitution of ion channels requires: the ion channel isolable in large
enough quantities to perform the experiments; an artificial membrane environment;
and an assay to probe the function of the reconstituted ion channel. A number of
ion channels have been successfully reconstituted previously in many membrane
environments and used with various different assays to determine the functional
state of the ion channel [1]. I want to reconstitute ion channels into lipid bilayer
vesicles. Vesicles are amenable to characterization in cuvettes, a requirement for
the future laser experiments. Previous ion channel reconstitutions into vesicles have
used a variety of functional assays including: radioactive ion fluxmeasurements [2],
fluorescence measurements [3, 4], and injection into oocytes for electrophysiologi-
cal measurements [5]. Radioactive measurements and fluorescence measurements
directly assay the ion channel in the artificial environment, and I will use these
to probe the function of reconstituted ion channels. In this chapter I discuss the
heterologous expression and purification of ELIC. I examine various methods, and
conditions used to reconstitute ELIC. I finally discuss the methods that succeeded
in the functional reconstitution of ELIC into liposomes.
4.2 Methods and Materials
4.2.1 General Procedures
Purification of ELIC and GLIC occurred as previously published [6]. Standard
biochemical techniques were used for the amplification of DNA in XL1-Blue E.
coli cells (EMD Millipore). Protein expression took place in the BL21(DE3) strain
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of E. coli, also obtained from EMD Millipore. Protein gel electrophoresis occured
using the PhastSystem (GE Healthcare), using SDS-PAGE (8-25%) gradient gels.
The precision blue protein ladder was used as reference (Bio-rad). All chemicals
were obtained from Sigma-Aldrich or Thermo Scientific and used without further
purification. Lipids were obtained from Avanti Polar Lipids, and used without
further purification. n-Dodecyl β-D-maltoside (DDM) detergent was obtained from
Anatrace. UV-Visible spectra were obtained using a 1 cm quartz cuvette and a HP-
8453 spectrometer. Steady-state luminescence experiments were conducted using
a Jobin Yvon Spex Fluorolog-3-11 spectrometer. Samples were excited by a 450
W xenon arc lamp through a monochromator for excitation wavelength selection.
Emission was collected upon scanning a monochromator, with detection achieved
by a Hamamatsu R928P photomultiplier tube in photon counting mode. FlexStation
(Molecular Devices) experiments used a standard glass-bottom 96-well plate for a
sample holder. Excitation occurred with a xenon arc-lamp, and wavelength was
selected using a monochromator. Emission was monitored over a single wavelength
using a photomultiplier tube in photon counting mode. A minimum of 50 µl of
solution was used for FlexStation experiments, which afforded complete coverage
of a single well. Addition of solutions occurred using the FlexMode setting of
the FlexStation, with addition of equi-volume of the below described manipulation
solution as the sample volume. The FlexStation PMT sensitivity was set to 8,
with sampling occurring as fast as possible. Stopped-flow measurements were
conducted on aKintekSF-2004 stopped-flow. Excitationwas fromaxenon arc-lamp,
wavelength selected using a monochromator. Emission was collected through band-
pass filters onto a photomultiplier tube in photon counting mode at the maximum
acquisition rate of 1000 Hz. All data work up was done in MATLAB R2013b
(Mathworks, Inc.).
4.2.2 Purification of ELIC
ELIC was purified as described elsewhere [6], and is discussed briefly here. ELIC
with anN-terminalmaltose-binding protein (MBP) tag, in pERCH6vectorwas trans-
formed into BL21(DE3) cells, and streaked onto an LB/agar petri dish. Overnight
growth at 37°C afforded individual colonies. Single colonies were then picked, and
allowed to grow overnight at 28°C in 25 mL of TB broth containing ampicillin. 5
mL of starter culture was used to innoculate 1 L of growth, which was shaken at
37°C until OD600 = 3. The cultures were cooled to 21°C for 1 hour. Expression
was induced upon addition of 1 mM ICPP, and the cells were incubated at 21°C
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overnight. Cells were then harvested upon centrifugation at 10,000 g. Each 1 L of
cells was resuspended in 10 mL of 50 mM Tris pH 7.5, 150 mM NaCl (Buffer A),
with the addition of 4 tablets of cOmplete protease inhibitor (Roche). Resuspension
occurred using a dounce homogenizer, and the resuspension passed through a mi-
crofluidizer for lysis. The lysate was then centrifuged at 12,000 g for 1 hour at 4°C.
Resuspension of the solid fraction in buffer A occurred, followed by centrifugation
at 110,000 g, 4°C for 2 hours to isolate the membrane fraction. The membrane
fraction was then homogenized in 1 mL of buffer per 1 g of dry weight in buffer A
with the addition of 2% DDM by weight. The resusupension was gently stirred at
4°C overnight. The next day the mixture was then centrifuged at 30,000 g to remove
any non-solublized components, and the supernatent was loaded onto an amylose
resin gravity column at 4°C. This column was washed with excess buffer A in the
presence of 0.1% DDM. After the elutant desplayed no A280 signal, the protein was
eluted with buffer A supplemented with 0.1%DDM and 20mMmaltose. TheMBP-
ELIC protein was then exposed to 100 equiv. of HRV 3C protease and incubated
overnight at 4°C. Separation of the ELIC from MBP occured using a Superdex 200
10/300 size exclusion column equilibrated with buffer A and 0.1% DDM. A flow
rate set to 0.1 mL/min yielded the best seperation. The second fraction tended to
be ELIC, which was verified using SDS-PAGE. ELIC was then concentrated to no
more than 10 mg/ml and either used fresh or flash frozen and stored at -80°C.
4.2.3 Formation of LUVs
The formation of large unilamellar vesicles (LUVs) was done using standard extru-
sion techniques available on the Avanti website, and briefly described below. Lipids
dissolved in chloroform were dried under argon, then overnight under vacuum, in a
glass vial. Resuspension of the lipids was achieved by addition of the desired so-
lution (buffer, fluorescent dye, salts, etc) to the dried lipids, and vigorously shaken
for 10 minutes. The samples were then subjected to five cycles of freeze-thaw
in a dry-ice/ethanol bath to induce formation of unilamellar vesicles. Following
the freeze-thaw cycles the lipids were extruded through a polycarbonate filter of
desired diameter an odd number of times, generally 27. If the buffer needed to
be exchanged these extruded liposomes were then subjected to standard PD-10 gel
filtration conditions. The lipid vesicles were used as rapidly as possible.
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4.2.4 Reconstitution without Detergent Destabilization
Purified ELIC or GLIC was mixed with preformed vesicles (with the desired encap-
sulated dye) to a desired w/w ratio. After incubation for 1 hour at room temperature,
activated bio-beadswere added (50mg). Incubationwith Bio-Beads SM2 (Bio-Rad)
for an hour followed, after which the solution was transferred to clean container with
new bio-beads. This process occurred for hours to days, depending on the sample.
After incubation with at least 3 rounds of bio-beads, the samples were either used
or stored at 4°C
4.2.5 Detergent-Destabilization Reconstitution
The procedure for detergent destabilization is generalized below [7]. Vesicles were
preformed as above. After extrusion, vesicles were mixed with either CHAPS (5
mM) or DDM (0.5%) and incubated for 1 hour. After incubation, purified ELIC
was added and incubated for 1 hour at room temperature. The addition of 5 rounds
of 100 mg bio-beads occured, with each round incubating for 30 minutes at room
temperature. After detergent extraction, the vesicles were either used immediately,
or stored overnight at 12.5°C. The protocol that resulted in the most successful
reconstitution of ELIC is as follows. 11.3 mg of DOPC and 3.7 mg of POPG were
mixed together to form a 3:1 DOPC:POPG (mol/mol) ratio andwere dried overnight.
The lipids were rehydrated in 1114 µl of 10 mMHEPES, 10 mM succinate, 100 mM
KNO3 pH 7.0 (hydration buffer), and 557 µl hydration buffer supplimented with
75 mM ANTS. Vortexing for three minutes afforded a cloudy green solution. This
solution was then subjected to 5 rounds of freeze-thaw. 5 mM CHAPS was added
and sonicated for 1 minute. Purified ELIC was then added (the higher concentration
the better), and incubated with the lipid solution for 1 hour at room temperature.
5 rounds of 100 mg addition of bio-beads occured over two and one half hours.
The solution was then desalted on a PD-10 column to remove excess ANTS from
solution. The samples were stored overnight at 12.5°C and used the next day.
4.3 Results and Discussion
4.3.1 Expression and Purification of ELIC
The plasmid for ELIC and the expression and purification protocols used were pro-
vided by Dr. Raimund Dutzler from the University of Zurich. I would like to
make several comments about the expression and purification of ELIC. Use of a mi-
crofluidizer for cell lysis is crucial; sonication was used to lyse cells and no purified
ELIC was isolated. Isolation of the membrane fraction, and proper resuspension
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before solubilization is crucial. Use of an ultra-centrifuge for membrane isolation
is required. A regular floor centrifuge did not isolate the cell membrane fractions
effectively. A dounce homogenizer effectively resuspended the membrane for sol-
ubilization. If large chunks of membrane remained after resuspension it is likely
complete exposure to detergent molecules did not occur, and ELIC was less effec-
tively solubilized. This sample also resulted in lower ELIC yields. All purification
should be done at 4°C. A 100% yield of cleavage of the maltose-binding protein
(MBP), with HRV3c protease, was never achieved. In the presence of huge excesses
of HRV3C protease, complete cleavage did not occur. Figure 4.1a shows a typical
chromatograph of the final sized exclusion column, with the large peak arising from
the uncleaved ELIC-MBP pentamers. The expression and purification of HRV3c
protease in house (it is very expensive to purchase) would allow for optimization
of ELIC-MBP cleavage, or the use of enough to result in full cleavage. Replacing
the HRV3C protease site with another common protease site is another potential
option. The uncleaved MBP-ELIC was purified from the cleavage reaction, but due
to limitations in protease supply I never subjected these fraction to repeated cleavage
conditions.
After isolation of purified, detergent-solublized, ELIC, gel electrophoresis was per-
formed to verify the protein purity (Figure 4.1b); the ELIC-MBP fusion protein,
ELIC monomer, and MBP monomer were observed. ELIC is purified as a pentamer
and elutes before MBP on the column (Figure 4.1a, not shown), but the denaturing
conditions of the gel result in the protein running as a monomer. Mass spectrometry
on the purified samples was unsuccessful; however, with the advances in mem-
brane protein mass spectrometry, use of mass spectrometry might prove useful [8].
Purified ELIC was either used fresh or flash frozen stored at -80°C until further
use. The concentration of ELIC was determined using the BCA assay (Figure 4.1c)
[9]. Comparison of the BCA derived ELIC concentration with that of the 280
(63495 M−1 cm−1 per monomer, 317475 M−1 cm−1 per pentamer) calculated from
the amino acid sequence using the ExPASy toolbox, yielded similar concentrations.
Future calculations of ELIC concentration used the absorbance measurements.
4.3.2 Reconstitution of GLIC and use of Sodium Green and SBFI as Func-
tional Reporters
I briefly mention efforts into the reconstitution of GLIC, using sodium green as
a reporter of functional channels. GLIC was purified in the same way as ELIC.
Lipid (3:1 POPC:POPG) vesicles were formed in the presence of 12 µM NaGreen,
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Figure 4.1: (a) The final size exclusion chromatograph of ELIC purification. The first peak is that
of the MBP-ELIC pentamer, followed by just the purified ELIC. Not shown is the peak associated
with the cleaved MBP. (b) All of the peaks were isolated and subjected to SDS-PAGE analysis.
The denaturing conditions of SDS-PAGE resulted in the isolated pentamers running as monomers.
Purified ELIC is observed around 37 kDa. (c) A BCA protein concentration calibration curve with
ELIC concentrations referenced. The ELIC concentration from the BCA assay was then compared
with the theoretical 280 value and found to be in good agreement.
and excess dye removed using size exclusion chromatography (PD-10 column).
Vesicles and detergent solubilized GLIC were mixed and incubated in the presence
of polystyrene beads (Bio-Beads). Bio-Beads selectively remove detergent from
solution [10]; removal of detergent will cause GLIC to enter the only membrane
envrionment remaining in solution, the vesicles. The proteoliposomes were then
subjected to size exclusion chromatography to remove all Na+ present in solution.
GLIC proteoliposomes were placed in a 96 well plate and each well was subjected
to different conditions. GLIC is an acid sensitive ion channel. Proteoliposomes
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were exposed to low pH buffers in the presence and absence of NaCl. Exposure
to low pH buffers resulted in the decrease of NaGreen fluorescence (Figure 4.2a).
NaGreen is a fluorescein-derived dye attached to a Na+ chelating moiety; fluorescein
luminescence is well known to have a pH dependence [11]. Functional GLIC
would have activated and allowed Na+ ions to flow through the channel, binding to
NaGreen and increasing fluorescence. An opposite trend is observed in the NaGreen
fluorescence. To examine the fluorescence of NaGreen as a function of pH, addition
of NaCl buffer at various pHs to a solution of just NaGreen (Figure 4.2b). A decrease
in fluorescence was observed for solution pH < 6.0, while an increase in fluorescence
was observed for pH > 6.0. The pH dependence of NaGreen fluorescence eliminates
the use of NaGreen as a reporter for the reconstituiton of acid sensitive ion channels.
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Figure 4.2: (a) GLIC proteoliposomes exposed to various low pH buffers, monitoring of NaGreen
fluorescence as a function of pH and time. A NaGreen fluorescence decrease is observed for low pH
buffers in the presence of Na+. (b) The NaGreen fluorescence monitored in the presence of various
pH buffers displays similar behaviours as what is observed in the proteoliposomes. This shows that
a obvious pH dependence in fluorescence is observed, and NaGreen is not a suitable indicator for
GLIC activation.
The use of sodium sensor SBFI was also examined (Figure 4.3). No SBFI fluores-
cence changed is observed in the presence of low pH and Na+ for GLIC proteolipo-
somes (Figure 4.3a). SBFI fluorescence was then monitored as a function of pH. A
SBFI fluorescence decrease was observed for solution pH < 6.0, while an increase
was observed for pH > 6.0 (Figure 4.3b). SBFI and NaGreen are two commercially
available sodium sensors that are described in the literature. The pH dependent
fluorescence observed suggests these two dyes are not viable fluorescence indica-
tors for functional reconstitution of acid-sensitive ion channels. Focus shifted to the
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reconstitution of ELIC, an amine-activated ion channel where pH is controlled.
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Figure 4.3: (a) GLIC proteoliposomes exposed to various low pH buffers, monitoring of SBFI
fluorescence as a function of pH and time. There is little fluorescence change observed in any of the
SBFI proteoliposome samples. This is likely due to the efficient removal of extravesicular SBFI.(b)
The SBFI fluorescence monitored in the presence of various pH buffers. Again, SBFI displays a
clear pH dependence of fluorescence in the range needed for GLIC activation. SBFI is not a useful
Na+ indicator for GLIC activation due to the pH-dependent fluorescence.
4.3.3 Reconstitution of ELIC and use of a Sodium Dependent Functional
Reporter
ELIChad previously been reconstituted into artificialmembranesmade of POPC:POPG
lipids [12]. I focused on the reconstitution of ELIC into LUVs. LUVs have a diame-
ter on the order of 100 nm, and have been used previously to reconstitute ligand-gated
ion channels [3–5, 13]. As with GLIC, measurements of ion flux will be used to
monitor the functional state of the reconstituted ion channels. Sodium selective dyes
are encapsulated within the LUVs; the fluorescence of the Na+ dye is monitored
under ELIC activation conditions. A fluorescence turn-on should only occur in the
presence of agonist and functional ELIC. Activation of ELIC will allow sodium
ions from the solution to flux into the lumen of the vesicles, bind to the sodium
sensitive dye, and increase fluorescence. Increase in fluorescence after addition of
agonist will indicate successful functional reconstitution. To further examine the
reconstituted state of the channels, a fluorescence dose-response curve can be ob-
tained and compared to the electrophysiology response of ELIC. This comparison
provides a measurement to the perturbation of channels as a result of reconstitution.
A dose-response similar to what is observed using electrophysiology will suggest
that the ion channels are functionally reconstituted.
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ELIC is activated by many small molecule amine agonists [14]; propylamine will
be used because of the high ELIC sensitivity and ease of manipulation. The fluo-
rescence of NaGreen was monitored when exposed to propylamine. An increase in
NaGreen fluorescence was observed upon addition of Na+ regardless of the presence
of propylamine (Figure 4.4b, black and green lines). Unlike the effect of pH on the
fluorescence of NaGreen propylamine does not alter the fluorescent properties of
the dye, suggesting NaGreen can be used as a functional Na+ flux indicator in ELIC
reconstitution experiments. ELIC was purified, and reconstitution undertaken in a
similar manner as with GLIC above. The fluorescence of NaGreen was monitored
upon addition of NaCl ± propylamine to ELIC proteoliposomes to test for func-
tion. Upon addition of the NaCl + propylamine buffer the fluorescence increased
(Figure 4.4a, red lines). However, fluorescence increase of a similar magnitude is
also observed with just the NaCl buffer (Figure 4.4a, blue lines). The nonselec-
tive fluorescence increase shows only Na+ is needed for the observed effect, not
propylamine + Na+. Functionally reconstituted ELIC would result in a differental
response in the presence of propylamine. Sodium ion flux through activated ELIC
would increase Na+ concentration within the vesicles increasing the NaGreen fluo-
rescence over the non-specific fluorescence. The anticipated propylamine-specific
increase in fluorescence is not observed. The fluorescence increase observed is due
to extravesicular NaGreen. The reconstitution protocol was repeated, and modified,
in an attempt to functionally reconstitute ELIC. ELIC amount, incubation time, and
fluorescent dye concentration were altered. None of the variations in reconstitution
protocol resulted in the selective increased fluorescence turn-on of NaGreen in the
presence of propylamine (Figure 4.5a), indicating that ELIC was not functionally
reconstituted.
To determine if the FlexStation is able to detect the fluorescence of NaGreen inside
the LUVs, Triton X-100 was used to lyse the vesicles. Addition of triton will
solublize the lipid vesicles and release the contents of the LUVs into the solution.
Upon addition of triton, a fluorescence increase is observed for the buffers containing
NaCl ± propylamine. The lysed fluorescence increase is larger than the non-specific
increase observed without triton (Figure 4.5b). The increase of fluorescence upon
lysis indicates that the detection method is sensitive enough to measure a theoretical
100% turn-on of the NaGreen inside the LUVs. Given that a fluorescence increase
can be observed upon intravesicular NaGreen binding sodium, it does not appear
that the reconstitution protocol used yields functional ion channels.
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(a) (b)
Figure 4.4: (a) ELIC proteoliposomes exposed to buffers containing 2mMpropylamine for activation,
monitoring of NaGreen fluorescence as a function of time. An increase in NaGreen fluorescence
is observed for buffers containing Na+ ions. No selective NaGreen fluorescence is observed upon
addition of proteoliposomes, suggesting that the ion channels are not functionally reconstituted (b)
NaGreen fluorescence monitored in the presence of propylamine displays an increase upon addition
of Na+ ions. No difference is observed in the fluorescence in the presence of propylamine suggesting
that the NaGreen dye can be used to monitor the activation of ELIC.
(a) (b)
Figure 4.5: (a) ELIC proteoliposomes exposed to buffers containing 2 mM propylaime for activation,
monitoring of NaGreen fluorescence as a function of time. No increase in fluorescence is observed
for the addition of Na+ ions. This shows that the ELIC ion channels are not functionally reconstituted,
and that the previously observed increase in fluorescence (Figure 4.4 is due to incomplete removal
of extravesicular NaGreen. (b) NaGreen fluorescence monitored upon lysis of proteoliposomes with
Triton X-100. A measurable fluorescence increase is observed in the presence of triton, showing
that the detection method is sensitive to the theoretical fluorescence increase from NaGreen binding
Na+.
4.3.4 Reconstitution of ELIC Through Partial Destabilization of Lipid Vesi-
cles
A new method for reconstitution of ELIC into LUVs was used. Vesicles were
formed with the desired dye trapped in the lumen, and moderately destabilized with
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detergent. Formation of vesicles, then addition of DDM detergent (0.05% w/w)
will generate lipid vesicles with saturating amounts of detergent in the lipid bilayers
(Figure 4.6a). Addition of more DDMwill result in the formation of lipid-detergent
micelles, while less detergent results in less destabilization of the bilayers. Following
destabilization of the vesicle, purified protein is added, and the detergent is removed
with biobeads. The assay to determine function is the same NaGreen fluorescence
assay used above.
ELIC was added to the destabilized vesicles, and incubated at room temperature for
2 hours. Biobeads were then added to remove the detergent. Replacement of the
biobeads every 90 minutes occurred, finally the vesicle/ELICmixture was incubated
overnight at 4°C in the presence of biobeads. Long incubation periods require ELIC
to be stable for extended periods. However, the stability of ELIC is not known;
a functional assay (once developed) can be used to test in vitro stability of ELIC.
After incubation overnight, the vesicle solution was isolated by ultracentrifugation.
Isolation, followed by resuspension of the proteoliposomes in protein-free, dye-free,
salt-free buffer occurred at least three times in an effort completely remove any
non-vesicle components. Following the final ultracentrifugation, the lipids were
resuspended to 20 mg/mL and either used immediately or flash frozen and stored at
-80°C.
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Figure 4.6: (a) Turbidity of liposomes, as measured by A560, in the presence of increasing amounts
of DDM detergent. As the detergent concentration increases the turbidity of the vesicle solution
decreases. This is a result of the formation of detergent-lipid micelles, which do not scatter light.
Minimal micellular formation is observed for DDM concentrations less than .01%. (b) NaGreen
fluorescence of reconstituted ELIC upon addition of NaCl ± propylamine ± Triton X-100. No fluo-
rescence increases observed in the presence of propylamine suggesting that ELIC is not functionally
reconstituted. A large fluorescence increase is observed for lysed vesicles.
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To determine if ELIC was present in the isolated vesicles SDS-PAGE analysis
was performed on the vesicles. Protein staining (Coomassie Blue) showed the
presence of protein consistent with the ELIC molecular weight suggesting that
ELIC is incorporated into the vesicles (Figure 4.7a) [15, 16]. Ultracentrifugation
of the lipid vesicles removes the soluble components of the reconstitution mixture
(excess dye, non-incorporated ion channel, etc). Protein analysis of the isolated lipid
vesicles provides a direct measurement as to the presence of the desired protein in
the lipid vesicles. The same FlexStation fluorescence assays unfortunately did not
yield evidence for functional ELIC (Figure 4.6b). Similar results were obtained
using SBFI as the fluorescence indicator, but are not shown. Application of high
NaCl buffers in the presence or absence of propylamine resulted in very minimal
increases in NaGreen fluorescence (Figure 4.6b, red and green lines). Lysis of the
vesicles exposed intravessicular NaGreen to the bulk, and resulted in a large increase
in fluorescence (Figure 4.6b, purple line), suggesting that NaGreen fluorescence can
detected if Na+ entered the vesicles through ELIC. The FlexStation results show
that no functional ELIC has been incorporated into the vesicles (Figure 4.6b, red
and green lines). Gel electrophoresis of the reconstituted lipid vesicles shows the
presence of ELIC protein in lipid vesicles isolated with ultracentrifugation. The
combined FlexStation and SDS-PAGE results indicate that whatever ELIC present
with the vesicles is not functional.
(a) (b)
Figure 4.7: (a) A coomassie-stained SDS-PAGE gel of the ultracentrifuge-isolated proteoliposomes
after reconstitution. The ELIC proteoliposomes display a clear band corresponding to ELIC, showing
evidence for successful ELIC reconstitution. This band is absent if no ELIC is added to the liposomes.
(b) SDS-PAGE coomassie-stained protein analysis of the various fractions of ELIC mixed with
liposomes, followed by immediate ultracentrifugation. The evidence of ELIC present in the top band
shows that the ELIC association with the liposomes is not specific to the reconstitution protocol used.
To determine if the ELIC observed in the vesicle isolate is specific to the reconsti-
104
tution protocol purified ELIC was added to a solution of vesicles, and instead of
subjecting the ELIC to the reconstitution protocol (vessicle destabilization, incuba-
tion, detergent removal), this sample was immediately spun down in the ultracen-
trifuge. The isolated lipids were resuspended, and along with the supernatent of
the centrifugation assayed for ELIC by gel electrophoresis. Surprisingly, after three
washes, and no reconstitution protocol, evidence for ELIC in the isolated vesicles
was present (Figure 4.7b). The presence of ELIC suggests that protein-gel analysis
is not a valid indication of the successful incorporation of ELIC into vesicles (Fig-
ure 4.7a). It appears that a non-specific interaction between ELIC and the vesicles
exists. This interaction is strong enough to survive multiple ultracentrifugation and
washing steps. Following this result, a new method for reconstitution is needed.
4.3.5 Test of NaGreen and SBFI for use in Monitoring Na+ Flux into Vesicles
I then determined if NaGreen or SBFI fluorescence is a valid method to monitor
functionally reconstituted systems. I sought to use a robust ion channel with well
established reconstitution protocols to test NaGreen and SBFI. Gramicidin is a 15
amino-acid peptide that self assembles to form ion channels in membranes, has been
studied extensively [17], can be purchased commercially, and many protocols exist
for the reconstitution of Gramicidin.
520 540 560 580 600 620 640 660
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Wavelength(nm)
N
or
m
al
iz
ed
 In
te
ns
ity
NaGreen Assay
 
 
Gramicidin
Gramicidin + Triton
LUVs
LUVs + Triton
No Salt Backgroung
(a)
400 450 500 550 600
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Wavelength(nm)
N
or
m
al
iz
ed
 In
te
ns
ity
SBFI Assay
 
 
Gramicidin
Gramicidin + Triton
LUVs
LUVs + Triton
No Salt Backgroung
(b)
Figure 4.8: (a) Steady-state fluorescence spectra of NaGreen with Gramicidin proteoliposomes in
the presence or absence of NaCl (blue and brown lines respectively). The NaGreen fluorescence of
pure liposomes is shown in the green line. There is little difference in fluorescence of the Gramicidin
vesicles. (b) The same measurements but with SBFI as the fluorescent dye. The small increase
of fluorescence in the presence of Gramicidin indicates that the NaGreen or SBFI dyes are not
robust measurements for Na+ flux measurements into vesicles. All the fluorescence intensities are
normalized to the intensity observed upon vessicle lysis of the sample (red and black lines).
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Gramicidin was reconstituted by addition, and overnight incubation, with vesicles
enclosing NaGreen or SBFI [18]. The fluorescence of NaGreen and SBFI was
monitored upon addition of NaCl solutions to the gramicidin proteoliposomes. Flu-
orescence measurements display a peak at ca.540 nm and ca.520 nm for NaGreen
and SBFI, respectively. Vesicle samples (±gramicidin) exhibited an increased flu-
orescence upon addition of Na+ ions (Figure 4.8, blue and green lines compared
to brown). Unfortunately, a large difference in fluorescence of gramicidin vesicles
compared with the control vesicles was not observed. A 5% change in fluorescence
in the presence of gramicidin is observed for NaGreen, while a 10% increase in fluo-
rescence of SBFI. Gramicidin reconstitution is basically idiot-proof, and gramicidin
channels are known to conduct ions effectively. If the NaGreen or SBFI indicators
were efficient reportors of Na+ flux, a large increase in fluorescence should have
been observed with Gramicidin vesicles. The very small difference of NaGreen
or SBFI fluorescence with gramicidin limits the use of NaGreen or SBFI in the
reconstitution of ELIC. As a result, further efforts into the reconstitution will use a
different indicator for testing of reconstitution ion channels.
4.3.6 Reconstitution of ELIC and use of a Thallium Quenching Assay
A new assay for monitoring the functional state of reconstituted ion channels was
needed. Common assays for ion channel reconstitution are radioactive ion flux
[2], and thallium fluorescence quenching [4, 19]. Neither option is ideal due to
the hazards of working with either material, and in the end I chose to use the Tl+
quenching assay. Nicotinic acetylcholine receptors, ion channels in the same family
as ELIC, have been functionally reconstituted and assayed using Tl+ flux [19].
In Tl+ flux assays, the fluorescence of 8-aminonaphthalene-1,3,6-trisulfonic acid,
disodium salt (ANTS) is monitored upon addition of agonist to a proteoliposome
sample. Thallium(I) is a similar size to K+, allowing thallium flux through the
cation-selective ion channels and into the vesicle. Inside the vesicle collisional
quenching of Tl+ with ANTS results in a decrease in ANTS fluorescence. The
activated ion channels provide a pathway for thallium to enter the vesicles, resulting
in increased ANTS quenching in the presence of functionally reconstituted ion
channels.
ELIC was reconstituted using the partially destabilizing protocol as above, incor-
porating ANTS inside the vesicles. ANTS quenching was monitored upon addition
of Tl+ containing buffers using the FlexStation. All thallium samples resulted in
quenching of ANTS fluorescence, and no difference in quenching was observed be-
106
100 200 300 400 500 600
110
120
130
140
150
160
170
180
Time (Seconds)
Fl
uo
re
sc
en
ce
 
 
ELIC Proteoliposomes No Tl+
ELIC Proteoliposomes + Tl+
ELIC Proteoliposomes + Tl+ + PrNH2
ELIC Proteoliposomes + PrNH2
(a)
0 50 100 150 200 250 3000.5
0.6
0.7
0.8
0.9
1
1.1
1.2
1.3
1.4
1.5
Time (Seconds)
N
or
m
al
iz
ed
 F
lu
or
es
ce
nc
e
 
 
Gramicidin No Tl+
Gramicidin + Tl+
Gramicidin + Tl+ + PrNH2
LUVs + Tl+
(b)
Figure 4.9: (a) The fluorescence of ANTS as ELIC proteoliposomes are exposed to Tl+ ± propy-
lamine. Quenching of fluorescence is observed for all samples that contain Tl+. (b) The ANTS
quenching by Tl+ with gramicidin proteoliposomes. A large quenching of ANTS is observed for
the gramicidin vesicles mixed with Tl+ buffers ± propylamine (blue and magenta lines). This shows
that propylamine does not effect the assay. Less fluorescence quenching is observed for LUVs alone
(black line), however quenching is still observed.
tween samples exposed to thallium in the presence or absence of propylamine (Figure
4.9a). To verify the assay gramicidin was reconstituted into liposomes and ANTS
quenching monitored using the FlexStation (Figure 4.9b). Addition of thallium
buffers resulted in a step-like quenching of ANTS fluorescence for vesicles ± gram-
icidin. Tl+ ions non-selectively cross membranes, and this gramicidin-independent
quenching suggests the FlexStation sampling rate is not fast enough to resolve se-
lective thallium flux through channels. A stopped-flow is required to separate the
rapid flux of Tl+ ions through the ion channel from non-selective flux across the
membrane. Gramicidin was reconstituted [18] and mixed with thallium buffers in
a stopped-flow. Rapid quenching of the ANTS fluorescence is observed only in in
the presence of gramicidin proteoliposomes (Figure 4.10b, green line). Thallium
quenching of ANTS fluorescence was much slower in the absence of gramicidin
(Figure 4.10b, blue line), consistent with literature observations [18, 19].
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Figure 4.10: (a) The fluorescence of ANTS as ELIC proteoliposomes are exposed to Tl+ ± propy-
lamine. ANTS quenching is observed upon exposure to Tl+ alone (blue line), with the slow quench-
ing of ANTS consistent with non-selective ion flux across the membrane. Addition of propylamine
and Tl+ to ELIC proteoliposomes resulted in an increase in quenching (green line), suggesting
that functional ELIC is present (in small quantities). (b) The fluorescence quenching of ANTS
when gramicidin proteoliposomes are exposed to Tl+ containing buffers. Slow ANTS quenching
is observed for LUVs without gramicidin (blue line), highlighting the non-specific flux across the
membrane. Rapid ANTS quenching is observed with gramicidin vesicles (green line). Gramicidin
vesicles form ion channels and allow for thallium to enter the vesicles through the ion channel, which
occurs much more rapidly then the flux across the membrane.
Reconstitution of ELIC was repeated, using the Tl+ quenching assay to moni-
tor function, using the reconstitution protocol of Russinova and coworkers [4].
POPC:POPG lipids were resuspended in an ANTS solution and CHAPS detergent
was added. The lipids were then sonicated; however, a clear lipid solution was
not achieved as in the published protocol [4]. The formation of a clear solution
indicates the formation of degergent/lipid micelles, and vesicles are then formed
by removal of the detergent in the presence of the ion channel. Regardless of the
inability to produce a clear solution, ELIC was added to this solution and incubated
for 30 minutes. Detergent removal with biobeads formed LUVs, which were then
extruded through a 100 nm pore. Excess ANTS dye was removed through size ex-
clusion chromatography. Mixing of ELIC proteoliposomes with thallium buffer in
the presence of propylamine resulted in an increased quenching of ANTS compared
with just thallium buffer alone (Figure 4.10a, green vs blue lines). This is the first
example where reconstituted ELIC exhibited a different behaviour in the presence of
propylamine suggesting some (albeit, minimal) functional reconstitution. Repeated
attempts to reconstitute ELIC in a similar manner resulted in limited improvements
of signal. Discussion with Russinova at Cornell Medical College highlighted the
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importance of complete formation of lipid/detergent micelles in the protocol, an
outcome that I was unable to achieve.
To optimize ELIC reconstitution I spent two weeks working with Russinova in the
Andersen lab. The protocol developed is outlined in the methods section above.
The optimized protocol uses a higher concentration of purified ELIC (9 mg/ml vs.
1 mg/ml) during the reconstitution protocol. Higher concentration results in less
dilution of the reconstitution mixture. Another difference in the developed protocol
was the use of DOPC lipids in place of POPC lipids, with the vesicles consisting
of 3:1 DOPC:POPG. Working in the Andersen lab, I was able to successfully
reconstitute ELIC using two different methods.
One method of reconstitution used the protocol of complete solubilization of lipids
[4], which I was previously not able to achieve due to the low-powered sonicator.
Reconstitution following complete solubilization resulted in increased thallium-
induced ANTS quenching with propylamine present in the solution (Figure 4.11a,
magenta line). Rapid quenching in the presence of propylamine suggests that ELIC is
functionally reconstituted. A large burst-phase in quenching was observed with this
reconstitution sample. The initial fluorescence with any thallium buffer was about
15% lower than the fluorescence in the absence of thallium (Figure 4.11a, magenta
and green lines). This burst-phase is attributed the quenching of free ANTS in
solution, an event that occurs faster than the dead-time of the stopped-flow. ELIC
proteoliposomes were prepared at a 1:15 (w/w) ratio of ELIC:lipids resulting in ca.
30 ELIC pentamers per vesicle. High concentration of protein in the vesicle can
lead to the destabilization of the vesicles, and subsequent leakage of ANTS. Excess
ANTS in the bulk solution would result in the large burst-phase quenching. The
goal of high protein concentration was to observe any signal possible, but it appears
that too much protein can be deleterious.
ELIC was also reconstituted with the partial destabilization protocol using lower
ELIC concentrations. ANTS quenching analysis revealed successful reconstitution
of ELIC. The samples all display similar burst-phase quenching of ANTS, with
about 5% quenching observed. This is much lower than the 15% observed above.
This is likely due to the lower concentration of ELIC in the vesicles, resulting in
less leakage of ANTS into solution. Stopped-flow mixing of ELIC proteoliposomes
with thallium resulted in slow nonselective ANTS quenching (Figure 4.11b, orange
line). Addition of propylamine activated reconstituted ELIC, and results in a rapid
increase in ANTS quenching (Figure 4.11b). Higher concentration of propylamine
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Figure 4.11: (a) ELIC, reconstituted using the complete solubilization protocol, assayed for function
using Tl+ quenching of ANTS. In the presence of thallium buffer (green and magenta lines) a 15%
decrease in ANTS fluorescence is observed at the initial timepoint. This is due to excess ANTS
in solution, the quenching of which occurs faster than the dead-time of the stopped-flow. The
slow ANTS quenching observed for mixing of ELIC proteoliposomes with Tl+ buffer alone (green
line) is due to non-selective Tl+ flux into the vesicle. Addition of propylamine to the solution
results in a rapid quenching of ANTS (magenta line). The increased quenching in the presence of
propylamine suggests some functional reconstitution of ELIC. (b) ELIC reconstitution using partial
destabilization, assayed using Tl+ flux quenching of ANTS at various concentrations of propylamine.
Increased ANTS quenching is observed upon an increase in the propylamine concentration. The
dose-response in quenching shows that with more agonist in solution, Tl+ is able to enter the vesicle
quicker. This occurs through the activation of ELIC ion channels, with more ELIC ion channels
being activated at higher agonist concentrations. The concentration-dependent quenching shows that
functional reconstitution of ELIC has occurred.
displayed an increase in quenching rate and magnitude. The agonist dose-response
in quenching has previously be observed with reconstituted ion channels KcsA
and nAChR [4, 19]. An increased concentration of agonist in solution allows for
activation of more ELIC channels present resulting in a more rapid quenching of
ANTS. ANTS quenching rate, and magnitude, increase are analogous to the dose-
response, observed as current, in electrophysiology experiments. The propylamine-
specific quenching of ANTS shows that ELIC has been functionally reconstituted.
ELIC is known to enter a ligand-bound nonconducting (desensitized) state upon
prolonged exposure to propylamine [14]. To further confirm that ANTS quenching
is due to ELIC activation, desensitization experiments were conducted. ELIC pro-
teoliposomes were pre-incubated with propylamine buffer lacking thallium. After
1 minute of pre-incubation, the proteoliposomes were mixed with thallium buffer
containing the same concentration of propylamine. Upon mixing with the thallium
buffer, the same burst-phase quenching is observed (Figure 4.12a). This suggests
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Figure 4.12: (a) ELIC desensitization observed upon 1minute pre-incubation with propylmaine. One
minute incubation with propylamine results in ELIC entering a propylamine-bound non-conducting
state (magenta line). In this state, thallium flux through ELIC is not possible. The only remaining
ANTS quenching pathway is the non-specific flux across the membrane. The quenching observed
with desensitized ELIC (magenta line), and just Tl+ (yellow line) is similar. (b) Desensitization
of ELIC as a function of pre-incubation time with propylamine. Desensitization is observed after
incubating ELIC for 200 ms with propylamine (magenta line). Incubation for 10 ms (green line)
results in a quenching profile that is similar to the no incubation mixing (blue line).
that the origin of the burst-phase is independent of ELIC. The subsequent quenching
of ANTS was significantly attenuated (Figure 4.12a, magenta vs. cyan lines). The
quenching rate and magnitude were similar to the thallium alone quenching rate
(Figure 4.12a, yellow line). The pre-incubation of ELIC proteoliposomes elimi-
nated any rapid ANTS quenching by Tl+. This ANTS quenching profile is further
evidence that the quenching observed without pre-incubation results from function-
ally reconstituted ELIC. The incubation with propylamine activates ELIC, followed
by ELIC entering a desensitized state. The desensitized state is non-conducting, and
when mixed with thallium the only ANTS quenching pathway is the non-selective
membrane flux pathway. Further desensitization experiments utilized a delay mech-
anism in the stopped-flow that allows for the precise control of the incubation time.
Incubation periods > 10ms resulted in similar desensitization behaviour as observed
with the one minute incubation (Figure 4.12b). Desensitization in electrophysiol-
ogy experiments was observed over the course of seconds, not milliseconds. The
discrepancy in desensitization rates suggests that the ELIC is reconstituted in a
different functional state. Reconstituted ELIC is activated at 7.5 mM, compared to
100% activation by 2 mM propylamine in electrophysiology experiments, showing
a decreased sensitivity of reconstituted ELIC to propylamine. The differences in
activation profiles of reconstituted ELIC from electrophysiology show ELIC has
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been perturbed out of the so-called native state.
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Figure 4.13: ELIC proteoliposomes functional assay the presence of propylamine (cyan line) and
known ELIC blocker, chloroform (purple line). The rapid quenching of ANTS is eliminated in the
presence of chloroform. Chloroform blocks ELIC ion channel activation, preventing any ion flux
through the pore. The elimination of rapid quenching with chloroform provides further support for
the successful reconstitution of ELIC.
ELIC Blocking studies further confirmed the ANTS quenching results from Tl+
flux through activated ELIC. ELIC is blocked by common anesthetic molecules
such as chloroform [20]. Chloroform was added to the thallium and propylamine
buffers, and mixed with ELIC proteoliposomes in the stopped-flow. A significant
attenuation of the ANTS quenching rate was observed with chloroform present
(Figure 4.13). Chloroform blocks ion flux through ELIC. The observed ANTS
quenching with chloroform is due to the non-selective Tl+ flux across the membrane.
The elimination of rapidANTS quenching in the presence of a ELIC-specific blocker
further confirms that ELIC has been functionally reconstituted
4.4 Conclusions and Future Directions
In this chapter I outlined efforts towards the functional reconstitution of ELIC
and GLIC ion channels. I was able to purify both receptors using a heterologous
expression system. Any measurement made on a biological system in vitro requires
that the function of the system has not been altered from the observed in vivo
properties. ELIC is a membrane protein activated by propylamine. ELIC was
reconstituted using LUVs as the in vitromembrane environment. LUVswere chosen
because a defined inside and outside of the vesicles exist, akin to the inside and
outside of a cell. Many different protocols for reconstitution of ELICwere attempted.
All of the functional assays used monitored the flux of ions through an activated
ELIC receptor. The use of sodium sensitive dyes did not prove a viable method for
the detection of Na+ flux through an activated ion channel. The Na+ sensitive dyes
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were not sensitive enough to report the small fluorescence changes needed. Thallium
quenching of a fluorescent dye (ANTS) encapsulated inside vesicles was then used to
monitor ion flux through the activated ion channels. These measurements required
the use of a stopped-flow, as non-selective thallium flux across the membrane occurs
on the order of seconds. After many attempts, and variations on the reconstitution
protocols, ELIC was functionally reconstituted. Rapid ANTS quenching upon
mixing with propylamine, and elimination of quenching in the presence of a specific
ELIC blocker, suggests that ELIC has been successfully reconstituted.
However, the functional state of reconstituted ELIC is different, as evident from the
shifted dose-response to propylamine. Further optimization is needed to bring the
reconstituted ELIC dose-response to levels observed in electrophysiology experi-
ments. The ELIC expression and purification is not a high-yielding process, which
limits the use of brute force optimization. Optimization should focus on shifting the
sensitivity to propylamine of reconstituted ELIC to values observed in electrophys-
iology experiments. The functional properties of reconstituted ELIC need to be the
same as in vivo ELIC for use in an in vitro system. Also, maximum activation of
the reconstituted ELIC will achieve higher signals of ANTS quenching and provide
a larger change in fluorescence for the mixer experiments. Alteration of the lipid
bilayer properties by changing the lipid head groups, or acyl chain length can serve
as a starting point for optimization. Examination of the lipid composition of the
native organism, Erwinia chrysanthemi, could provide valuable insight.
Reconstitution yields a statistical distribution of the orientation of ion channels. Half
the ion channels are oriented correctly, with the extracellular domain residing in the
bulk buffer, and half the opposite incorrect orientation. Activation of ELIC requires
agonist binding to the extracellular domain preventing half of the reconstituted ELIC
frombeing activated. There has been some success in the orientation of reconstituted
ion channels [21], but without specialized protocols I assume that half of the ion
channels will be oriented in the incorrect manner. The orientation and insensitivity
of reconstituted ELIC results in low signals (5 - 10% of max quenching). Increased
agonist sensitivity will activate more of ELIC channels present allowing for more
quenching of ANTS. More ELIC channels will also result in large quenching of
ANTS. The reconstitution of ca. 30 pentamers resulted in destabilization of the
proteoliposomes. A 100 nm LUV has a surface area of roughly 125,000 nm2, and
the transmembrane area of ELIC is roughly 2000 nm2. From resulting sizes, 30
ELIC pentamers will occupy almost half of the surface area of a 100 nm LUV; it
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does not come as a surprise that the high concentration proteoliposomes could cause
leakage across the membrane. A detailed study investigating the signal vs. ELIC
concentration would allow for maximum signal to be obtained. Many protocols
were used in the reconstitution of ELIC. There was very little difference between
the unsuccessful attempts, and the successful protocol conducted in the Andersen
lab. The differences are as follows: 1 - detergent-solubilized ELIC concentration
was 10 times higher, and 2 - the lipids used were DOPC:POPG (3:1) as opposed to
POPC:POPG (3:1). It seems remarkable that such little difference in protocols can
make all the difference. Regardless, the use of these modifications resulted in the
functional incorporation of ELIC into liposomes.
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C h a p t e r 5
USE OF ULTRA-FAST CONTINUOUS-FLOWMIXING FOR
RAPID ACTIVATION OF ELIC
5.1 Introduction
As the thesis title might suggest, I have developed methods to rapidly and precisely
control the activation of ligand-gated ion channels. A lot of work (see Chapter 2
and 3) has focused on the development of photochemical triggers. The idea of rapid
mixing of ion channels with agonist was always pushed aside, despite the fact that
rapid mixing had been used previously to study biological events such as protein
folding [1–3]. Rapid mixing is able to achieve mixing times in the 10’s of µs
regime [4]. Outlined in Figure 5.1 is a schematic of the ultra-fast mixer used in
these studies. The mixing on the 10−5 s timescale provides a substantial gain in
temporal resolution for the monitoring of ion channel activation.
Figure 5.1: A schematic of the ultra-fast continuous-flow mixer used in these experiments. Two
solutions (reconstituted ion channel and agonist in this schematic) are held in separate syringes and
a syringe pump is used to drive the solutions through the mixer. The mixing speed is determined by
the rate of volume flow, and is controlled by the syringe pump. The mixed solutions travels down an
observation channel; the distance from the point of mixing can be converted into time after mixing
and allows for monitoring reactions during the process (blue lines). The sample then gets collected in
the trash (far right of the figure). The mixing channel is made out of 200 µm thick stainless steel plate
that is sandwiched in between two quartz pieces (dotted box) which allow for optical measurements
to be made.
ELIC is much larger than the proteins used previously [2, 5], and also must exist
in a lipid vesicle environment. Mixing on the 10 µs timescale requires extremely
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high velocities (12 m/s) and might result in the perturbation of the vesicles or pro-
teoliposomes in solution. ELIC has successfully been reconstituted into liposomes
(see Chapter 4 for details), and the proteoliposomes will be subjected to ultra-fast
continuous-flow mixing. Mixing of ELIC proteoliposomes with propylamine will
allow for activation of ELIC on the microsecond timescale. In this chapter I examine
the effects of ultra-fast mixing on liposomes and proteoliposomes. I then design
and calibrate an intensity-based detection system for use in the ultra-fast mixing
experiments. Finally I will discuss the work done to monitor the activation of ELIC
at early time points.
5.2 Methods and Materials
5.2.1 General Considerations
ELIC was expressed and reconstituted as above (Chapter 4). All chemicals were
obtained from Sigma-Aldrich and used without further purification. Os(bpy)32+ was
synthesized by stirring Os(bpy)2Cl2 with 5 equiv. of 2,2’-bipyridine in methanol
at reflux overnight. The solution was then filtered over celite, and the solvent
evaporated. The solid was then dissolved in acetonitrile, loaded onto a alumna
column, washed with excess acetonitrile, and eluted as a green band with 100%
methanol. The UV-visible spectrum agreed well with the published values [6, 7].
Ru(bpy)33+ was formed by oxidation of a solution of Ru(bpy)32+ with PbO2, and
filtering to remove excess PbO2 yielding a green solution, the spectrum of which
agreed with the published spectrum [7, 8]. The concentration of Fe2+ in solution
was determined using the 1,10-phenanthroline titration assay described previously
[9]. Stopped-flow and steady-state luminescence measurements were performed as
described above (Chapter 4). Dynamic light scattering measurements were made on
Wyatt Technology NanoStar, using 659 nm laser for measurements. Cryo-electron
microscopy used a FEI Tecnai 120 keV tranmission electron microscope. Images
were collected on a Gatan Ultrascan 2 x 2K camera with 14 µm pixel size. Samples
were frozen on a FEI vitrobot mkIII in ethane on quantifoil grids. The operating
conditions were as follows: -170°C, 120 keV, magnification 22,000x, objective
aperature size of 40 µm, and exposure times of 0.3s. The ultra-fast continuous-flow
mixer used was home built as described in [1]. The detection system is described
below, and the samples were mixed using a syringe pump (Harvard Apparatus) set
to the desired mixing speed. Images were collected using a Thorlabs DCC1545M
CMOS detector. Typically 100 frame movies were collected, at a sampling rate
of 5 frames per second, a pixel clock speed of 10 MHz, and integration times that
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allowed for maximum intensity values without saturating the camera. Images were
processed in ImageJ. The movie files were imported as grayscale videos, and z-
stack averaged. The averaged image was then saved as a tiff file, and imported into
MATLAB for further analysis. All data work up was done in MATLAB R2013b
(Mathworks, Inc.).
5.3 Results and Discussion
5.3.1 Microfludic ultra-fast Continuous-Flow Mixing of Lipid Vesicles
Initial ultra-fast mixing experiments examined the mixing of liposomes alone.
Liposome-only mixing will establish the stability of empty vesicles to the mixing
conditions. If empty vesicles do not survive mixing, it is unlikely proteoliposomes
would. The study of only LUVs also limits the use of ELIC, which is a very time con-
suming and costly protein to purify. Previous experiments using this mixer resulted
in a dead-time of mixing was estimated to be ca. 150 µs [1]; a 150 µs dead-time
is almost an order of magnitude faster than previous ion channel activation studies.
Mixing of lipid vesicles occurred under similar conditions. Characterization of the
vesicles before and after mixing allows for any perturbation of the vesicles to be
monitored.
Vesiclewere characterized prior to, and following,mixing in the ultra-fast continuous-
flow mixer. The vesicles were characterized using dynamic light scattering (DLS),
fluorescence leakage assays, and cryo-EM tomography ensuring that no change in
the vesicles occurred upon mixing. Dynamic light scattering monitors the bulk
particle size in solution [10]; use of DLS will determine the vesicle size distribution
before and after mixing. DLS measurements of vesicles before and after mixing
resulted in a similar observed size-distribution (Figure 5.2). The vesicle radius is
centered around 60 nm, in good agreement with the expected size from use of a 100
nm polycarbonate filter during vesicle formation. No bulk size change in the vesicle
solution suggests that there are no fusion or rupturing events that occur during the
mixing process. This does not rule out the complete dissolution of the vesicles and
the subsequent formation of lipid micelles smaller then the measurement limits of
DLS.
Slight deformation of the vesicle bilayer, which could result in undesired exchange
between the lumen solution and the bulk, could occur with out an observed change
in the DLS signal. A fluorescence leakage assay was used to examine the possibility
of this event from occurring. A quenched fluorescent dye is encapsulated inside
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(a) (b)
Figure 5.2: DLS measurements of fluorescein-encapsulated LUVs (a) and ANTS/DPX-encapsulated
LUVs (b) before and after mixing with a calculated mixing speed of 2000 mm/s. The vesicle size
before and after mixing are the same. This suggests that the mixing conditions do not disrupt the
bulk properties of the LUVs.
the LUVs, and with perturbation of the lipid bilayer the dye can escape the lumen
and enter the bulk. Bulk dye is no longer quenched, resulting in a fluorescence
increase. Two different dye and quenching methods were used. I will first mention
the fluorescein quenching experiments. At high concentrations, fluorescein is self-
quenched [11], and has been used previously to monitor vesicle leakage [12]. The
complete removal of extra-vesicular fluorescein was very difficult and resulted in
high background fluorescence signals (Figure 5.3a). Regardless, the fluorescein
leakage experiments suggest that little disruption of the vesicles occurs. The mixed
sample only had around 5% greater fluorescence (Figure 5.3a, Red vs. Black lines).
In a effort to have lower background fluorescence, ANTS (fluorophore) and DPX
(quencher) were contained within vesicles [13, 14]. Background fluorescence sig-
nals of 25% of the theoretical maximum (Figure 5.3b, black line) were observed
using ANTS/DPX. LUVs containing ANTS and DPX were mixed, and collected
after mixing for fluorescence measurements. To control for inconsistencies aris-
ing from dilution errors, and the sample-to-sample variation in fluorescence, each
sample was normalized to the 100% fluorescence intensity (Figure 5.3, blue line).
The 100% fluorescence intensity was obtained by lysing each sample with Triton
X-100 detergent (Figure 5.3, Blue lines). Lysis of the vesicles releases ANTS and
DPX into the bulk, diluting the effective concentration of each, and at these dilute
concentrations ANTS is not quenched by DPX. The fluorescence observed from the
lysed samples then results in the fluorescence from a 0% quenched ANTS. Around a
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Figure 5.3: (a) Steady-state luminescence spectrum of LUVs with self-quenching fluorescein en-
capsulated within the lumen before and after mixing. A background fluorescence of around 70%
is observed for the quenched fluorescein samples (black line). A ca. 5% increase in fluorescein
fluorescence is seem for the mixed LUVs (red line), when compared to the unmixed samples. (b)
ANTS/DPX encapsulated vesicles steady-state luminescence spectrum before and after mixing. The
background fluorescence of the ANTS/DPX assay 25% (black line); much lower background fluo-
rescence is observed for ANTS/DPX than fluorescein. Mixing of the LUVs resulted in a 5% increase
in ANTS fluorescence (red line). The minimal increase in fluorescence after mixing of the vesicles
suggests that little perturbation of the lipid vesicles occurs.
5% difference in the fluorescence of ANTS between the mixed or unmixed vesicles
(Figure 5.3b, Red and Black lines) was observed. This was true for a number of
mixing speeds and liposome concentrations. Perturbation of the lipid membrane
would release ANTS and DPX into the bulk solution and result in a increase of
fluorescence. The similar ANTS fluorescence of the mixed and unmixed samples
shows that little perturbation of the lipid bilayer occurs during the mixing process.
Cyro-EM tomographywas the last characterization technique used tomonitor vesicle
stability. Vesicles were collected after mixing, and the mixed and unmixed vesicles
were flash-frozen on separate EM grids. Cryo-EM allowed for direct imaging of
the lipid vesicles. The morphologies and size distribution of the lipid vesicles did
not change significantly as observed by cryo-EM (Figure 5.4). The mixing speeds
of the above experiments were the same as previous experiments that yielded a 150
µs dead-time. The maximum linear velocity of solution in the flow channel, as
determined by conversion of volume flow, is 2000 mm/sec. The vesicle stability
and dead-time are both functions of this mixing speed; changing the mixing speed
will require the reexamination of both the vesicle stability and dead-time. Under
a velocity of 2000 mm/sec, DLS, fluorescence leakage, and cryo-EM indicate that
121
(a) (b)
Figure 5.4: Cryo-EM tomography images of ANTS/DPX filled vesicles before (a) and after (b)
mixing through the ultra-fast continuous-flow mixer at 2000 mm/s. The scale bar for each figure is
100 nm. (b) The insets (boxed in red) which are separate images of the same mixed sample. The
concentration of the mixed sample is lower than the pre-mixed sample, and the multiple images are
used to display a number of vesicles that were observed. In all the images, the vesicles appeared
circular, mostly unilamellar, and around 100 nm in diameter. No deformation of the vesicles confirms
that there is no perturbation of LUVs upon mixing.
there is little perturbation of the liposomes under the ultra-fast continuous-flow
mixing conditions.
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Figure 5.5: ELIC proteoliposomes functional assay using Tl+ quenching before and after mixing
in the ultra-fast continuous-flow mixer at 2000 mm/s. Rapid ANTS quenching is observed in upon
mixing ELIC proteoliposomes with propylamine. This quenching is attenuated with the addition of
chloroform, a known ELIC inhibitor. Mixing of ELIC proteoliposomes does not alter the ANTS
quenching profiles, showing that ELIC proteoliposomes retain function after ultra-fast mixing.
I want to mix reconstituted ELIC with propylamine to monitor the activation of
ELIC. Mixing of ELIC proteoliposomes requires that mixing does not perturb
122
ELIC proteoliposomes as well; it is not known the effect ELIC will have on the
properties of the liposomes. To address this, ELIC was reconstituted into vesicles
and function confirmed as above. Functional ELIC proteoliposomes were then
mixed through the ultra-fast continuous-flow mixer and collected after mixing.
The ELIC proteoliposome function was then tested. ELIC proteoliposomes after
mixing displayed the same functional behaviour as unmixed samples; an increased
quenching rate was observed in the presence of propylamine, which was inhibited
by the addition of chloroform (Figure 5.5). This result shows ELIC function is
retained after the rapid mixing. While the function of ELIC is retained it is unclear
the extent to which function is retained; a portion of the sample could be rendered
nonfunctional by the mixing. Use of the DLS, fluorescence leakage, and cyro-EM
assays as above, could address this issue. The raw fluorescence intensity under
activation could also be used. Lower intensity might suggest that fewer channels are
activated, an indication that mixing perturbs some of the system. I am hesitant to use
intensity measurements because of the fluctuation in this value. I have previously
observed large fluctuations in raw measurements between different repeats of the
same sample. Regardless, the thallium quenching assay would not work if there was
complete proteoliposome destruction. Functionally reconstituted ELIC in liposomes
is able to retain function after rapid mixing.
5.3.2 Fluorescence Intensity Detection Setup
I have established both lipid vesicles, and functionally reconstituted ELIC, can
survive the rapid mixing. An assay that will measure ion channel activation at this
timescale needs to be developed; initial efforts will focus on using the established
ANTS quenching assay to monitor the first few milliseconds of the ion channel
activation [3]. Thesemeasurementswill examine the initial burst phase of quenching
that is observed in the stopped-flow measurements. A flow velocity of 2000 mm/s
will translate to an observable time of 6 ms in the mixing channel. On this timescale,
thallium flux across the membrane in a non-selective manner is not a concern, which
will simplify the analysis. The readout for the ultra-fast continuous-flow mixing
will be ANTS fluorescence quenching by thallium, as was the case in the stopped-
flow measurements. Because the lifetime of the ANTS is not needed for these
measurements, a new detection system was designed that can measure the intensity
of ANTS fluorescence in the mixer.
A fluorescence-intensity detection system was built (Figure 5.6). The ANTS optical
absorption spectrum has a peak at 355 nm, with the emission peak at 520 nm. A 405
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Figure 5.6: A schematic representation of the fluorescence detection system using a 405 nm diode
laser for excitation, and a Thorlabs CMOS sensor for luminescence detection. The sample is mixed
through the mixer with the desired buffer. The excitation from the 405 nm laser is shaped into a sheet
and excites the mixing channel (highlighted in a dashed box). The fluorescence is then collected
using a camera lens, and imaged on a detector. An image of the fluorescence observed from the
mixing of ANTS-filled LUVs with water is found at the far right of the figure.
nm diode laser was used as an excitation source; the absorbance peak is broad and
405 nm will be able to excite ANTS. The laser is then defocused using a negative
focal length lens, followed by a cylindrical lens. The cylindrical lens focuses the
laser into a sheet that is used to excite the mixing channel. Emission was then
focused using a camera lens, onto a commercially available monochromatic CMOS
detector from Thorlabs. Excitation light was rejected using two highly refelective
405 nm dielectric mirrors, one placed before the collection lens, and the other placed
in front of the CMOS detector. Use of just one mirror resulted in detection of the
excitation source. The ultra-fast continuous-flow mixer image was then projected
onto the entire CMOS detector sensor. A few dark pixels on either end of the
mixing chamber were used to provide background measurements. Mixing speeds
of 2000 mm/s resulted in 6 µs per pixel time resolution. Magnification of the
mixing chamber would allow for faster time resolution; however, imaging the entire
channel proved more useful. Lipid vesicles were prepared in the absence of ELIC
to determine the fluorescence sensitivity of the detector setup. Imaging of these
vesicles resulted in ANTS fluorescence observed in the mixing chamber (Figure 5.6,
far right). The fluorescence was not present without excitation or without ANTS
present. This result shows that the detection system developed is able to image
100% of the ANTS fluorescence that will be present in the ELIC proteoliposomes.
5.3.3 Determination of Mixing Dead-Time
The mixer dead-time needs to be determined in conjunction with use of the detector
setup. Standard dead-time calibrations of stopped-flows and continuous-flowmixers
[3, 15] use the fluorescence quenching of N-acetyl-L-tryptophanamide (NATA) by
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N-bromosuccinimide (NBS). In this reaction NATA is excited with UV (254 nm)
light, and the fluorescence is monitored at 330 nm. This assay will not work with
the current detection system. The CMOS detector is not sensitive to UV light.
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Figure 5.7: (a) The UV-visible spectra of 8-hydroxyquinoline (8HQ, red line), 8HQ + 10 mMMgCl2
(green line) and 8HQ + 100 mM MgCl2 (blue line). Addition of Mg to a solution of 8HQ results in
a the formation of a Mg-8HQ chelate, as is evident from the shift in the UV-visible spectrum. There
is very low absorbance at 405 nm of the Mg-8HQ chelate. (b) Steady-state luminescence spectra of
8HQ upon excitation at 405 nm (red line), and with addition of 10 mM and 100 mM MgCl2 (green
and blue lines, respectively). No emission is observed without Mg present. A weak fluorescence
peak is observed at ca. 530 nm. The water Raman stretch is also visible at 460 nm, which highlights
how weak the fluorescence of the Mg-8HQ chelate is with 405 nm excitation.
Magnesiumchelation of 8-hydroxyquinoline has been reported as a visible-wavelength
fluorescence turn-on assay used to measure dead-times of mixing [16]. This assay
was not successful. No fluorescence of the Mg-8HQ chelate was observed using
the CMOS detector. This result is not shown because it is a black image. Little 405
nm absorbance was observed even at high Mg concentrations (Figure 5.7a). Using
a steady-state fluorometer, weak fluorescence of the Mg-8HQ system is observed
(Figure 5.7b). The luminescence (405 nm excitation) is so weak that the water
Raman scattering (Figure 5.7b, peak at 460 nm) can be observed; the Raman scatter
is typically washed out in the luminescence. The steady-state fluorometer uses a
PMT for fluorescence detection, which is a method that results in amplification of
the signal. This amplification of the signal allows for the weak fluorescence to be
observed. The CMOS detector is a direct intensity measurement. The low fluores-
cence observed with the fluorometer suggests that this assay is not adaptable for the
detection system utilizing the CMOS camera.
A new dead-time determination assay is needed that has the following requirements:
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Figure 5.8: (a) Luminescence quenching of Os(bpy)32+ by hexachloroiridate as observed under
steady-state conditions, λex = 405 nm. The luminescence peak is observed at 720 nm, and is
quenched upon addition of increasing equiv. of Ir4+. This oxidation by Ir4+ results formation of Os3+
which is not luminescent. (b) Stopped-flow luminescence of Os(bpy)32+ with increasing amounts
of Ir4+ quencher. In the absence of Ir4+, and at maximum detector voltage, there is very little Os2+
luminescence observed (red line). Addition of Ir4+ will quench the luminescence, and results in no
signal detected (green, purple, and cyan lines). The quenching of Os2+ appears as a decrease in the
intensity, this shows that the reaction with Ir4+ is complete under the mixing conditions. (c) Image
of the luminescence of Os(bpy)32+ within the ultra-fast continuous-flow mixer using the Thorlabs
detector (Figure 5.6). The incomplete image in is due to misalignment of the detector system, and
not quenching of the luminescence.
1 - visible light fluorescence, 2 - 405 nm excitation, and 3 - large quantum yield of
emission. Two systems were designed that met these requirements. The first would
examine the Os(bpy)32+ luminescence quenching by oxidation of Os2+ to Os3+ with
hexachloroiridate (Figure 5.8a). Os2+ luminescence was observed with 405 nm
excitation in the ultra-fast mixer detection setup with the Thorlabs detector (Figure
5.8c). To verify the use of Os2+ oxidation to determine the dead-time, the mixing
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of Os2+ with Ir4+ occurred in a stopped-flow (Figure 5.8b). Using a stopped-flow
allows for referencing the Os2+ method with the established NATA/NBS protocol,
and determination of the second-order rate constant for Ir4+ oxidation of Os2+.
Unfortunately, the Os2+ data did not yield useful information. Os(bpy)32+ lumines-
cence is weak and red-shifted; the emission peak is at 720 nm [7]. Stopped flow
measurements of Os2+ fluorescence in the absence of Ir4+ yielded very little signal
(Figure 5.8b, red line). This is likely due to the combination of weak luminescence,
coupled with red emission. The sensitivity of the PMT detector is about ten-fold
less sensitive at 720 nm than at the maximum sensitivity wavelength. Mixing Os2+
with Ir4+ yields a decrease in the luminescence signal that is not resolved in the
stopped-flow (Figure 5.8b, green, purple and cyan line). This behaviour suggests
that the reaction between Os2+ and Ir4+ occurs faster than the response time of
the instrument. To observe this reaction the Os2+ concentration could be lowered;
unfortunately, the small unquenched Os2+ luminescence does not allow the concen-
tration to be lowered. As a result, the Os2+ system is not amenable for dead-time
calculations.
A new method was developed for use in the determination of the dead-time of
the mixer, which has higher luminescence quantum yields and a blue-shifted emis-
sion (limitations of the Os2+ assay). The oxidation of Fe2+ ions by mixing with
Ru(bpy)33+ was examined. The resulting solution will give Fe3+ and luminescent
Ru(bpy)32+. At neutral pH, Ru3+ is not stable requiring the experiments to be
conducted in 1 M perchloric acid. Working with such highly acidic solutions is
likely to increase the viscosity of the solutions. A higher viscosity solution will
alter the mixing properties, but would provide a lower-limit of mixing dead-time.
Fortunately, 1 M perchloric acid has a similar viscosity (ca. 1 cPa) as water at 20°C
[17, 18]. To confirm the CMOS detector can detect Ru2+ luminescence, Ru(bpy)32+
was mixed and the luminescence detected (Figure 5.9d).
This assay had not been used previously for dead-time determination; the dead-
time of a stopped-flow was determined. Oxidation of Fe2+ by Ru3+ resulted in a
dead-time of ca. 2 ms (Figure 5.9b). The use of NATA/NBS assay resulted in a
dead-time of around 1.5 ms (Figure 5.9a). The second-order rate constant observed
for Fe2+ oxidation was similar to the published value [8]. The Ru3+ reaction is
a turn-on fluorescence assay, as opposed to the quenching NATA/NBS reaction.
For the determination of the dead-time using NATA/NBS, the pseudo-first order
quenching rate is fit to a single exponenetial and extrapolated beyond observed t0 to
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Figure 5.9: (a)Dead-time determination of the stopped-flowusing a the standardNATA/NBS reaction
[15]; inset is magnification around the observe zero time point. The dead-time of the stopped-flow
is around 1.5 ms. For (a) and (b) the luminescence intensity values are shown as circles, with the
single-exponential fits as solid lines. (b) Verification of Ru3+/Fe2+ assay for dead-time determination;
inset is magnification around time zero. The fluorescence intensity of Ru(bpy)32+ is monitored as
a function of time. Increasing time results in formation of more luminescent Ru(bpy)32+ and an
increase in signal. The luminescence intensity is normalized to the last points. Extrapolation of the
exponential fit results in a dead-time of 2 ms, close to the value obtained in (a). (c) Second-order
quenching reaction of Ru3+ with Fe2+ under pseudo-first order conditions; slope is the second-
order rate constant, in good agreement with the published value [8]. (d) Image of RuRu(bpy)32+
luminescence in the ultra-fast continuous-flow mixer, the difference in intensity across the mixer is
due to the vignetting of the image.
a point where the fits intersect. The difference in time between observed t0 and point
of intersection is the dead-time of the reaction. The Fe2+ oxidation reaction was
normalized to the t∞ luminescence value, fit to a single exponential, and extrapolated
past observed t0 to a point of crossing. Extrapolation of the fit before t0 provides
values of either 100% fluorescence (NATA/NBS) or 0% fluorescence (Ru3+/Fe2+),
a point in which there has been no mixing of the two components. The difference
between this time point and the observed t0 is the dead-time of the instrument.
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The Ru3+/Fe2+ assay was then used to determine the dead-time of the ultra-fast
continuous flow mixer. Mixing at speeds used previously (2000 mm/s), the Ru2+
fluorescence was monitored over the length of the channel. The complete reduction
of Ru3+ occurred by the end of the mixing channel. The data obtained from the
mixer fluorescence detection system needs to be corrected for the reduction of the
image intensity at the edge of the image (vignetting) observed. To correct for image
distortion, a 100% luminescence sample (Ru2+ of the same concentration was mixed
in the absence of Fe2+) and used as a correction curve. The luminescence intensity
should be the constant across the entire mixing channel, and any difference in
intensity is due to vignetting of the image. The Ru2+ image was normalized, and all
of the other images were multiplied by the reciprocal of the normalized pixel value.
In the case of the Ru2+ sample, the correct image results in completely flat line across
the mixing chamber. All of the pixel rows that consisted of the Ru2+ luminescence
signal were combined and averaged. The final adjustment converts the pixel number
to a timepoint. This was achieved by using the known mixer channel distance (13.5
mm) and converting the pixel to mm using ImageJ64 measurement tools.
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Figure 5.10: (a) Dead-time determination of the mixer using a the oxidation of Fe2+ by Ru3+; inset
is magnification around the observe zero time point. Corrected luminescence intensity is shown as
circles, with the single-exponential fits as solid lines. The intensity values are normalized to the last
pixel in the mixer. A increase in Ru2+ formation is observed under higher Fe ion concentrations.
Extrapolation of the exponential fits of the reaction results in a dead-time between 100 and 200
µs. (b) Second-order quenching reaction of Ru(III) with Fe(II) under pseudo-first order conditions;
slope is the second-order rate constant, which is different than what is observed using stopped-flow
measurements.
Using the above image correction method, luminescence traces were obtained (Fig-
ure 5.10a) for the oxidation of Fe2+ by Ru3+. A concentration-dependent increase in
luminescence was observed for these mixing conditions (Figure 5.10a). Fitting the
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turn-on luminescence curves resulted in a second-order rate constant for the reaction
of 2.2 ×105M−1s−1 (Figure 5.10b), about three fold lower than the published value.
The second-order rate constant is consistently low across multiple samples. One
source of error could come from the sensitivity of this measurement towards the
alignment of the detection system. Misalignment results in uneven illumination of
the mixing chamber and skewing the image collected on the detector. Misalignment
causes in unequal weight placed on pixels during the correction process. Because
these measurements are raw intensity measurements, it is critical to collect the ref-
erence (Ru2+) image in the exact same manner as the experimental data. If the
alignment changes slightly throughout sample collection, error in the correction of
the samples will occur.
One additional complication, and potential source of error, is that Ru3+ is a 1.23 V
oxidant [7]. Ru3+ was reduced by the mixer in the absence of any aqueous Fe2+
ions. One source of reduction of Ru3+ was exposure to the stainless-steel filter.
Removal of these filters from the lines resulted in less Ru3+ reduction observed in
the absence of Fe2+. Stainless-steel oxidation by Ru3+ is not too surprising, 1.23
V is very oxidizing, and stainless-steel has a lot of additives which could serve as
reductants. Flow through a high-surface area frit provides much more exposure to
the steel. The removal of all the stainless steel in the mixer could not occur. The
mixer housing and the mixing channel are both made of stainless steel, and neither
of these pieces can be removed from the mixer. Ru3+ reduction did not occur if the
mixing speed remained at 2000 mm/s in the absence of the frits. Slower mixing
speeds, or static Ru3+ in the mixing chamber resulted in the formation of Ru2+ in
the absence of aqueous Fe2+ ions. The non-specific reaction between Ru3+ and
the mixer can complicate dead-time determination. Unfortunately, the removal of
the filters caused the channel to become clogged with dust particles. Removing
these particles required dismantling of the detection setup; this dismantling alters
the imaging position and causing errors during the vignetting correction procedure.
Despite all of these issues with the assay, the dead-time was determined using this
assay. The extrapolated fits intersect at a value between 100 µs and 200 µs (Figure
5.10a, inset), a number that will be used conservatively as the dead-time of the mixer
with this detection setup.
5.3.4 Measurement of ELIC Activation using the Continuous-Flow Mixer
Thefluorescence detection systemabovewas used tomonitor theANTSfluorescence-
quenching by Tl+ with reconstituted ELIC. ELIC was reconstituted as above, and
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function verified by stopped-flow (Figure 5.11a). ELIC proteoliposomes were then
mixed in the ultra-fast continuous-flowmixerwith blank buffer (no thalliumor propy-
lamine), Tl+ buffer, Tl+ buffer with propylamine, and finally Tl+, propylamine, and
chloroform buffer. ANTS fluorescence is not quenched in the absence of thallium
and the blank buffer was the image used for correction of the observed vignetting.
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Figure 5.11: (a) Stopped-flowANTS fluorescence intensity of ELIC proteoliposomes in the presence
of thallium (Purple line) with activating proplyamine (Red line), and ELIC blocker (Green line). A
rapid quenching of ANTS fluorescence is observed in the presence of propylamine, which is attenu-
ated by chloroform. This shows that the ELIC is functionally reconstituted into these proteoliposomes
(b) Monitoring of ANTS fluorescence from ELIC proteoliposomes exposed to thallium (Purple line)
with activating proplyamine (Red line), and ELIC blocker (Green line) in the ultra-fast continuous-
flow mixer using the Thorlabs detection system. The mixing channel starts around 400 µs. There is
no difference in ANTS fluorescence observed for any Tl+ sample. The lack of propylamine-specific
quenching demonstrates that the activation of ELIC is not observed using this setup.
No difference in ANTS fluorescence quenching was observed for all the samples
exposed to thallium (Figure 5.11b). All of the Tl+ buffers resulted in quenched
ANTS fluorescence. The non-specific quenching is likely due to the quenching
of free ANTS in solution, the burst-phase quenching observed in the stopped-flow
measurements. Examination of the stopped-flow experiments show a 4% decrease
in ANTS fluorescence (in the first 100 ms), and a much smaller decrease in the first
6 ms, for activated ELIC proteoliposomes. ELIC proteoliposomes in the absence
of propylamine recorded a change of about 1% in ANTS fluorescence over this
timescale. These are very small fluorescence changes, especially when attempting
to distinguish between the two. The scatter in the mixer data appears to be around
±2%. The sensitivity of the mixing experiments is not high enough to distinguish a
difference in the ANTS quenching of ELIC proteoliposomes as a result. At longer
timepoints, there is around 10% change in fluorescence; however, a stopped-flow
is a perfect tool for measurement at these longer time points. Use of a different
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detector, such as a cooled CCD or CMOS detector, might provide higher dynamic
range, and lower the noise. One issue I would like to mention is that continuous-
flow measurements use an absurd amount of sample. This presents a problem when
conducting experiments with sample limitations such as the ELIC experiments. The
ELIC continuous-flow mixing results suggest the fluorescence detection system, as
designed, is not suitable to monitor ELIC activation on these timescales.
5.4 Conclusions and Future Outlooks
Despite the altered in vitro functional state of ELIC, the above (Chapter 4) recon-
stitution protocol was used to monitor the first 6 ms of ANTS quenching using a
continuous-flow mixer. I was able to show that lipid vesicles were able to survive
rapid mixing that affords a 150 µs mixing dead-time. I was also able to show that
the functionality of ELIC was preserved upon mixing. A fluorescence detection
system was then designed, using a CMOS detector, which would allow for direct
intensity measurements to be made of the rapid mixing events. A new dead-time
determination assay was developed utilizing the oxidation of Fe2+ by Ru(bpy)33+.
Using this assay, with the fluorescence detection system, resulted in the determina-
tion of dead-time of mixing (ca. 200 µs) of the continuous-flow mixer. The mixer
was then used, in combination with the ANTS quenching assay, to monitor the early
stage activation of ELIC. Unfortunately, with the functionally reconstituted samples
available, monitoring of ELIC activation was not possible with this new system.
What I have established in this chapter are a few initial results that can serve as
starting points for further optimization of the system. Optimization of the dead-
time calibration is necessary; the second-order rate constant should agree with the
literature value (as was observed in the using stopped-flow, shown in 5.9c). This
discrepancy could be due to the reaction of Ru3+ with other species besides Fe2+ ions
in the mixer, or an error in the Fe2+ concentration. A fluorescence quenching assay
monitoring the oxidation of tris(tetramethyl-dipyridyl)Ru2+ by Ir4+ could be used
as an alternative assay. The reduction potential of this substituted Ru2+ complex
is similar to the Os(bpy)32+ allowing for oxidation by Ir4+. Verification the mixer
detection setup can monitor the ANTS quenching is also necessary. Collection of
more frames to limit the noise is not the most practical approach; S/N goes as the
square of the sample number and is not possible for sample-limited experiments.
Gramicidin vesicles could be used to verify the detector setup. Gramicidin vesicles
result in a 10 - 15% change in ANTS fluorescence in the first few ms (Figure
4.10b) which might provide a signal large enough to be observed. Gramicidin is
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commercially available so the sample would not be limited. A different detector also
could provide greater sensitivity, but detectors are expensive and unless the system
will be used extensively I do not recommend this. Time-resolved measurements
is another potential avenue that could be explored; dynamic quenching of ANTS
would result in a decrease in ANTS fluorescence lifetime dependent on thallium
concentration. ANTS/thallium quenching rates could be determined in vitro and
compared with those obtained in the mixing experiments. This method, however,
depends on dynamic quenching of ANTS by thallium which needs to be confirmed
first. Also, time-resolved measurements, using a streak-camera for detection, would
require even more sample. This limits the practicality of these experiments. While
I do not advocate pursuing this system further, I have outlined above potential
places for improvement. In all I believe that this work presents initial attempts at
the monitoring of ion channel activation gaining about one order of magnitude on
previous measurements.
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C h a p t e r 6
FUTURE DIRECTION TO OBSERVE ION CHANNEL GATING
6.1 Introduction
The goal that motivated this thesis in motion, to monitor ion channel activation,
never actually came to fruition. However, I never lost sight of the ultimate goal and
in the last few months I have been thinking about the big picture and how I might go
about trying to achieve that goal. I want to use this chapter to lay out how I would
now approach the project, and hopefully be able to monitor the conformational
changes associated with ligand-gated ion channel activation.
6.2 Azobenzene Phototriggers for Ion Channel Activation
I still think that the hardest part in the entire project will be to activate ion channels
with precise control. One photochemical method of ion channel activation that I
did not explore is the use of azobenzene molecules. Azobenzene molecules are
well-studied organic chromophores that, upon irradiation, undergo rapid cis-trans
isomerization. The isomerization is accompanied by a structural change that results
in a 5 Å contraction of the distance between the 4 and 4’ carbons [1]. Azobenzene
molecules have been used as molecular switches, to photoactivate peptides, and to
induce hairpin formation in DNA [2]. Additionally, azobenzene molecules have
been used to activate ion channels with light. In early ion channel studies, Lester
and coworkers were able to induce activation and inhibition using azobenzene
molecules covalently attached to the protein of interest [3, 4]. More recently
Trauner synthesized a series of azobenzene molecules that enabled optical control
of iGluR channels, pLGICs, and K+ channels [5–7].
Azobenzene photoactivation of ion channels can occur by covalent linkage of one
end of the azobenzene to the protein. The other end of the molecule has an appended
ligand that can activate the desired ion channel. Upon irradiation the azobenzene
will isomerize and the resulting structural changes will bring the agonist into ligand-
binding site and activate the ion channel. To induce the opposite isomerization
event the azobenzene can then be irradiated again which will allow for reversible
activation of the ion channel. Azobenzene molecules are synthetically tuneable
and many biologically important modulating ligands could be attached to potentiate
different ion channels. The wavelength of cis-trans isomerization is also tunable.
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For example red-shifted azobenzene molecules will allow for isomerization without
the use of UV irradiation [8].
The photoisomerization properties of azobenzenes are amenable rapid activation of
ion channels. The trans isomer of azobenzene is present at room temperature, and
upon irradiation undergoes isomerization to the cis-form within a few picoseconds
[9]. Thermal cis-to-trans back isomerization rates can vary widely (hours to ms);
the cis-to-trans isomerization occurs within picoseconds if phototriggered [2].
The quantum yield for photoisomerization also varied depending on the specific
azobenzene molecule, and can be as high as 0.20 [2, 9]. The relatively high
quantum yield allows for efficient photochemical triggering of isomerization in both
directions. This, coupled with the reversible nature of the azobenzene activation,
provides a huge advantage in application to the study of ion channels.
Thermal or phototriggered cis-to-trans isomerization will allow for the precise
control of the deactivation of ion channels, and potentially facilitate monitoring
of ion channel activation and deactivation. The rapid rates at which azobenzene
molecules isomerize are crucial for the precise and rapid control of ion channel
activation/deactivation. Picosecond isomerization rates allows for the ligand to bind
in advance of ion channel activation events (vida supra). It is crucial that the rapid
isomerization occurs. Knowledge of the thermal cis-trans isomerization is also
crucial; deactivation occurring during any measurements will present a problem.
Nevertheless, the photophysical properties of azobenzeme molecules should allow
for the rapid activation and deactivation of ligand-gated ion channels.
6.3 Using Lanthanide Energy Transfer to Monitor Ion Channel Activation
The use of time-resolved energy transfer provides a dynamic experimental method
to monitor the activation of ion channels. Luminescence resonance energy transfer
(LRET) measurements monitor the stimulated-emission lifetime of an acceptor
fluorophore using a lanthanide-cheleate donor [10, 11]. The lifetime is proportional
to the energy transfer efficiency of the donor-acceptor pair and it is a sensitive probe
of the distance between the donor and acceptor [12, 13]. The distances obtained
from the lifetime measurements are then used to map out conformational changes of
the protein. As outlined above (Chapter 1), LRET was previously used to monitor
the conformational changes of voltaged-gated ion channels under activation [14–
16].
Lanthanide luminescence is not efficiently triggered with direct excitation of the
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metal center and requires sensitization [17]. Excitation of an organic dye ap-
pended to a lanthanide chelate allows for energy transfer from the excited dye to
the metal-centered excited states [18, 19]. The metal-centered excited states can
then undergo intersystem crossing and radiatively decay to ground state. The lan-
thanide emission contains many sharp peaks with large Stokes-shifts. An organic
fluorphore with absorbance overlap with a lanthanide emission band is used as the
acceptor. The lanthanide luminescence and the acceptor stimulated-emission can be
spectrally separated because of multiple sharp emission features of the lanthanide
luminescence. The spectral seperation of the donor and acceptor emission allows
for concurrent measurements of the donor and acceptor lifetimes. The long lifetime
of the acceptor stimulated-emission allows for the temporal separation of any direct
fluorescence from the acceptor. Fluorescence lifetimes of common small-molecule
organic fluorphores are on the order of nanoseconds. Gating of the fluorescence
measurements, i.e. delaying the start of data acquisition, by tens of nanoseconds
will allow for the rejection of any direct fluorescence measurement.
The long lifetimes of the LRET measurements also allow for the use of PMT de-
tectors. The TR-FET measurements use photon counting to detect the fluorescence
lifetime. The photon counting detection is a direct measurement, and requires longer
acquisition times to get good signal. PMT detectors can be coupled with electronic
amplifiers to measure the long-lifetimes of the LRET emissions. This could provide
much quicker acquisition times, and use of less sample. LRET acceptor (and donor)
lifetime measurements will provide information about the energy transfer efficiency,
and as a consequence, the distance between donor and acceptor.
6.4 Labeling of Ion Channels
The reason I never incorporated azobenzene molecules into my research was the
requirement for covalent attachment to the ion channel. The design of the experiment
requires that the azobenzene, the donor, and the acceptor are covalently attached
to the ion channels. These three orthogonal labeling reactions would result in a
very low yield of fully labeled ion channels. This becomes a larger issue when
heterologous expression and purification of the ion channel is needed. The function
of the labeled ion channel needs to be verified, and I was never able to efficiently
and functionally (without any perturbation) reconstitute ion channels in vitro.
I propose to use Xenopus laevis oocytes as the expression system, as well as the
ultimate membrane environment with which the experiments are conducted [20].
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The oocyte system is known to robustly express ion channels, and standard electro-
physiological techniques can be used to monitor the function of the ion channels.
Mutations can bemade site-specifically to incorporate functional handleswithwhich
to label the ion channel. Every mutant permutation can be subjected to electrophys-
iology to confirm the presence of functional ion channel. Any shift in EC50 would
provide an easy readout of perturbation to the system. Oocytes also allow for more
"rapid" screening of different labeling sites; two-day incubation of injected oocytes
is a lot shorter than the week (or more) that it takes to purify and reconstitute ion
channels. The use of oocytes also allows for the extension of these studies to a larger
subset of ion channels.
An issue with this proposal is orthogonality in the labeling. The initial efforts could
focus on incorporating cysteine mutants at specific sites of interest. The background
ion channel cysteines would have to be mutated, and the Cys-free ion channel would
need to be fully functional. Cysteine labeling would not provide an orthogonal
method of labeling, but the use of LRET coupled with an azobenzene phototrigger
might not require completely orthogonal labeling. Ion channel activation will only
occur if the azobenzene phototrigger is labeled at the correct site [5]. The use
of LRET for monitoring conformational changes will only allow the ion channels
labeled with a donor and acceptor pair to be monitored [10]. The stimulated-
emission of the acceptor only occurs with the correct labeling. The direct acceptor
emission lifetime is much shorter than the stimulated emission. The temporal
difference in the acceptor emission allows for the identification of the correctly
labeled systems. The use of non-specific labeling of the ion channel with the
azobenzene phototrigger, donor, and acceptor would provide a means by which only
correctly labeled ion channel activation could be monitored.
The true advantage to using the oocyte system is leveraging the unnatural amino
acid (UAA) mutagenesis methods that have been developed in the Dougherty group
[21]. These methods allow for multiple orthogonal labeling sites to be incorpo-
rated. For example the use of azide-substituted aminoacids would provide a handle
for [3+2] cycloadditions conjugation reactions, and incorporation of many other
bioorthogonal handles could be achieved with similar methods [22]. Direct incor-
poration of the donor, acceptor, and/or azobenzene required for the experiments,
could also occur with UAA mutagenesis. The Dougherty group has demonstrated
successful incorporation of multiple fluorescent amino acids [23]. The azobenzene
phototrigger could be synthetically modified to be attached to an UAA, and placed
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very specifically within the protein framework near the ligand binding site. A com-
bination of UAAmutagenesis and traditional labeling strategies could be pursued to
optimize the conditions necessary for the experiments. The use of UAAmutagenesis
provides a highly orthogonal labeling strategy that could greatly increase the yield
of fully labeled ion channels.
6.5 The Final Experimental Design
The ion channel of interest (I recommend themuscle-type nAChR as a starting point)
would be expressed in oocytes. Site-directed mutagenesis near the ligand-binding
site can be used to label the azobenzene phototrigger [4, 5]. The azobenzene can
either be attached through bioconjugation chemistry (Cys-labeling, or "click," for
example), or incorporated directly as an UAA. The donor chelate ligand, and the
acceptor fluorophore can be incorporated by similar means. Terbium (or any other
lanthanide of choice) will then be added to solution to allow for formation of the
lanthanide-chelate donor complex. After complete labeling of the ion channel with
the azobenzene phototrigger, donor, and acceptor, the triply-labeled ion channel
function can be probed by electrophysiology. Any shift in the dose-response from
wild-type would indicate perturbation of the ion channel function. The locations
of the three labels could be moved accordingly to afford a minimally-perturbed
system. Photoactivation by the azobenzene should also be confirmed by irradiating
labeled oocytes and monitoring ion channel activation by electrophysiology. It
is crucial that activation only occurs under irradiation, and the thermal relaxation
(or phototriggered back isomerization) results in a closed ion channel. Cycling of
the photoactivation/photo-deactivation will determine the robustness of the sample.
For any mutant that is made it would be necessary to reconfirm the properties listed
above. After confirmation of functionally labeled ion channel is obtained the system
can then be used in the LRET measurements.
There will be some technical challenges associated with this project. The azoben-
zene isomerization needs to be triggered, and could be achieved using a pulsed laser
of the necessary wavelength. The lanthanide will also need to be excited. It would
be best if the lanthanide excitation wavelength is different from the azobenzene. The
timing of the lanthanide excitation with relation to the azobenzene photoisomeriza-
tion is critical. The photoisomerization will activate the ion channel and we want
to measure the conformational changes during activation. This requires that the
LRET measurements occur at various timepoints after ligand binding. Lanthanide
excitation before the azobenzene should provide measurements corresponding to
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the resting state. Likewise, excitation at time points seconds after azobenzene ir-
radiation will provide information about the open or desensitized states. Changing
the delay time between the azobenzene isomerization trigger, and the LRET trigger
will allow for the mapping of conformational changes during the entire activation
process. The direct fluorescence of the acceptor, and any auto-fluorescence from
the oocytes will need to be rejected. Previous LRET meaurements used electronic
gating to turn off the detector around the excitation pulse. The exact timing of the
gating will need to be optimized; the maximum amount of data with the lowest
non-specific fluorescence should be achieved. If photoisomerization to the resting
state is desired, a third light source will need to be used. This could be a LED
that can be shuttered independently of the lasers. The timing of the excitation and
collection systems is crucial, and I imagine will prove non-trivial.
6.6 Conclusion
After the laser system is built, and the ion channel is functional with three labels,
the experiments could proceed. The crystal structures provide a good starting
point for the geometric analysis of any distance changes that are observed. Initial
measurement on the resting and open (or desensitized) state would serve as a proof
of principle. I think that the most challenging parts of the experiments will be the
successful labeling of three sites with the correct molecules. UAA and oocytes will
help, but expression of anUAA can alter the function of the ion channel dramatically.
The lanthanide chelate and fluorescent acceptor could be chosen to accommodate
the necessary properties required. Rejection of any autofluorescence of the oocyte,
and the fluorescent acceptor emission will also be critical to gaining a clear picture
of gating. The long stimulated-emission of the acceptor should help with this. I
am still very interested in figuring out a way to monitor the conformational changes
associated with ion channel gating. If I were to start this project now I would
approach it in the above fashion. The exercise is left to the reader. Godspeed.
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A p p e n d i x A
MECHANISTIC STUDY OF QUINONE PHOTOREDUCTION
A.1 Introduction
I participated in a collaborative study with the Dougherty group investigating the
mechanism of a new photocage. A series of organic molecules that undergo pho-
todissociation of a protected amide or ester were synthesized. The compound of
interest consists of a 1,4-benzoquinone building block, with addition of a thioether,
and a trimethyl-lock (TML) moiety to the 1 and 5 positions (Figure A.1). Photore-
duction of quinones is known and can occur via intramolecular and intermolecular
reductive quenching [1, 2]. The TML is a well studied decaging strategy; the
nucelophilic phenol of the reduced quinone can react with the sterically crowded
TML [3–5]. Lactonization of the TML moiety occurs rapidly and results in the
release of the protected ester or amide. Lactone formation occurs more rapidly for
esters than amides [5]. The moieties necessary for intramolecular photoreduction
and TML lactonization were combined into a series of generic photolabile pro-
tecting groups (Figure A.1). Irradiation of the thioether-quinone-TML compound
(S-R PRTL) results in two-electron reduction of the quinone followed by lactoniza-
tion of the TML group. Lactone formation releases the protected ester or amide
molecule (Figure A.1) [6]. The system is synthetically modular; the substitution
on the thioether and the trimethyl-lock can afford many different variants of the
molecule. I have investigated a series of S-R PRTL compounds and examined the
transient absorption spectra, as well as the electrochemical and spectroelectrochem-
ical (SpecEChem) properties. I will discuss below the results of those experiments
and their implications towards the mechanism of photorelease. This compound is
designed as a generic photolabile protecting group for use in the treatment of trau-
matic brain injury (TBI). For use in TBI, near-infrared (NIR) irradiation is needed
for any significant light penetration of the skull to occur. Mechanistic understanding
of how these molecules undergo photodissociation provides insights allowing for
the synthetic modifications of the base building block to achieve a NIR photocage.
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Figure A.1: The general structure of the PRTL compounds contains a thioether attached to a 1,4-
benzoquinone, containing a TML group. Under irradiation in MeOH, lactone formation occurs
and releases the protected ester, EtOH in this example. The wavelength of light used to trigger the
photochemical reaction, and the efficiency of release, depend on the thioether substitution. Some
unusual PRTL derivatives are shown on the bottom. These were used to investigate the mechanism
by transient absorption spectroscopy and electrochemistry.
A.2 Methods and Materials
A.2.1 General Considerations
All of the PRTL compounds were obtained from D. Paul Walton in the Dougherty
group, and the synthetic route should be published shortly. These complexes were
stored in the dark, and samples were prepared fresh for each experiment. All of the
samples contained a protected ethanol on the ester of the TML group unless oth-
erwise noted. Analysis of the samples before and after experimentation confirmed
that laser photolysis resulted in the same photochemistry as bulk photolysis.
A.2.2 Laser Sample Preparation
S-R PRTL was dissolved in the indicated solvent, and the concentration was diluted
such that A355 < 0.4. The sample was placed in a four sided quartz cuvette (Starna
Cells) with a small stir bar. This cuvette was open to air for the oxygen-saturated
samples. Air-free samples underwent three freeze-pump-thaw cycles to remove any
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oxygen, and after the final thaw were backfilled with argon. A custom cuvette that
could connect to a Schlenk line, and be sealed using a high-vacuum Teflon valve
(Kontes), was used for samples void of oxygen.
A.2.3 Transient Absorption Spectroscopy
Excitation using the third harmonic from a Q-switched Nd:YAG laser (Spectra-
Physics, Quanta-Ray PRO Series) provided 355 nm pulses, 8 ns, at 10 Hz. For
single-wavelength transient absorption experiments, a 75 W Xe arc-lamp operated
in continuous or pulsed mode, was passed through the sample colinearly with the
excitation pulse. Probe wavelengths were selected using a double monochromator,
with appropriate short-pass and long-pass filters to remove stray light, as well as a
neutral density filter to regulate intensity. Light was detected by a photomultiplier
tube (HamamatsuR928), and amplified using a 200MHzwideband voltage amplifier
(FEMTO, DHPVA-200). Around 150 shots were collected for each wavelength, and
the data were log-compressed and then fit in MATLAB. For full-spectrum transient
absorption, data were collected using the same laser system, but using a nanosecond
flash lamp and diode detector as described elsewhere [7].
A.2.4 Electrochemistry
Electrochemical experiments were carried out under an inert atmosphere inside a
glovebox, using a Gamry Reference 600 potentiostat/galvanostat using a standard
three electrode configuration. In all experiments acetonitrile was used as the solvent,
and the supporting electrolyte was 0.1 M tetrabutlyammonium hexafluorophosphate
(Fluka, electrochemical grade). Typical cyclic votammetry experiments used a
basel-plane graphite working electrode, with a platinum wire counter electrode, and
a silver wire quasi-reference electrode. The quasi-reference electrode was immersed
in a 0.1 M solution of TBAPF6, and separated from the main solution using a vycor
frit. The ferricenium/ferrocene couple was used as an external reference. Typical
concentrations of compound used were 10−3 M.
A.2.5 UV-Visible Spectroelectrochemistry
Spectroelectrochemical measurements were carried out under similar conditions to
the electrochemical measurements. The sample was placed in a quartz cuvette, with
a 1 mm optical pathlength. The above three-electrode configuration was used with
a modification to the working electrode; a platinum-wire mesh working electrode
was used which provides optical transparency for UV-visible data collection. After
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equilibration with an applied potential in chronoamperommerty mode, spectra were
collected using an Ocean Optics USB2000+ spectrometer.
A.3 Results and Discussion
A.3.1 Transient Absorption Spectroscopy of PRTL Compounds
All of the PRTL compounds tested have similar absorbance features. There are
strong features in the UV region of the spectrum, and a weaker ( = 1000 M−1cm−1)
feature in the visible with a peak at 411 nm for the S-Me derivative, resulting in
a yellow colour. Irradiation at 410 nm and 365 nm (in bulk) results in lactone
formation (Figure A.1a, top), and formation of a colourless solution. Use of 355 nm
excitation in the laser experiments occurred for ease of experimentation.
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Figure A.2: (a) Full-spectrum transient absorption trace for S-Me in air-equilibrated acetonitrile.
The transient species has a peak at 480 nm, and decays to baseline by 1 µs. (b) The single-wavelength
kinetics traces from 405 nm to 575 nmwith 5 nm steps between wavelengths shows the same apparent
transient species. The inset shows the 480 nm trace fit to a single exponential yielding a lifetime of
238 ns.
Excitation of the SMe-PRTL compound induces a large increase in absorbance
from 410 nm to 580 nm, with a peak at 480 nm (Figure A.2). The species decayed
to baseline by 1 µs for an air-equilibrated solution, with a lifetime of 191 ns (in
MeOH). No other transient species were observed on longer timescales. No clear
solvent dependence on the transient lifetime of S-Me PRTL was observed; hexanes,
acetonitrile, and MeOH samples all decayed to baseline by 1 µs (Figure A.3a, solid
lines). Formation of only the lactone product occurs in MeOH, with irradiation in
MeCN and hexanes forming an intractable mixture of products. It is interesting that
there is no clear solvent dependency of the transient.
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Figure A.3: (a) The transient absorption decay at 480 nm of S-Me in MeOH (blue), Hexanes (green),
and MeCN (red) in air-equilibrated solvents (solid lines) and under an atmosphere of Ar (dotted
lines). The air-equilibrated lifetimes are independent of the solvent. Removal of oxygen results in
a solvent-dependent lifetime being observed. (b) The transient species (480 nm) in the presence of
oxygen has a derivative-independent lifetime.
The transient absorption spectra were also collected for a variety of S-R derivatives
(S-Bn, S-BuOH, S-cPrMe, S-iPr) in MeOH. A strong absorbance increase in the
visible centered at 480 nm was observed for all the derivatives. The transient
lifetimes for all of the samples are between 100 ns and 200 ns, in air-equilibrated
solutions (Figure A.3b). The bulk quantum yields for lactonization differ depending
on the derivative; the lactonization yield of S-Bn is five times larger than S-Me, with
all other derivatives falling in between. The observed transient lifetimes vary by a
factor of 2, while the quantum yield for photodissociation varies by 5 fold. This
suggests that the transient decay does not proceed to 100% product.
To examine the effect of oxygen on the system, the samples were degassed as
described above. A five-fold increase in lifetime of the transient decay (930 ns)
was observed in the absence of oxygen (Figure A.3a, blue lines). For the S-Me
PRTL solvent-dependent lifetimes were observed (Figure A.3a, dotted lines) in the
absence of oxygen (τMeCN = 2600 ns, τHexanes = 1400 ns,τMeOH = 930 ns). The
photochemistry only occurs in good yield in MeOH and the cause of the solvent
dependence is not obvious. Transient absorption studies on other PRTL derivatives
were only conducted in MeOH.
The transient lifetimes of various S-R derivatives (for an entire list see Table A.1)
were examined in the absence of oxygen and were found to vary depending on the
thioether substitutation. Transient lifetimes of the PRTL compounds increased in the
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absence of oxygen. The transient species observed in the air-equilibrated samples
likely decays due to oxygen quenching, as well as the other decay mechanisms.
The solubility of oxygen in methanol is ca. 10 mM [8]; if a diffusion controlled
reaction between the transient species and O2 is assumed (109 M−1s−1) a reaction
would be observed in ca. 100 ns. For oxygen to quench the transient species, the
decay pathways of the transient species must be slower than oxygen quenching rate.
The lifetime of S-Bn PRTL is roughly the same with and without the presence of
oxygen, suggesting that the transient decay pathways of S-Bn PRTL competes with
oxygen quenching. S-Bn PRTL is the most efficient compound for photoinduced
lactone formation, and correspondingly has the shortest lifetime. The S-cPrMe
PRTL compound contains a well known radical clock. The transient lifetime of the
S-cPrMe PRTL compound is the same as the analogous S-iPr PRTL compound.
Radical-induced rearrangement occurs more rapidly than the transient decay ("The
rates are in The Book, what page Dennis?" - OSS, "p479" - DAD). This suggests
that the transient observed decay does not proceed through a radical. The transient
lifetimes correlate well with the quantum yield for TML lactone formation, and
shorter lifetimes have higher quantum yields of lactonization, supporting the notion
that the transient is on path.
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S-R Solvent Atm Rate (sec−1) Lifetime (ns)
S-Ph MeOH FPT 1.79 x 107 56
S-Bn 6.99 x 106 143
S-Bn-pCl 5.38 x 106 186
TMTML 5.03 x 106 199
S-CH2-C(O)OMe 4.85 x 106 206
S-Me no TML 3.45 x 106 290
S-Me + 10mM TEA 2.70 x 106 370
S-iPr 1.84 x 106 543
S-cPrMe 1.84 x 106 544
S-CH2-CH2-TMS 1.80 x 106 555
S-Bn-pOMe 1.79 x 106 560
S-Bn-D2 1.73 x 106 577
S-CH2-CH2-tBu 1.61 x 106 620
S-neopentyl 1.58 x 106 633
S-C6F5 1.54 x 106 650
S-fluorenyl 1.47 x 106 680
S-Et 1.33 x 106 750
S-Me-Amide 1.30 x 106 770
S-Me 1.08 x 106 930
S-CD3 9.35 x 105 1070
S-CH2-CF2 9.17 x 105 1091
S-tBu ∅ ∅
S-CH2-TMS ∅ ∅
S-Me Hexane 7.1 x 105 1414
S-Me MeCN 3.8 x 105 2647
S-Bn MeOH Air 1.0 x 107 96
S-Me Hexane 6.9 x 106 146
S-cPrMe MeOH 6.0 x 106 166
S-iPr 5.4 x 106 186
S-Me 5.2 x 106 191
S-BuOH 4.9 x 106 202
S-Me MeCN 4.2 x 106 238
S-tBu MeCN ∅ ∅
Table A.1: Table of rates and lifetimes of the transient species observed at 480 nm. Not all of
the derivatives result in productive photochemistry. Experimental data fit to a single exponential
f (x) = A ∗ e−kt + C. All of the PRTL compounds were excited at 355 nm with a pulse energy of 5
mJ/pulse. If a value is missing from the table, the value is the same as the previous entries value.
To examine the quenching of the transient, a well established quencher, and electron
donor, triethylamine (TEA) was used [9]. The transient lifetime of the S-Me PRTL
complex was quenched in the presence of 10 mM TEA to ca. 300 ns in the absence
of oxygen (Figure A.4a). Experiments with TEA resulted in a transient spectrum
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with a peak blue-shifted to 460 nm. A long-lived species (ca. 500 ms) was also
observed (Figure A.4b). The quenching of the transient species with TEA supports
that the observed species is a triplet. Quenching by TEA likely occurs via an electron
transfer to the excited state quinone, analogous to species that have been studied
previously [1]. More investigation into the transient with TEA present is needed, the
full-spectrum of the transient should be obtained and compared with the spectrum
obtained via spectroelectrochemistry (vida infra).
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Figure A.4: The transient lifetime at 480 nm observed upon excitation of S-Me is quenched with the
addition of 10 mM TEA (blue line). The lifetime in the presence of TEA is 370 ns. The transient
feature observed at 480 nm does not return to zero by 10 µs in the presence of TEA. The prolonged
state is consistent with previous work on reductive quenching of duroquinone [1]. (b) The long-lived
transient does not decay to baseline after 500 ms.
The photoreduction, and lactonization, requires proton transfer to balance the reac-
tion. To examine the impact of proton transfer on the transient lifetime the deuterated
S-Me PRTL and S-Bn PRTL compounds were studied (Figure A.5). A 10% increase
in lifetime was observed for the S-Me PRTL complex (Figure A.5a); the S-Bn(D2)
PRTL complex displayed a four fold increase in lifetime (Figure A.5b). The quan-
tum yield for bulk lactonization for the deuterated SMe-PRTL and SBn-PRTL are
four fold and two fold lower, respectively. The differences in relative lifetime and
quantum yield measurements shows that the transient species (if on path) is not
100% decaying via proton transfer mechanism.
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Figure A.5: (a) The transient decay of S-Me (red line) and S-CD3 (blue line) at 480 nm in MeOH
under an atmosphere ofAr. The decay lifetime of the deuterated compound does not shift substantially
from the proteo-derivative. (b) The S-Bn (red line) and S-Bn(D2) 480 nm transient decay in MeOH.
There is a four fold increase in lifetime for the transient in the deuterated complex. An isotope effect
might have been expected to be observed if the transient decay pathway involves proton shift.
Two PRTL derivatives examined did not result in an observable transient species,
S-tBu PRTL and S-CH2TMS PRTL. The S-tBu PRTL cannot undergo lactone
formation by the same mechanism because no proton is available to shift. The lack
of transient with the S-tBu PRTL compound suggests that the transient that observed
occurs after the initial proton transfer. The S-tBu PRTL compound has a shifted
UV-visible absorbance spectrum, and is also predicted to have a distorted geometry
compared with the other derivatives. For these reasons it might not be the best direct
comparison.
Derivatives that provided PRTL core variations (Figure A.1, bottom) were also
examined. Substitution of the protected ester for an amide resulted in a similar
transient species. The lactone formation of the S-Me amide compound is much
slower than the analogous ester [5]. The reduced S-Me amide lactonization has
been observed byNMR, indicating that the lactone formation happens on a very slow
timescale. The observed transient lifetime is 770 ns, suggesting that the transient
decay is not due to lactone formation. S-Me PRTLwithout the TML (S-Me no TML)
moiety was also studied. This compound has a lifetime of 290 ns, significantly
shorter than the parent S-Me PRTL compound. Removing the thioether moiety
produced a trimethyl-TML (TMTML) compound that had an observed lifetime of
200 ns. The TML appendage is sterically bulky and removing the TML might
create a different chromophore. Likewise, without the thioether, intramolecular ET
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is unlikely to occur. It would be good to collect the transient full-spectrum of these
compounds to confirm that the transient species is the same as the S-Me PRTL
derivative.
A.3.2 Electrochemistry and Spectroelectrochemistry of PRTL Compounds
Chemical reduction of the PRTL compounds results in lacotonization so the electro-
chemical andUV-visible spectroelectrochemical properties of the PRTL compounds
were also examined. The electrochemistry of the following PRTL derivatives were
investigated: S-Me, S-tBu, S-cPrMe, S-Me amide, and S-Me no TML (Figure A.6).
In all cases two reductive peaks are observed. The first occurs around -1.0 V vs.
Fc+/Fc, and is a quasi-reversible one-electron reduction (Figure A.6a, red line). At
-1.8V vs. Fc+/Fc a second reductive peak is observed. This peak is not reversible,
and scanning past this peak results in a chemical reaction (Figure A.6a, black line).
The first reduction becomes less reversible, and an oxidative feature is observed at
-0.1 V vs. Fc+/Fc (Figure A.6c). This oxidation peak is only present after scanning
past the second reduction, indicative of electrochemical-chemical-electrochemical
behaviour. Lactone formation requires two-electron reduction. It is then likely that
after the second reduction lactone formation occurs. The observed oxidative peak
could be due to the newly formed lactone compound.
To investigate if the oxidative feature is due to lactone formation, the amide-protected
S-Me PRTL compound was investigated (Figure A.6b). Cyclic voltammatry of
the amide compound shows the same reversible first reduction, with the second
reduction becoming more reversible. Notably, no oxidation is observed, consistent
with lactone formation occurringmuch slower in the amide derivatives. The S-Meno
TML compound was also investigated; this compound cannot form a lactone under
reduction. Reversible reductions occur at the same potentials as observed in the
other derivatives, and no oxidation is observed. The reversible nature of the second
reduction event, and no observed oxidation, in the PRTL derivatives that do not form
lactones suggests the oxidation at -0.1 V is likely due to the lactone product. The
PRTL compounds display electrochemistry consistent with the observed chemical
and photochemical reduction requiring two electrons to undergo lactone formation.
The UV-visible spectroelectrochemistry of the PRTL compounds was also inves-
tigated (Figure A.7). The SpecEChem measurements are able to provide the UV-
visible absorption spectrum under a defined potential. This allows for the UV-visible
spectrum to be obtained under one-electron and two-electron conditions. The one-
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Figure A.6: (a) The cyclic voltammetry of S-Me PRTL performed under an inert atmosphere in
MeCN with 0.1 M TBAPF6, at a scan rate of 100 mV/s. The first reduction is at ca. -1.0 V (red line)
and the second reduction is found at -1.8 V (black line). The first reduction is quasi-reversible and
scanning just to the first wave results in a clean return oxidation peak. The second reduction appears
irreversible. There are no oxidative features observed if scanned to positive potential initially (blue
line). The irreversible nature of the second reduction is consistent with lactone formation occuring
after two-electron reduction of the system. Lactone formation results in a new molecule that does
not have the same electrochemistry, resulting in the irreversible nature of the second reductive peak.
(b) The S-Me amide compound was investigated to examine the effect of lactone formation on the
second reduction feature. The amide derivative undergoes the same lactone formation but at a much
slower rate. The second reduction of the amide derivative is quasi-reversible suggesting that the
oxidation of the two-electron reduced species is able to occur before lactone formation. (c) The full
sweep of the remaining PRTL derivatives tested. The reductive peaks appear in relatively the same
place for all the derivatives. If the compound doubly-reduced, an oxidation peak is visible around
-0.1 V due to the lactone species. The electrochemistry of the S-Me no TML derivative shows a
reversible second reduction peak and no oxidation, much like the S-Me amide. This shows that the
oxidation is likely the occurring on the lactonized compound, an ECE mechanism.
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electron and two-electron reduced spectra are then used to determine if the transient
spectrum is of the reduced species.
154
300 350 400 450 500 550 6000
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
Wavelength (nm)
A
bs
or
ba
nc
e
S−Me
 
 
−1.65V
−1.20V
−0.50V
No Potential
(a)
300 350 400 450 500 550 6000
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
Wavelength (nm)
A
bs
or
ba
nc
e
S−cPrMe
 
 
−1.65V
−1.20V
−0.50V
No Potential
(b)
300 350 400 450 500 550 600
0
0.5
1
1.5
2
2.5
Wavelength (nm)
A
bs
or
ba
nc
e 
(O
D)
S−tBu
 
 
No Potential
−0.7485 V
−1.6485 V (40 sec)
−1.6485 V (120 sec)
−2.148 V (60 sec)
−2.148 V (140 sec)
(c)
300 350 400 450 500 550 6000
0.5
1
1.5
Wavelength (nm)
A
bs
or
ba
nc
e 
(O
D)
S−Me Amide
 
 
No Potential
−0.7485 V
−1.6485 V (40 sec)
−1.6485 V (150 sec)
−2.148 V (40 sec)
−2.148 V (150 sec)
−2.148 V (300 sec)
(d)
300 350 400 450 500 550 6000
0.2
0.4
0.6
0.8
1
Wavelength (nm)
A
bs
or
ba
nc
e
S−Me NoTML
 
 
No Potential
−0.5 V
−1.2 V
−1.8 V 60 sec
−1.8 V 100 sec
−1.8 V 300 sec
−1.8 V 600 sec
(e)
Figure A.7: UV-visible spectroelectrochemistry of a variety of PRTL derivatives performed under an
inert atmosphere, in MeCN with 0.1 M TBAPF6. Without polarization of the solution the spectrum
appears like the ground state spectrum (black line). Spectra were acquired after polarization of the
cell to the indicated voltage. For all samples there is no change in the spectrum upon polarization to -
0.5 V (green line), a value at which no reduction occurs (Figure A.6). Polarizationmore negative than
the first reduction peak results in a large visible band with a peak around 460 nm (red line). Prolonged
polarization at the one-electron reduced potential results in a change in the optical spectrum, likely
due to disproportionation. Polarization beyond the second reduction results in growth of a band
at 375 nm, followed by disappearance of the visible band over continued polarization. The optical
spectra observed under electrochemical reduction are different that what is observed in the transient
absorption experiments (Figure A.2). This suggests that the transient species is not a simple one- or
two-electron reduced PRTL compound.
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TheUV-visible spectra under no external polarization, and > -1.0Vpolarization look
the same (Figure A.7, black and green lines, respectively). This is consistent with
the electrochemistry observed. No polarization provides the ground state spectrum,
and polarization to a value less negative than the first reduction peak does not change
the spectrum because no reduction occurs. The spectra of all the PRTL derivatives
are similar upon one-electron reduction (Figure A.7, red line). A large increase in
the visible from 400 nm to 500 nm is observed; two clear peaks in the spectra, one
at 425 nm and the other at 460 nm, are seen. The one-electron reduced UV-visible
spectrum is independent of the substitutions on the PRTL compound suggesting
the spectrum observed is primarily of a reduced quinone. The similarity of S-Me
no TML further confirms this (Figure A.7e). The one-electron reduced spectra are
different from the spectra obtained in transient absorption studies. The transient
spectra have a red-shifted peak (480 nm), and absorption extends into the red.
Significant absorbance at 400 nm is observed in the singly-reduced species, whereas
little absorption by the transient species (Figure A.2) is observed in this region.
Prolonged polarization at the one-electron potential results in degradation of the
spectrum, which could be due to disproportionation of the molecule. Polarization
of the solution beyond the second reduction potential results in a new spectrum
(Figure A.7, blue line). There are not any prominent features in the visible region
for any of the compounds, which suggests that the transient spectra observed are
distinct from the two-electron reduced quinone. Two-electron reduction results
in lactone formation and an entirely different chemical species is then present in
solution. The spectrum of the two-electron reduced species should appear similar
to the photolysis product, though these experiments were never done. The starting
UV-visible spectrum is observed after polarization is stopped.
The S-Me no TML derivative cannot undergo lactone formation, and the UV-visible
spectrum of the one-electron reduced species is remarkably similar to the parent S-
Me PRTL. This suggests that single-electron reduction of the PRLT compounds is
quinone centered. The second reduction of theNo-TMLderivative displays a slightly
different spectrum, and is more persistent that any of the TML derivatives. Lactone
formation can occur with all the other derivatives, which will alter the spectrum.
This is not possible for the no-TML derivative. The spectroelectrochemistry of
the S-tBu PRTL is slightly different from the other derivatives. The S-tBu PRTL
compound cannot undergo photoreduction, but under the two-electron reducing
conditions that are present in electrochemistry lactone formation can occur. The
difference in the spectra likely reflects difference in geometry, and is represented
156
by the altered ground-state UV-visible spectrum. The similarity between all of
the PRTL derivative’s observed spectra suggests that the spectra are largely quinone
based. It also shows that the spectra obtained in the transient absorption experiments
correspond to different species.
A.4 Conclusions and Future Outlooks
A set of new photocages was developed in the Dougherty group by D. Paul Walton.
This system is verymodular, and in collaborationwith themembers of theDougherty
group, we set out to gainmechanistic understanding of the photorelease. I was able to
contribute by providing nanosecond transient absorption studies and electrochemical
studies. The results above outline the transient absorption and electrochemical
experiments performed on the a variety of PRTL compounds. The transient spectra
obtained were very similar for all of the derivatives examined, with a peak at 480
nm. The lifetime of the transient was 930 ns for the S-Me PRTL parent complex.
The lifetime of the transient was shorter in the presence of oxygen, and independent
of the derivative. The oxygen sensitivity suggests that triplet quenching occurs; the
transient lifetime is also quenched by the well established triplet quencher TEA. The
lifetime in the absence of oxygen correlates well with the quantum yield for bulk
photolysis product formation. Product formation is a result of lactonization; the
transient species observed does not decay via lactone formation because derivatives
that are much slower to form lactones decay at similar rates. It was also established
that the decay mechanism isn’t due to the formation of a radical. Experiments
with derivatives that undergo rearrangement upon radical formation decay at the
same rate as the analogous compounds. In combination with the other mechanistic
work done in the Dougherty group, it would appear that the transient is a triplet the
species, might be on path, and is not decaying through lactone formation.
The electrochemistry of the PRTL compounds was all similar regardless of the
derivative. A reversible one-electron reduction occurred around -1.0 V (vs Fc+/Fc),
with a second one-electron reduction occurring at < 1.8 V (vs Fc+/Fc). The second
reduction is irreversible, consistent with the known chemical reaction; two-electron
reduction of the PRLT compound results in lactone formation. No oxidation was
observed for any of the PRTL compounds. After two-electron reduction of the
PRLT compounds an oxidation peak became apparent (ca. -0.1 V (vs Fc+/Fc)).
The oxidation is only present if the solution had been polarized at potentials more
negative than the second reduction peak, suggesting oxidation of a different chemical
species is occurring. Lactone formation occurs after two-electron reduction and is
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likely the species being oxidized. Study of a PRTL compound that undergoes
slow (S-Me amide PRTL), or no (S-Me no TML), lactone formation resulted in a
reversible second reduction peak, and no oxidation event.
The spectroelectrochemistry of the derivatives looks similar. The singly-reduced
species exhibited a visible absorbance from 400 nm to 500 nm; the second reduction
resulted in formation of a broad shoulder in the visible. Prolonged polarization at any
reducing potential likely resulted in disproportionation of the species. The steady-
state spectra are not similar to the transient spectra, suggesting that the transient
species that is observed is not the purely one- or two-electron reduced quinone.
Clint Regan has shown that the photochemistry can be sensitized by thioxanthone
in bulk and it might be useful to reproduce these experiments using the transient
absorption system. It would be interesting to see if the same transient species is ob-
served in the sensitization experiments. Likewise, more extensive triplet quenching
experiments could be performed. Transient full-spectrum traces of the pared down
PRTL derivatives (Figure A.1, bottom) would also be useful. This will allow for
more accurate comparison of the various derivatives. Ultrafast transient absorption
experiments might provide some insight into the early photochemical events as well.
The experiments that I believe would be interesting are nanosecond-IR experiments.
The photolysis of the PRTL compounds converts a quinone to a hydroquinone. The
necessary controls need to be run first to determine if the starting material and prod-
uct need to have sufficient spectroscopic handles for TR-IR to be a viable experiment.
These experiments would consume large quantities of sample due to the irreversible
photochemistry that occurs so a flow-cell is needed. Regardless, I think that the IR
experiments would serve as a nice compliment to the time-resolved visible spectra
already obtained. Monitoring the reaction by time-resolved IR experiments might
further help us understand the mechanism, allowing us to design new compounds
with the desired properties.
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A p p e n d i x B
USE OF COBALT AS A PROTECTING GROUP FOR RELEASE
OF AMINES
B.1 Introduction
The aim of this work was to use Co3+-amine complexes as photocages for the release
of propylamine to activate ELIC. Reduction of Co3+will formCo2+, and rapid ligand
exchange will occur. Co2+ complexes are substitutionally labile, whereas Co3+
are substitutionally inert. This ligand exchange releases any amine ligands, and
forms Co(H2O)62+. The release of amines occurs rapidly upon reduction of Co3+
complexes; release of 6 NH3 ligands occurs by 700 µs [1, 2]. Release of cheleated
amines such as ethylenediamine is slower, but still occurs. Photochemical reduction
of the Co3+ center was done by intramolecular reduction from an oxalate ligand
[3]. Irradiation of an oxalato-cobalt3+ complex undergoes intramolecular reduction
with irradiation into the ligand-to-metal charge transfer (LMCT) band. This resuts
in the formation of a Co2+ center, and release of CO2 as well as CO2 radical [3].
The radical is then able to reduce another Co3+ molecule in solution. Theoretically,
with one photon, up to eight ligands can be released from an oxalato-tetra(amine)-
Co3+ complex. We sought to use oxalato-tetrakis(n-propylamino)cobalt3+ (Co-
propylamine) as a photocage for the release of propylamine for the activation of
ELIC.
B.2 Methods and Materials
B.2.1 General Considerations
All the chemicals were purchased from Sigma-Aldrich. Procedures for synthesis of
cobalt compounds are have been previously published and were adapted with mini-
malmodification [4–6]. The synthesis of oxalato-tetrakis(n-propylamino)cobalt(III)
occurred by dissolving Co(NH3)4(C2O4) in neat propylamine and stirring for 5 days
[7]. The solution was filtered to remove any excess starting material, and the filtrate
was purple. The solvent was then removed with a rotovap, and a purple solid was
obtained and dried in vaccuo. This solid was used without further purification.
The NMR and UV-visible spectra suggested that the compound was made; crystal
growth did not yield crystals amenable to XRD studies. ELIC was expressed, and
electrophysiology was performed, as above (Chapter 3). A 365 nm LED (Thorlabs,
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M365L1) was used for irradiation of the Co-propylamine complex.
B.3 Results and Discussion
TheUV-visible spectrumofCo-propylamine has two clear peaks, one centered at 355
nm, and the second at 511 nm (Figure B.1a). The 1HNMRof the Co-complex shows
only the propylamine peaks, which are shifted from free propylamine resonances
(Figure B.1b). The down-field shift observed is likely due to the ligation of the
propylamine onto the cobalt metal. The amine protons are not visible in the NMR
due to proton exchange with the solvent. Irradiation of this complex in water with
365 nm light results in an increase in the pH of the solution. For some reason I
never irradiated an NMR sample to watch the release of propylamine. The only
issue with this is upon irradiation, formation of a Co2+ paramagnetic species occurs.
To confirm propylamine release, irradiation of the Co-propylamine complex in the
presence of an acyl chloride would result in the acyl chloride reacting with the
free propylamine. Isolation of the newly formed amide compound might provide
evidence for propylamine release. Regardless, this compound was then used for the
activation of ELIC.
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Figure B.1: (a) The UV-visible spectrum of Co-propylamine, with a peak at 355 nm and another peak
at 511 nm. This results in a nice purple colour. (b) The 1H NMR spectra of free propylamine and
Co-propylamine in D2O. The propylamine peaks are shifted down-field from the free propylamine
peaks.
Application of Co-propylamine to ELIC-expressing oocytes resulted in an imme-
diate increase in current observed indicative of activation of ELIC (Figure B.2a).
Activation of ELIC occurred before irradiation, suggesting that the Co-propylamine
is an agonist of ELIC, and not suitable for use as a photocage. To examine the agonist
behaviour of Co-propylamine further, a dose-response curve for the activation of
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ELIC by Co-propylamine was obtained (Figure B.2b). The effective concentration
of half-maximal activation (EC50 of ELIC obtained for Co-propylamine was 480
µM. This value is among themost potent agonists of ELIC [8]. It was surprising that
the Co-propylamine compound was an agonist of ELIC. In an effort to understand
the ELIC-Co interactions, crystals of ELIC were soaked with Co-propylamine. Un-
fortunately, these crystals did not diffract to a quality amenable for high-resolution
structural characterization. No activation should be observed in the dark and the
agonist behaviour of Co-propylamine eliminates the use of this compound as a
photocage of ELIC.
(a) (b)
Figure B.2: (a) Whole-cell voltage-clamp electrophysiology trace (see Figure 1.3 for background)
of ELIC-expressing oocytes with increasing concentrations of Co-propylamine. Application of
Co-propylamine results in the activation of ELIC, and demonstrates the agonist behaviour of Co-
propylamine towards ELIC. (b) The normalized current response of ELIC to various concentrations
of Co-propylamine. The data is fit to the hill equation, with an EC50 = 480 µM and a hill coefficient
of 3.5. ELIC is a very insensitive ligand-gated ion channel and Co-propylamine is among the most
potent agonists that have been reported [8]. The agonist behaviour that is observed suggests that
Co-propylamine is not a useful photocage because activation occurs prior to irradiation.
The efficacy of Co-propylamine was also examined. In these experiments, a maxi-
mum activation concentration of propylamine was applied to ELIC. The maximum
activation concentration of Co-propylamine was then applied to the same oocyte.
The current response of propylamine activation was then compared with the current
response of Co-propylamine activation. The current response for maximum activa-
tion of ELIC by Co-propylamine is ca. 25% of the current elicited from propylamine
activation, showing that Co-propylamine is a partial agonist of ELIC (Figure B.3).
One explanation for the observed agonist behaviour of Co-propylamine was that
exposure to adventitious light could trigger the photochemical reaction and release
propylamine into solution. The resulting free propylamine in solution would then
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be the true agonist in solution. This is unlikely because irradiation of a solution of
Co-propylamine (in vitro) with visible light does not result in an increase in the pH.
The solutions that were applied to ELIC were prepared fresh and kept in an opaque
plastic container that would absorb any UV photons present. Also the markedly
different EC50 value and the partial agonist activity suggests that Co-propylamine is
acting as a distinct agonist.
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Figure B.3: The application of a maximum-activation dose of Co-propylamine elicits a current
response (blue line) that is 25% of the maximum current observed using propylamine (red line) as
the agonist. Co-propylamine is a partial agonist of ELIC.
Irradiation of Co-propylamine should cause the release of (at least) four propylamine
molecules. Activation of ELIC might still be possible at low concentrations of Co-
propylamine because of the four-fold increase in propylamine concentration upon
irradiation. ELIC exposed to Co-propylamine was irradiated with 365 nm light
(Figure B.4a). Before irradiation ELIC was already activated (vida supra). Irradi-
ation of the Co-propylamine solution results in a decrease in the ELIC-activation
currents. The decrease of current suggests that the photoproduct of the reaction
interacts with ELIC in an inhibitory manner. The photoproducts of the reaction are
CO2, Co2+, and propylamine. Propylamine is known to activate ELIC, and CO2
was assumed to mind its own business. To investigate the effect of Co2+ on ELIC,
ELIC was activated by propylamine, and addition of Co2+ in solution resulted in a
decrease in current of ELIC (Figure B.4b, blue line). This is not surprising as ELIC
is blocked by divalent cations. Co2+ is about the same size as Zn2+ and it has been
shown that Zn2+ plugs the bottom of the pore of a related ion channel. The block
of ELIC by Co2+ eliminates the use of the Co-propylamine complex (and any other
Co3+ complex that will ultimately form Co2+) as a photocage for ELIC.
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(a) (b)
Figure B.4: (a) The application of Co-propylamine results in the activation of ELIC (vida supra).
Irradiation of Co-propylamine in the presence of activated ELIC results in a substantial decrease in
the ELIC signal. Co-propylamine is a partial agonist, and irradiation releases four equivalents of
propylamine suggesting that the current decrease observed under irradiation is due to some interaction
of the photoproduct with activated ELIC. (b) Application of Co2+ in solutionwith propylamine results
in significant attenuation of ELIC signals. The photoproduct in (a) is Co2+, which has now been
shown to inhibit ELIC signals. The inhibition observed eliminates the reduction of Co3+ for use as
protecting groups for the activation of ELIC.
B.4 Conclusions
The reduction of a substitutionally-inert Co3+-amine complexwill form a labile Co2+
species and eject the ligated amines. Attachment of propylamine to a Co3+ system
allowed for the caging of an ELIC agonist. The Co-propylamine complex was made,
under 365 nm irradiation appears to release propylamine. Co-propylamine was then
applied to ELIC and activation was observed; Co-propylamine was found to be a
partial agonist with ca. 25% efficacy, and have an EC50 of 480 µM. Irradiation of
the Co-propylamine solution in the presence of activated ELIC resulted in a decrease
in signal. Irradiation of Co-propylamine will release propylamine, but also Co2+.
Co2+ was found to inhibit activated ELIC alone. The activation of ELIC in the
dark by Co-propylamine and the inhibition by the photoproduct eliminate the use of
Co-propylamine as photocage for ELIC.
The reason that I am putting this work in the thesis is because I want to make sure
that people are aware of the hazards involved with Co protecting groups. Different
cobalt complexes were synthesized that contained chelating ELIC agonists. The
chelated Co3+ complexes were not agonists of ELIC. Other reductive mechanisms
were also implemented using Ru(bpy)32+ as an electron donor. This was all before
any of the other ruthenium work was conducted (Chapter 3), so the deleterious
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interactions between Ru and ELIC were not known. Regardless, any use of Co3+ as
a protecting group will ultimately form Co2+ that will then go and block ELIC, and
potentially other monovalent cation-selective ion channels. Activation of anion-
selective channels might be able to be accomplished using this strategy. Also
formation of a Co2+ complex that is not Co(H2O)62+ is another approach [1].
Using a high-affinity bulky ligand such as nitrilotriacetic acid (NTA) might result
in the formation of a Co2+-NTA complex that is unable to block the channel. The
Co3+-NTA complex would need to be reduced somehow. Attaching a Co3+ system
to a Ru(bpy)32+ complex has been used previously to achieve ligand substitution
of a Co3+ system in a biological setting [9]. It might be interesting to use this
dinuclear complex to activate ion channels. In all, one has to be careful anytime
hexaaquo-Co2+ is formed in solution with an ion channel, and it might not be a
generically applicable photocage.
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